Visualmed 2007 revolutionierend - 500 Beiträge pro Seite (Seite 7)

[Goetterdaemmerungen]

Ich habe es jetzt doch getan. Und das schreibt A.Gelston:

Please note that Visualmed Associates is not a daughter company of visualmed Solutions. It does,however,have the rights to market the visualmed clinical Information System.

[Fritz77]

Antwort auf Beitrag Nr.: 36.275.277 von Goetterdaemmerungen am 29.12.08 16:00:50

Hallo Götterdämmerungen

Ich glaube nicht so recht das die groß etwas sagen werden, mein Englisch ist so la la, für eine Anfrage dürfte es aber reichen und ich werde es die nächsten Tage mal versuchen, aber erwarte dir da nur nichts großartiges davon.

Ich denke das die Servicepflichten und eventuelle weitere Geschäfte in eine neue Firma verlagert haben damit die Ideen weiter überleben können, das ist aber nicht mehr als eine Vermutung und ich habe mich nicht weiter damit beschäftigt da das alles Zeit braucht und ich mir nur wenig erhoffe, auch bin ich natürlich nur ein einfacher Kleinanleger der sich selbst zu wenig selbständig erkundigte und daraufhin hier sein Geld verbrannt hat.
Momentan erwarte ich höchstens noch Schokolade aus der Schweiz von diesem Investment.
Wundere dich nicht über fehlende Resonanz hier, da haben schon einige hier ihr Lehrgeld bezahlt.

Gruß Fritz

[erch]

Mal sehen, wie viele Jahre der Titel sich noch über 1 Cent hält bzw. überhaupt gelistet wird.
Zum kotzen langweilig, dieses ewige Siechtum!

[Fritz77]

Antwort auf Beitrag Nr.: 36.286.193 von erch am 31.12.08 13:11:25

Hi erch
Ein alternatives schnelles Ende würde mir aber auch nicht gefallen, da bevorzuge ich das Siechtum.
Gruß und einen guten Rutsch
Fritz

[Goetterdaemmerungen]

Antwort auf Beitrag Nr.: 36.286.445 von Fritz77 am 31.12.08 14:14:25

Mir wäre lieber es passiert ein Wunder, schwubs die Visualmed website geht morgen wider auf mit zehn neuen Projekten.
Ich weiß, das ist ein schöner Traum.Euch allen auch einen guten Rutesch und ein gesundes neues Jahr.
Danke für deine Bemühungen in voraus Fritz.

[Fritz77]

Antwort auf Beitrag Nr.: 36.286.855 von Goetterdaemmerungen am 31.12.08 15:55:39

Hallo GD
Habe gerade eine kurze Anfrage rund um die Kernfrage die dich zu beschäftigen scheint verfaßt, mehr kann ich jetzt auch nicht machen.
Hier der Text der Frage und sollte ich eine Antwort erhalten werde ich sie natürlich posten.

Dear Mr Angelstone
As Austrian shareholders of VMCS my native language is German, why I hope you ignore formal defects of my inquiry.
All implantations listed on your homepage are former VMCS implantations.
The service and the further distribution is now as I understand it in the hand of VisualMedAssociates, so I would if possible like to know if VMCS as a company will also profit of possible further sellings and a positive development of the buisiness, or is the chance for a survival of VMCS already gone?
Yours faithfully
XXX

Gruß Fritz

[Fritz77]

Antwort auf Beitrag Nr.: 36.289.415 von Fritz77 am 01.01.09 22:42:26

Hi GD

Habe eine schnelle und nichtssagende Antwort erhalten.

Dear Sir -

I am sorry but I cannot be of very much assistance as I have not been
employed by VMCS since last May. Please address any inquiries to Mr. Dab, at
VisualMED Clinical Solutions Corp (VMCS), 1035 Ave. Laurier W., Montreal. I
cannot comment on the business prospects of VMCS.

Sincerely,

A. Gelston

Gruß Fritz

[meveric]

Hallo Investierte.

@ Fritz

Besten Dank für deinen Einsatz mit dem Mail an Visualmed. Wenigstens kam noch eine Antwort. Diese klingt jedoch wiklich so, als ob in den Chefetagen von Visualmed etwas stattgefundet hat. Also im negativen Sinn gemeint.

Nun zu den Dividenden ;-)

Ich habe meine Wette grausam verloren und werde noch meinen Wetteinsatz ausgleichen.

Schickt mir doch mal per PN eure Adressen. Natürlich nur die, welche auch bei der Wette mitgemacht haben. Wenn jemand Käse möchte, einfach noch sagen ob eher cremig, rezent, scharf, salzig, hart.


MFG

Meveric

[Fritz77]

Antwort auf Beitrag Nr.: 36.305.785 von meveric am 05.01.09 15:02:03

Hi meveric

Die Anfrage war eigentlich an VisualMedAssociates, die haben das Geschäft irgendwie in eine andere Firma verlagert, also nicht wirklich beglückend.
Der hat nicht mal eine Mailadresse von Dab angegeben, das klingt alles nicht nach dem großen Durchbruch.

An die Wette kann ich mich im Detail gar nicht mehr so genau erinnern, weshalb ich dir gerne deine Schuld mir gegenüber erlasse, der Kurs ist Strafe genug für uns, da will ich dich nicht auch noch um deine Käsevorräte erleichtern.
Habt ihr in der Schweiz eigentlich auch die Ricola Werbung mit "Wer hat' s erfunden"? Gefällt mir sehr gut.

Wie auch immer, Gruß in die Schweiz.
Fritz

[meveric]

Hallo Fritz

Wettschulden sind Ehrenschulden. Sicherlich schicke ich Euch den Käse und die Schokolade zu. Gib mir doch per PN die Adresse.

Hoffe die lassen diese Lieferung ohne Probleme die Grenze passieren ;-)

Ja die Ricola Werbung haben wir in der Schweiz auch. Wobei ich sagen muss. Ich habe eine Satellitenanlage montiert und schaue immer die Deutschen RTL, Pro Sieben etc. Weil mich das schweizer Programm nervt. Anstatt der Funky Kitchen Club mit "Schudel, René Schudel" schaue ich lieber die Simpsons ;-)

LG

meveric

[Fritz77]

Antwort auf Beitrag Nr.: 36.320.782 von meveric am 07.01.09 06:55:34

Hi meveric

Solange du keine weißen Pulverchen, oder so schickst wird es keine Probleme geben und ja für mich sind Wettschulden auch Ehrenschulden.
Für Simpsons bin ich nicht so leicht zu begeistern, sehe aber sowieso kaum fern, aber deutsches Fernsehen, wo es doch auch ein eigenes gibt, das kann ich nicht verstehen, die sprechen doch alle deutsch
Gruß Fritz
Schreibe dir noch eine BM

[meveric]

Hallo Fritz

Nein gibt keine Pülverchen. Gibt Käse und Schokolade

Also das Fernsehprogramm ist in der Schweiz ähnlich wie in Deutschland. Nur gibt es eben spezielle Sendungen, die bei Euch oder bei uns laufen. Am bestens sieht man es über Satellit, gibt für jedes deutschsprachige Land ein eigenes RTL und Pro Sieben und Sat 1.

http://www.prosieben.ch/lifestyle_magazine/funkykitchenclub/

Und da läuft z.B. eben dieser Funky Kitchen Club. Glaub mir, die Simpsons sind besser.

Aber auch bei der Werbung wird in jedem Land etwas anderes ausgestrahlt. Weil es ja nicht in jedem Land die selben Artikel gibt.

Wünsche einen schönen Tag.

Freundlicher Gruss

[Fritz77]

Antwort auf Beitrag Nr.: 36.329.178 von meveric am 08.01.09 08:18:04

Hi meveric

Nachdem ich deinen Link verfolgt habe glaube ich dir gerne, den Funky Koch würde auch ich nicht in mein Leben integrieren.

Dann noch viel Glück beim zappen, nur nicht vergessen die beste Sendung ist meist die, die man verpaßt.

Gruß Fritz

[hermitderkohle]

Falls es jemanden interessiert, nicht nur die Visualmed Website ist tot, auch der Tel. Amschluß ist nicht mehr in Betrieb. Würde mal sagen, die Firma existiert nur noch auf dem Papier und in diesem Forum!

Was bleibt, ist Käse.

Gruß

wegistdieKohle

[meveric]

an die, welche mir die Adresse gegeben haben.

Der Käse kommt. Weiss nur noch nicht ob der durch den Zoll geht!

[Goetterdaemmerungen]

Überall ist nichts zu holen.Visualmed ist wirklich revolutionierend

wenn nichts mehr geht dann pusht man halt Titel die eigentlich schon

tot sind. Aber wer ist sonst schon alles halb tot - General Motors,

Scheffler, Merklin . Naja Visualmed hat keine website mehr und so

wie ich gehört habe kann mann telefonich auch niemanden erreichen,

dafür finde ich ist der momentane Kurs einfach super. Also Freunde

wenn nichts mehr geht nimm visualmed.

[Depotmanager04]

Ist das ein scheiß Kursverlauf

sorry für diese harten Worte...

[meveric]

Also ich habe bei meinen Investments die ich im Jahr 2006 bis 2007 gemacht habe viel gelernt.

Nur noch in bodenständige Firmen investieren. Keinen Kack mehr aus dem Ausland glauben, nichts mehr kaufen welches bei der OTC Börse gehandelt wird. Und nur noch mit kleinem Einsatz Zocken.

Visualmed war wieder einmal so ein Beispiel für den scheiss Kapitalismus.

[Goetterdaemmerungen]

Hey visualmed hat zu mindest die homepage wider geöffnet. Doch noch nicht Mausetot? Oder ein Karnevalsscherz.
Egal ich freue mich ich habe zwar kein Geld mehr aber ich habe Sie auch noch nicht verkauft.

[Fritz77]

Antwort auf Beitrag Nr.: 36.634.110 von Goetterdaemmerungen am 23.02.09 15:12:09

Hi
Die Seite ist doch total hinüber, versuchst du die Telefonnummer zu wählen entstehen dir wahrscheinlich keine Kosten.
Gruß Fritz

[Goetterdaemmerungen]

Antwort auf Beitrag Nr.: 36.683.462 von Fritz77 am 02.03.09 18:24:00

Egal,besser wie Keine. Ein bißchen presens tut doch gut! Ende dieses

Jahres ist sie bestimmt komplett wider da.

War nur ein Scherz!

[ricky2009]

Antwort auf Beitrag Nr.: 36.684.330 von Goetterdaemmerungen am 02.03.09 19:57:27

Hallo Freunde, es dauert nicht bis ende Jahres! Dab hat mal wieder geantwortet an die Aktionaere. Es gelingt mir nicht diesen Brief zu kopieren. Der Brief wurde publiciert auf dem Yahoo-Board, unter VMCS-OB.

Sehr shockierend: schon 11 Krankenhauser und 4 Privat-Kliniken haben Visualmed-Systeme.

Ricky.

[ricky2009]

Antwort auf Beitrag Nr.: 36.769.447 von ricky2009 am 15.03.09 13:32:43

Es ist doch gelungen:


Dear Shareholders
We have been getting many letters from fellow
shareholders and I have written a fairly elaborate
answer to a group in the Netherlands that I will now
share with all of you.

Dear Hans

In response to your queries I will agree with you that
the time has come to reflect on the current status of
the company, take stock of the events of 2008 and
explain the major restructuring of our operations
carried out in the last 9 months so we could profit from
the superior technology we own.

We have continued to pare down cost, improve client
services, and have entered into a series of new
marketing and service partnerships with companies that
do focus on sales and customer service. VisualMED as the
sole owner of the suite of clinical modules will
continue to operate as a ‘fab lab’ that delivers
commercial applications and receives significant royalty
streams from its marketing partners.

A major achievement has been the continuing reduction of
our core operating costs to a level such that it will
now be much easier to achieve break even status. Most of
the year we have been operating with cash derived from
customer revenues. Consequently shareholders have not
been diluted and there have been no private placements
or share issues at these depressed prices.

We will be publishing our consolidated financial
statements and a press release to that effect before the
end of the month.

Meanwhile I can share with you some salient financial
data. Total expenses for the year stood at $4,810,924
with a net loss of $4,256,211 an improvement of almost
75% over last year’s losses. With record revenues of
$709,621 and deferred revenues of $600,435 we obviously
made real progress towards achieving break even from
operations. Total liability and stockholder deficit
stood at $167,488. Total shares outstanding on a fully
diluted basis stood at 67,million.Thanks to our
partners’ progress, the list of establishments having
signed up to use applications running on our technology
has now reached a critical mass of 11 hospitals and 4
private clinics all in North America.

An important milestone has been the completion of our
VisualONCOLOGY system implementation at the Segal Cancer
Center of McGill affiliate Sir Mortimer B. Davis Jewish
General Hospital in Montreal. Another milestone was the
deployment of the same in a private context at the
Ville-Marie Breast Center, also in Montreal, a private
facility specializing in women’s health, having tens of
thousands of patient files. The clinic has been able to
command better revenues and was recently featured on
Canadian television.

In order to maximize the potential of these major
technology achievements, we have entered into licensing
agreements for our oncology suite with a consortium led
by Greenwich Science Partners of Edmonton, Alberta, and
by Integrated Cancer Care Corp., a private Nevada
company. We will be working closely with this consortium
supporting their marketing drive in the United States
with technical and medical expertise. We will be
receiving a royalty stream ranging between 15% and 40%
on all sales made by Integrated Cancer Care.

Much of the improvement in our business remodeling is
based on the ability to share client support resources
with our many technology and distribution partners
across the broad scope of products currently offered in
the marketplace.

Our partner for Italy and Western Europe, VisualMED
Distribution Inc. continues to support and explore
opportunities there. VisualMED Distribution has also
been began to explore new market opportunities in Canada
and the United States as part of a strategy to increase
our distribution channel and increase brand visibility
and market presence.

Our Internet affiliate Medical.MD of Montreal has been
making progress in its core internet personal health
record business, having signed an agreement to provide
hundreds of thousands Personal Health Record to one of
America’s largest medical complexes. Delivery is
expected in the next quarter.

We have strengthened our partnership with Plexo Inc., a
leading Canadian provider of corporate and executive
health services. We have entered into an agreement with
Plexo for a joint cooperative effort to complete the
migration of the entire VisualMED Suites to a new
dot.Net platform. Together we are also strengthening new
general practice applications which have been delivered
to their three clinics. As part of the agreement Plexo
obtains distribution rights for the General Practice
market in Canada.

We are still cooperating with Cardinal Health and
continue to expand of network of resellers. Having a
greater number of independent marketing partners
increases the reach and scope of our distribution
channels. As the mix of products running on our
technology evolves and grows we believe that we will be
better able to benefit from some of the changes in
public policy which may result from the current
financial crisis.

There is some 19 billion specifically earmarked for
healthcare IT in the stimulus package passed by congress
that will be spent to help hospitals and clinics
purchase clinical automation systems that actually help
patients. Systems that cannot demonstrate direct patient
benefits will be excluded from this program. This is
great news for our company as most of you understand.
The amounts per doctor of more than $40,000 per doctor
over four years easily covers the cost of acquisition of
our systems and make it a profitable proposition for
companies like ours. See news at
http://www.healthcareitnews.com/news/obama-calls-healthcare-…


Let me conclude by stating that we have turned our back
resolutely on the way we had done business in the past
and have radically changed the focus of the company.
Where once we were a proprietary medical information
company run by doctors for doctors, we have now reverted
to a more traditional software model where we license
our technology to the greatest number of resellers. We
are now targeting those administrators and managers who
are the final decision makers.

I look forward to any questions on the part of our
investors, and to any discussions regarding the
direction and future of VisualMED.

Hoping 2009 will prove to be a positive year in the
development of our business together, I remain,

Yours Sincerely,


Gerard Dab
Chairman and CEO
VisualMED Clinical Solutions Corp
1035 Laurier West, 2nd Floor
Montreal, Quebec H2V 2L1
Tel. [phone]
Fax. [phone]
Cell. 514.582.5220

[Fritz77]

Antwort auf Beitrag Nr.: 36.769.926 von ricky2009 am 15.03.09 16:28:52

Hi ricky

Von wann ist der Brief?
Immerhin eine Erwähnung der Finanzkrise, also kann er nicht so alt sein.
Alle die noch drinnen sind haben Geduld bewiesen, ist zumindest die beste Nachricht seit langem, ich habe ja meine Anteile schon abgeschrieben, mal schauen ob es doch noch was wird, wenn nicht kann es mich auch nicht schocken.

Gruß Fritz

[ricky2009]

Antwort auf Beitrag Nr.: 36.770.966 von Fritz77 am 15.03.09 21:40:11

Hi Fritz,

Der Brief wurde vor etwa eine Woche geschrieben. Bin gespannd ob die finanzielle Daten vor dem ersten April publiziert werden!

Ricky.

[ricky2009]

Antwort auf Beitrag Nr.: 36.771.108 von ricky2009 am 15.03.09 22:25:25

Gutemorgen Fritz,

Wass glaubst du: wird der Aktienkurs anstiegen? Ich habe letzter Zeit noch etwa 150.000 (OTC) extra angekauft. Bin fest ueberzeugt, dass die alten Zeiten (kurs > $1,00) wieder zuruck kommen. Und das dauert nicht lange!!!

Ricky.

[Fritz77]

Antwort auf Beitrag Nr.: 36.772.018 von ricky2009 am 16.03.09 09:19:03

Hi ricky

Da hast du eine ganz nette Sammlung.
Ich traue mich hier nicht groß sagen wie es kommen wird, da ist mir das alles zu undurchsichtig, aber wie man sieht wurden die Kosten sehr stark gekürzt und man kämpft ums überleben.
Sollten die Vermarkter das Produkt besser an den Mann bringen kann es gut sein das der Totgeglaubte noch lebt und sich wieder erhebt.
Ich wünsche dir auf jeden Fall alles Gute und auch ich habe ein paar Stücke, wenn auch sehr viel weniger gesammelt.
Ich würde nur nicht auf die zu schnelle Erholung hoffen, auch wenn das politische Klima sich in den USA keinesfalls zum Nachteil der Software gewandelt hat, wird sicher auch die Konkurrenz nicht geschlafen haben.
Ich habe die Geduld einige Jahre zu warten um dann nachzuschauen ob es gelaufen ist.
Sollte das Geschäft auf eine der vielen möglichen Weisen anrennen werden wir uns sicher beide freuen.

Gruß Fritz

[Goetterdaemmerungen]

Wenn an der Nachricht nur ein bißchen wahr ist dann glaube ich auch

an ein come back. Was haben wir denn zu verlieren bei dem momentanen

Kurs. Eigentlich gar nichts. Also viel Glück euch allen !!!!!

[Fritz77]

Antwort auf Beitrag Nr.: 36.777.943 von Goetterdaemmerungen am 16.03.09 20:13:51

Hallo GD

Wir haben nicht mehr viel zu verlieren, nur müßt du die Käufer erst finden die den Kurs wieder hochkaufen und davon das es brummt ist der Laden noch meilenweit entfernt, aber noch lebt VM und damit habe ich ehrlich gesagt nicht gerechnet.

Gruß Fritz

[Depotmanager04]

Hallo, tja noch lebt er; das stimmt. Allerdings wurde der Laden damals unwahrscheinlich hochgepusht. Es entsprach nicht im geringsten der Realität, was man da vorhergesagt hatte. Auch ich bin darauf herrein gefallen. Ob wir jemals diese Höhen wieder erreichen oder sogar übersteigen, bezweifle ich sehr stark. Natürlich wäre es sehr schön für uns, wenn diese alten Höhen erreicht würden. Dann aber bitte ohne einen Pusher. Ich glaube auch nicht dass bei Visualmed nocheinmal einer einsteigt. Weiterhin frage ich mich allen Ernstes, wie Visualmed noch bestehen kann. Euer Depot..

[erch]

Ich habe das Gefühl, dass durch die neuen Verträge mit Distributoren etc. schon jetzt ein eventueller späterer Gewinn stark beeinträchtigt ist; der würde zum Großteil gar nicht mehr bei VMCS anfallen. Wenn ich mich irre, verzeiht, aber so habe ich das mit den Kooperationen verstanden.
Wundere mich auch, dass die Firma noch läuft.
Schließe mich Fritz und Depotmanager an. Wir waren dumm. Hoffentlich WAREN wir dumm ...

[meveric]

Schickt mit bitte den Käse zurück Fritz und Erch

Nein im Ernst. Ich kann es nicht fassen was ich hier lese. Ich habe keine Ahnung was ich dasvon halten sollt. Entwerder braucht Herr Dab wieder Geld und will die Aktie nochmals puschen, oder da ist wirklich noch etwas am laufen.

Auf jedenfall ist der Internetauftritt und die ganze Geschichte mehr als unprofessionell. Das eine Firma so noch leben kann grenzt an ein Wunder. Was mich noch mehr stört ist die Tatsache, dass die erwähnten Krankenhäuser bereits vor zwei Jahren erwähnt wurden. Die Einnahmen sehen immer noch gleich aus und die Ausgaben haben sich nur minim nach unten korrigiert.
(habe noch keine Zahlen gesehen, nur aus dem Brief interpretiert)

Was meint Ihr? Nochmals eine Wette bis Ende 2009?

gruz Meveric

[Goetterdaemmerungen]

Keine Wette wagen nur investiert bleiben. Schauen wir mal was
passiert.

[meveric]

Es ist schwierig nach so einer NEWS-losen Zeit vertrauen in so eine Firma zu stecken. Vor allem noch mehr Geld!


Mr. Gerard Dab
Co-Founder, Chairman, Chief Executive Officer...
Age: 60
Total Annual Compensation: $176.3K


Mr. Barry Scharf
Chief Operating Officer, Vice President of Cl...
Age: 63
Total Annual Compensation: $176.3K

Ist das der Jahreslohn? Finde ich ein wenig hoch, würde ich ein wenig hoch finden, wenn der Laden so schlecht läuft.

Und was ist mit der Webseite?
http://www.wallstreet-online.de/diskussion/1076602-3021-3030…

Da gibts ja auch keine NEWS oder Infos.

[hermitderkohle]

Fritz und Erch haben Käse bekommen??

[meveric]

@HMDK

Ich erinnere Dich an das Posting vom 05.01.2009


Hallo Investierte.

@ Fritz

Besten Dank für deinen Einsatz mit dem Mail an Visualmed. Wenigstens kam noch eine Antwort. Diese klingt jedoch wiklich so, als ob in den Chefetagen von Visualmed etwas stattgefundet hat. Also im negativen Sinn gemeint.

Nun zu den Dividenden ;-)

Ich habe meine Wette grausam verloren und werde noch meinen Wetteinsatz ausgleichen.

Schickt mir doch mal per PN eure Adressen. Natürlich nur die, welche auch bei der Wette mitgemacht haben. Wenn jemand Käse möchte, einfach noch sagen ob eher cremig, rezent, scharf, salzig, hart.


MFG

Meveric

Bekommst natürlich auch Käse wenn Du mir die Adresse zukommen lässt.

[erch]

Meverics Käse war spitze - ganz im Gegensatz zu dem Käse, den wir von Dab zu lesen kriegen.

[Fritz77]

Antwort auf Beitrag Nr.: 36.862.061 von erch am 27.03.09 10:26:21

Hi erch

Meverics Käse war ein Gedicht und eine Gaumenfreude, bei so ziemlich allem was mit Dab zu tun hat wird eher die Galle angesprochen.

Gruß Fritz

[meveric]

Freut mich, dass er Euch geschmeckt hat.

Es fällt mir schwer, dem Geschwätz von DAB etwas zu glauben.

[Fritz77]

Antwort auf Beitrag Nr.: 36.878.421 von meveric am 30.03.09 11:59:57

Hi Meveric

Große Hoffnungen mache ich mir da sicher nicht, sollten die aber da wir schon beim Käse sein wie guter Käse im Laufe der Zeit reifen wir es wohl keinen hier stören und wenn die wie ich eher erwarte wie schlecht gelagerter Käse verfaulen habe ich immerhin damit gerechnet.
Bei mir sind sämtliche Emotionen aus dieser Aktie raus.
Was der Dab sagt glaube ich von vornherein nicht nur es ist zumindest nicht unmöglich das er mal recht hat, mehr kann ich da gar nicht dazu sagen.
Immerhin sie lebt noch und wir haben ein wenig Stoff zum Tratschen.
Gruß Fritz

[meveric]

Wurden uns nicht noch einige NEWS versprochen??

Wieder nur heisse Luft oder weiss jemand etwas neues?

Wünsche schöne Ostern.

Freundlicher Gruss

[hermitderkohle]

Das war wohl nur wieder heiße Luft. Aber wer weiß, vielleicht macht Visualmed in nächster Zukunft mal wieder ganz was anderes, und dann wird wieder gepusht was das Zeug hält!

[2008]

Alert wo bist du ????????????

[Goetterdaemmerungen]

Nur geduld. Ich glaube da kommt in den nächsten Tagen was. Fragt sich nur ob es auch was gutes ist.
Wenn Fiat sich für Opel interessieren darf dann ist für visualmed auch noch alles drin!!!!

[meveric]

Was sollte denn kommen?

[Depotmanager04]

Antwort auf Beitrag Nr.: 37.117.296 von meveric am 07.05.09 11:43:58

bestimmt heiße Luft aus einem Versuch....

[binda]

May 14, 2009 14:16 ETVisualMED Clinical Solutions announces distribution deal with China IT provider
Successful reform of operating model translates into revenue
Highlighted Links


VisualMED Clincal Solutions


MacReport Media PublishingMONTREAL--(Marketwire - May 14, 2009) - VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6.F) announces that it has entered into a preliminary agreement to integrate its flagship clinical software into a multi-site regional solution for the Chinese market. The Chinese partner will handle all marketing and technicals while VisualMED will continue to provide medical contents and academic validation.

Another major development has been the passing of the American Recovery and Reinvestment Act, the Obama Administration stimulus package passed by Congress. Provisions for the automation of healthcare are estimated to be as much as $170 billion. Included is a measure that will pay up to $50,000 per physician for healthcare information technology purchases.

"The VisualMED solution can be comfortably sold for this type of budget with good margins," says Chairman Gerard Dab. "The China deal is in keeping with our new policy of licensing our rich technology portfolio to market operators that already have existing clients and established sales networks."

After the successful restructuring of the company's operation in 2008, we have continued to reduce cost and have made it easier for the company to reach financial equilibrium. The 2009 estimated operating run rate will be approximately $900,000, down from last year's $4,810,924. Although it may be premature to predict profitability, our last year's revenues of $709,621 and deferred revenues of $600,435, indicate real progress towards achieving break even from operations.

Most of the year we have been operating with cash derived from customer revenues. Consequently, shareholders have not been diluted and there have been no sales of shares at our current depressed prices.

As a result of the numerous marketing and service partnerships we have entered into over the past 9 months with companies that focus on sales and customer service, the number of healthcare facilities signed up to use applications running on our technology has now reached a critical mass of 11 hospitals and 3 private clinics, all in North America.

We have continued to improve client services, and as the sole owner of the suite of clinical modules, we will continue to operate as a 'fab lab' that delivers commercial applications and receives significant royalty streams from marketing partners.

An important milestone has been the successful completion of our oncology system implementation at the Segal Cancer Center, a unit of McGill affiliate Sir Mortimer B. Davis Jewish General Hospital in Montreal. Another milestone was the deployment of the same system in a private context at the Ville-Marie Breast Center, a leading Canadian private facility specialized in women's health, with tens of thousands of patient files.

Taking advantage of these breakthrough installations, we have entered into a number of new licensing agreements. One of these involves licensing our complete oncology suite with a consortium led by Greenwich Science Partners of Edmonton, Alberta. We will be working closely with this consortium supporting their marketing drive in the US with technical and medical expertise. The agreement calls for royalties ranging from 15% to 30% of sales.

Much of the improvement in our business remodeling is based on the ability to share client support resources with our many technology and distribution partners across the broad scope of products currently offered in the marketplace.

Our Internet affiliate Medical.MD of Montreal has been making progress in its core internet personal health record business, having signed an agreement to provide hundreds of thousands Personal Health Record to some of America's largest medical complexes.

Our partner for Italy and Western Europe, VisualMED Distribution Inc. continues to support and explore opportunities there. VisualMED Distribution has also been began to explore new market opportunities in Canada and the United States as part of a strategy to increase our distribution channel and increase brand visibility and market presence.

We have strengthened our partnership with Plexo Inc., a leading Canadian provider of corporate and executive health services. We have entered into an agreement with Plexo for a joint cooperative effort to complete the migration of the entire VisualMED Suites to a new .Net platform. Together we are also strengthening new general practice applications that are being delivered to their many clinics.

We are still cooperating with Cardinal Health, part of our move to increase the reach and scope of our distribution channels. As the mix of products running on our technology evolves and grows, we believe that we will be better able to benefit from some of the changes in public policy resulting from the current financial crisis.

The focus of the company has radically changed. Where once we were a proprietary medical information company run by doctors for doctors, management has now reverted to a more traditional software model where we license our technology to the greatest number of resellers. "The Board and I remain strongly committed to exploiting our proprietary technology for the benefit of our shareholders. We were prematurely ahead of the curve, but the world is coming around to what we have to offer," concludes Gerard Dab.

The past 9 months reflect the positive benefit of shifting cost to our distributors, and of a widening marketing and distribution network. We remain well positioned to immediately benefit from a clear culture change in healthcare management and information technology purchasing, and from the changes in public policy.

ABOUT VISUALMED

VisualMED Clinical Solutions Corp. markets and distributes proprietary clinical management solutions that help hospitals and healthcare authorities reduce medication errors, increase personnel efficiency and bring down operating costs.

One of its key decision support components is a core solution in the new agenda to promote greater patient safety and reduce risks due to medication errors.

Detailed information on our company and its products is available on our web site at www.visualmedsolutions.com.

FORWARD-LOOKING STATEMENTS

Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.

Contact:

Gerard Dab
CEO
VisualMED Clinical Solutions Corp.
Tel: [phone]

http://www.finanznachrichten.de/ext/goto.asp?id=13915312

Die Auferstehung

[binda]

habe es mal von google übersetzen lassen
Liest sich ziemlich blöd...naja...

Übersetzung: Englisch » Deutsch

... gibt bekannt, dass sie in eine vorläufige Vereinbarung über die Integration ihrer klinischen Flaggschiff-Software in eine Multi-Site-regionale Lösung für den chinesischen Markt. Der chinesische Partner wird alle Marketing-und Technik, während VisualMED wird die medizinischen Inhalte und die akademische Anerkennung.

Eine weitere wichtige Entwicklung war die Verabschiedung des amerikanischen Recovery und Wiederanlage, das Paket zur Stimulierung der Obama-Administration vom Kongress. Rückstellungen für die Automatisierung der Gesundheitsversorgung sind Schätzungen zufolge bis zu $ 170 Milliarden. Inbegriffen ist eine Maßnahme, die bis zu 50.000 US-Dollar pro Arzt für medizinische Informationstechnologie Einkäufe.

"Die VisualMED-Lösung lassen sich bequem die für diese Art von Budget mit guten Margen", sagt Vorsitzender Gerard Dab. "Die China wird sich im Einklang mit unserer neuen Politik der Lizenzvergabe unser reichhaltiges Technologie-Portfolio an die Marktteilnehmer, die bereits bestehenden Kunden und etablierte Vertriebsnetze."

Nach der erfolgreichen Umstrukturierung des Unternehmens in 2008 haben wir die Kosten zu senken und haben es leichter für das Unternehmen finanzielle Gleichgewicht zu erreichen. Die 2009 geschätzten operativen Rate von rund $ 900.000, gegenüber dem letzten $ 4810924. Obwohl es vielleicht zu früh, um vorherzusagen, Rentabilität, unsere im letzten Jahr die Einnahmen von $ 709.621 und latente Umsatz von $ 600.435, sind echte Fortschritte bei der Verwirklichung von Break-even-Operationen.

Die meiste Zeit des Jahres haben wir, die mit Geld aus Kunden aus. Folglich haben die Aktionäre nicht verwässert, und es wurden keine Verkäufe von Aktien an unserer aktuellen Preise gedrückt.

Als Folge der zahlreichen Marketing-und Service-Partnerschaften haben wir in den letzten 9 Monaten mit den Unternehmen, die sich auf Vertrieb und Kundenservice, die Zahl der Einrichtungen des Gesundheitswesens unterzeichnet, bis zu Anwendungen, die auf unserer Technologie hat inzwischen eine kritische Masse an 11 Krankenhäuser und 3 private Kliniken, die alle in Nordamerika.

Wir haben zur Verbesserung der Client Services, und als alleiniger Eigentümer der Sammlung von klinischen Module, werden wir auch weiterhin als "Fab Lab", das kommerzielle Anwendungen und erhält erhebliche Lizenzgebühren-Streams aus dem Marketing-Partner.

Ein wichtiger Meilenstein war der erfolgreiche Abschluss der Onkologie-System Umsetzung auf Segal Cancer Center, eine Einheit der McGill Affiliate Sir Mortimer B. Davis Jewish General Hospital in Montreal. Ein weiterer Meilenstein war die Einführung des gleichen Systems in einem privaten Rahmen auf der Ville-Marie Breast Center, einem der führenden kanadischen private Einrichtung spezialisiert auf die Gesundheit von Frauen, mit Zehntausenden von Patienten-Dateien.

Unter Verwendung dieser Durchbruch-Anlagen, haben wir in einer Reihe von neuen Lizenzverträgen. Einer von ihnen betrifft die Lizenzierung unsere Onkologie-Suite mit einem Konsortium unter Leitung von Greenwich Wissenschaft Partner von Edmonton, Alberta. Wir werden in enger Zusammenarbeit mit diesem Konsortium die Unterstützung ihrer Marketing-Offensive in den USA mit technischen und medizinischen Know-how. Die Vereinbarung fordert Lizenzgebühren von 15% bis 30% des Umsatzes.

Ein Großteil der Verbesserungen in unserem Geschäft Renovieren beruht auf der Fähigkeit, Client-Support-Ressourcen mit vielen Technologie-und Vertriebspartner in der gesamten Umfang der angebotenen Produkte, die derzeit auf dem Markt.

Unsere Internet-Partner Medical.MD von Montreal hat die Fortschritte in seinem Kerngeschäft Internet-Gesundheitsakte Unternehmen, die eine Vereinbarung unterzeichnet, um Hunderttausende Personal Health Record auf einige von Amerika die größte medizinische Komplexe.

Unser Partner in Italien und Westeuropa, VisualMED Distribution Inc. weiterhin zu unterstützen und welche Möglichkeiten gibt. VisualMED Vertrieb wurde auch begonnen, um neue Marktchancen in Kanada und den Vereinigten Staaten als Teil einer Strategie zur Steigerung der Vertriebsweg und die Marke Sichtbarkeit und Präsenz im Markt.

Wir haben unsere Partnerschaft mit Plexo Inc., ein führender kanadischer Anbieter von Corporate und Executive Gesundheitswesen. Wir sind in einer Vereinbarung mit Plexo für eine gemeinsame Kooperation, um die Migration der gesamten VisualMED Suiten zu einem neuen. NET-Plattform. Gemeinsam sind wir auch der Stärkung neuen Praxis-Anwendungen, die sich an die vielen Kliniken.

Wir sind immer noch die Zusammenarbeit mit Cardinal Health, Teil der Bewegung zur Erhöhung der Reichweite und Umfang unserer Vertriebskanäle. Da die Mischung von Produkten, die auf unsere Technologie entwickelt und wächst, glauben wir, dass wir besser in der Lage, Nutzen aus einigen der Veränderungen in der öffentlichen Politik, die aus der aktuellen Finanzkrise.

Der Schwerpunkt des Unternehmens hat sich seitdem radikal verändert. Wo einst waren wir eine eigene Firma medizinische Informationen, die von Ärzten für Ärzte, hat jetzt wieder zu einer traditionellen Software-Lizenz-Modell, wo wir unsere Technologie auf die größte Zahl von Wiederverkäufern. "Der Vorstand und ich nach wie vor stark entschlossen, unsere proprietäre Technologie zum Nutzen unserer Aktionäre. Wir waren zu früh vor der Kurve, aber die Welt kommt, um zu dem, was wir zu bieten haben", sagt Gerard Dab.

Die letzten 9 Monate den positiven Nutzen der Verlagerung der Kosten für unsere Händler, und eine Ausweitung der Marketing-und Vertriebsnetz. Wir sind nach wie vor gut positioniert, um sofort profitieren von einem klaren kulturellen Wandel im Gesundheitswesen und Informationstechnologie Einkauf, sowie aus den Veränderungen in der öffentlichen Politik.

ÜBER VISUALMED

VisualMED Clinical Solutions Corp Märkte und vertreibt proprietäre klinische Management-Lösungen, die helfen, Krankenhäusern und Behörden im Gesundheitswesen reduzieren Medikamente Fehler, Personal Erhöhung der Effizienz und Senkung der Betriebskosten.

Eine der wichtigsten Komponenten zur Unterstützung ist eine zentrale Lösung in die neue Agenda, um eine größere Patientensicherheit und Verringerung der Risiken durch Medikamente Fehler.

Detaillierte Informationen über unser Unternehmen und seine Produkte finden Sie auf unserer Website unter www.visualmedsolutions.com.

[meveric]

Was haltet Ihr von diesem Schreiben?

Kann das noch ernst genommen werden?? Also ich habe das Vertrauen irgendwie verloren. Die wollen entweder einfach nur wieder eingesammelte Aktien verticken oder sonst was krummes abziehen.

Auf der Webseite fand seit über einem Jahr keine Änderung statt. Keine NEWS etc. Jetzt kommt plötzlich wieder etwas? Also ich weiss nicht?!?

[Fritz77]

Antwort auf Beitrag Nr.: 37.182.577 von meveric am 15.05.09 11:21:11

Hi meveric

Jedes mal wenn ich von dir was lese denke ich an die köstlichen schweizer Käsesorten.
Immerhin ist noch Leben in der Firma und ich finde es sehr gut das man die Vermarktung ausgelagert hat nachdem die erkannt haben das es so nichts wird, wirklich erreicht scheinen die zwar noch nichts zu haben, aber immerhin die Chance lebt und so ist es mir lieber, als wenn wir die Nachricht vom Konkurs erhalten hätten.
So kann es vielleicht noch funktionieren.

Gruß Fritz

[meveric]

Hallo Fritz

Es geht mir gleich mit den Mozartkugeln. Welche übrigens nicht lange überlebt haben

Eine Lieferung bin ich noch schuldig. HmdK schuldig, leider bis jetzt nicht dazu gekommen. Die Wirtschaftskrise hat mich so hart getroffen, dass ich die letzten zwei Wochen gar nichts mehr zu Essen einkaufen konnte.

Jetzt sieht es natürlich wieder besser aus und ich kann den Käse doch noch versenden.

Ja die Hoffnung stirbt bekanntlich zuletzt. Schauen wir doch einmal was genau passiert. Aber die Webseite von VSM sieht nicht gerade informativ aus. Oder gibt es eine neue? Ist ja nur ein Bild ohne Links??

[Fritz77]

Antwort auf Beitrag Nr.: 37.183.633 von meveric am 15.05.09 12:57:52

Hi Meveric

Freut mich das die geschmeckt haben, den Steirerkäse wollen wir besser nicht weiter erwähnen.

Sofern das mit dem Vertrieb durch Marketingpartner funktioniert sehe ich die defekte Page mal als Kostenersparnis, obwohl schwach ist das natürlich schon, wo es doch jeder zweite Grundschüler für ein Taschengeld schaffen würde so eine Homepage zu erstellen.

Warten sind wir gewohnt, zu verlieren gibt es auch nicht mehr viel, da fällt es mir leicht mal zu sehen ob es doch noch was wird.

Gruß Fritz

[binda]

After the successful restructuring of the company's operation in 2008, we have continued to reduce cost and have made it easier for the company to reach financial equilibrium. The 2009 estimated operating run rate will be approximately $900,000, down from last year's $4,810,924. Although it may be premature to predict profitability, our last year's revenues of $709,621 and deferred revenues of $600,435, indicate real progress towards achieving break even from operations.

"Betriebsaufwendungen reduziert: von $4,810,924 auf ca. $900,000
Die Einnahmen im letzten Jahr von $709,621 und verschobene Einnahmen von $600,435 sind echte Fortschritte bei der Verwirklichung des Break-even im Betrieb."

Das wäre schön, nur glauben kann ich es noch nicht.

[meveric]

Also die 4.8 Mio stammen ja noch aus dem Verkauf der Aktien. Es ist kein Geld zum verbraten mehr da. Darum nur noch 900T

ja vom Steierkäse werde ich noch ein Bild posten. Muste letzte Woche lachen als ich die Kamera an den Computer gehängt habe.

[Fritz77]

Antwort auf Beitrag Nr.: 37.185.605 von binda am 15.05.09 16:01:32

Hi binda

Da hast du falsch übersetzt The 2009 estimated operating run rate will be approximately $900,000, down from last year's das bedeutet nicht auf 900,000 runter sondern um 900,000 runter.

Gruß Fritz

[Fritz77]

Antwort auf Beitrag Nr.: 37.185.708 von meveric am 15.05.09 16:10:20

Hi Meveric

Gerade heute habe ich im Ennstal lecker Steirerkaskrapfen gegessen.

Gruß Fritz

[meveric]

Potz

Eigentlich sollte ich jetzt verkaufen!!!

0,046 +109,09%
+0,024
13:27 30.000
0,030 0,060
30.000 13.90

[binda]

Antwort auf Beitrag Nr.: 37.218.318 von meveric am 20.05.09 13:54:10

jetzt schon 0,06

[ricky2009]

Antwort auf Beitrag Nr.: 37.218.318 von meveric am 20.05.09 13:54:10

Well Meveric,

If I were you, I wouldn't sell. Finally this turd has come to life, probably due to the company-update from a week ago. Wait untill the yearly figures 2008 are out. Should have been published a year ago, so I can wait some time longer.

Now that they have restructured and making steps toward a break-even situation, the stockprice should move back upwards. Break-down value of this company is some $35 million, lets say between $0,50 and $1,00. If the market picks up from here (Obama is quite a stimulus) the stockprice will move further up.

So, why sell and loose your investment?

(sorry, my German is rather poor; it takes me to long to respond in German)

[meveric]

@ricky

No Problem with your German, my English is not better

War natürlich ein Witz mit dem Verkauf von meinen Aktien. It was e joke, to sell my shares.

Aber ich habe das Vertrauen in die Firma ein wenig verloren.
I have loose the confidence in the company.

Wir werden sehen wie es weiter geht.

We will see what the future brings.

[Fritz77]

Antwort auf Beitrag Nr.: 37.219.690 von meveric am 20.05.09 15:56:04

Hi meveric

Ich würde da auch einfach locker bleiben, nur weil in Deutschland mal ein paar VisualMed gekauft werden ist noch lange nichts passiert, da brauchen wir imo erst mal Erfolge die nachhaltig sind.
In den Staaten kommt ja noch keine Bewegung rein, nur sollten sie es noch schaffen bringe ich inzwischen leicht die nötige Geduld auf, das ist der Vorteil wenn man so lange leidet;-)

Gruß Fritz

[Fritz77]

Antwort auf Beitrag Nr.: 37.218.697 von ricky2009 am 20.05.09 14:33:34

Hi Ricky

The problem with stepping towards break even is that you to it with each coin earned and I think we as investors have no posibility to check if any of the wanted successes is getting real although I am happy they changed their business model, else I think we could no longer trade them;-)
So it' s time to wait for further earnings, as it was some months ago.

Regards Fritz

[erch]

Wenn was dran ist an der aktuellen Auskunft, dann sind wir bald rasch deutlich über 10 Eurocent. Der Wert ist dermaßen markteng, dass der Kurs bei einem deutlichen Indiz, dass der breakeaven bis 2010 da sein könnte, sich überschlagen wird.

[Fritz77]

Antwort auf Beitrag Nr.: 37.234.913 von erch am 22.05.09 17:12:03

Hi erch

Sollte es so kommen darfst du nur nicht vergessen das nach dem Erreichen des break evens points noch eine ganze Menge an Schulden zu bezahlen sind die weitere Mittel benötigen.
Auf gut deutsch gesagt wenn ich jahrelang nur Schulden mache und es dann einmal schaffe ein Jahr etwas mehr einzunehmen als ich ausgebe bin ich noch nicht unbedingt über den Berg, aber immerhin es ist ein Anfang.

Gruß Fritz

[erch]

Hi Fritz!
Das ist klar. Dennoch wäre break-even die Wende. Die Lizenzen laufen ja nochmalerweise weiter. Da gibt es - wenn (endlich!) - nur noch weiteren Zuwachs. Wenn das operative Geschäft die laufenden Kosten inklusive Schuldendienst trägt, dann verdient die Bude Geld.

Wer sich noch mal richtig frustrieren will, sehe sich mal den Dreijahreschart an. Igitt!

[Fritz77]

Antwort auf Beitrag Nr.: 37.236.146 von erch am 22.05.09 19:47:12

Hi erch

So gesehen hast du schon recht, break even ist zumindest ein Anfang um hier Geld zu verdienen.
Schauen wir mal was die in nächster Zeit so schaffen und was es mit der Geschichte mit den Chinesen auf sich hat.
Der chinesische Markt ist groß genug für gute Geschäfte, sofern sich die dann auch an die Spielregeln halten und nicht einfach alles klauen was sie an Software in die Hände bekommen.

Gruß Fritz

[meveric]

Ich habe meinen Privatkredit nun in alle möglichen Aktien auf dem Markt gesteckt. Gemischt in verschiedene Segmente von Versicherung über Wohnen bis Essen.

Und im Schnitt sollte mir mein Investment nun Jahr für Jahr mindestens 7-10% Dividendenrendite bringen. Mal schauen was dabei raus kommt.

Auf jedenfall habe ich keine Visualmed nachgekauft. So lange diese Bude keinen anständigen Internetauftritt zu stande bringt. Glaube ich diesen Jungs kein Wort.

Nicht einmal unsere Nachbargemeinde mit 150 Einwohner hat so einen schlechten Internetauftritt. Die Seite ist weder informativ, noch koopearativ und somit nicht lukrativ.

Werbung ist das A und O und wenn nur 1 Mal im Jahr eine Meldung von einer Dubiosen Stelle erscheint, dann ist dies nicht sehr glaubwürdig.

Ich denke, dass genau in diesem Moment Euer Geld in sinnvolleres investiert werden kann. Ausser ihr wollt Casino spielen. Dann ist das Casino oder Visualmed genau das Richtige.

[binda]

JahreschartUSOTC:VMCS

[Fritz77]

Antwort auf Beitrag Nr.: 37.246.769 von meveric am 25.05.09 17:54:27

Hi meveric

Punkt eins ist genau das was man eigentlich nicht machen sollte.
Kannst aufgrund der Krise natürlich Glück damit gehabt haben, ich habe zwar auch Eier, aber ich lege sie nicht unter einen Hammer.

Gruß Fritz

[meveric]

@Fritz

Natürlich hätte ich das mit Punkt 1 nicht machen sollen. Aber diese Chance lasse ich mir nicht nehmen.

Wenns funktioniert werden viele Leute dumm aus der Wäsche schauen. Wenns schief geht, hab ich zumindest etwas dabei gelernt und werde es sicherlich nicht noch einmal machen.

Es handelt sich dabei genau um den Betrag, welcher ich in naher Zukunft hätte investieren wollen. Da aber dieses Geld est in ca. 1-2 Jahren flüssig ist, hab ich das mit dem Kredit gemacht. Also nicht so tragisch wie es klingt.

[binda]

111% in USA

[Fritz77]

Antwort auf Beitrag Nr.: 37.258.460 von meveric am 26.05.09 23:15:31

@ meveric

Viel Glück bei deinem Investment, es geht mich ja nichts an was du mit deinem Geld machst.
Hab es erwähnt da ich denke zocken auf Kreide kann die Nerven belasten, das war es aber auch schon von mir.

Gruß Fritz

[meveric]

@fritz

Danke für deine Sorge um mich. Es braucht immer wieder Leute die mich zur Vernunft bringen.

Aber weisst Du Fritz. Die Chance dass es schlimmer kommt als es schon ist oder wahr, ist vermutlich kleiner als die Gewinnaussichten. Darum musste ich das Risiko auf mich nehmen. Es ist ja nicht ein hoher Betrag und er ist ja als Objekt in Form eines Autos ja schon vorhanden

Darum. Wenn dieser Betrag in 10 Jahren evtl. ver 10 facht wurde, dann kann ich sagen. Doch, hab alles richtig gemacht. Wenn nicht, schickt mir evtl. der Fritz nochmals ein Käse weil ich nichts mehr zu essen habe

[Fritz77]

Antwort auf Beitrag Nr.: 37.318.663 von meveric am 04.06.09 13:27:37

Hi Meveric

Alles klar, sollte es von Nöten sein helfe ich gerne mit steirischem Käse aus, sofern deine körperliche Verfassung diese Ernährung zulässt.

Unserer VMCS fehlt es leider noch gänzlich an Volumen, jetzt wäre es wie schon vor Jahren an der Zeit für gute Nachrichten.

Gruß Fritz

[Goetterdaemmerungen]

Genau ein paar news müssen Herr, mann es gibt doch soviele chinesen bitte kauft die IT-krankenhauslösung Visualmed!!!

Habe nach wie vor noch alle Aktien und würde mich freuen wenn Treue sich auszahlt!!

[done22]

Ja, der Kurs hat absolut nichts zu sagen, solange nicht mehr wie ein paar Hundert Euro in das Papier investiert werden. Auf die China-Nachrichten ist doch kaum jemand angesprungen. Ich trau dem Braten nicht. Das Volumen hätte normalerweise riesig sein müssen ...

Bin seit Jahren in das Ding investiert und hab's einfach liegen lassen frei nach Kostelany. War er doch oder? Wär natürlich super, wenn's endlich wieder aufwärts ginge, aber dann mit entsprechendem Volumen bitte!

[Fritz77]

Antwort auf Beitrag Nr.: 37.324.996 von done22 am 05.06.09 00:12:50

Hi done22

Das war wohl der mit den Schlaftabletten, aber soweit ich informiert bin hat er die Geduld auch nur aufgebracht solange er an eine Firma oder Entwicklung geglaubt hat.
So leicht springt da sicher kein Millionenpublikum mehr auf, ohne das es wirklich mal bestätigte gute News und nicht nur wenn-dann-vielleicht Geschichten gibt.
Da werden wir wahrscheinlich noch die eine oder andere Stunde schlummern können, bevor der Wirbel um VMCS und die daraus resultierende Aufregung uns den Schlaf raubt.

Gruß Fritz

[hermitderkohle]

Antwort auf Beitrag Nr.: 37.325.170 von Fritz77 am 05.06.09 01:52:21

Über 100% in nur wenigen Tagen, da haben wir doch endlich, was wir uns vor 2 Jahren alle erhofft hatten!

[ricky2009]

Antwort auf Beitrag Nr.: 37.343.815 von hermitderkohle am 08.06.09 15:22:51

To my German friends: the next step was for Visualmed to create a licensee to sell the Electronic Patient Record. Their new website is online now:

www.medicalmd.ca

Take a look!

[Fritz77]

Antwort auf Beitrag Nr.: 37.343.815 von hermitderkohle am 08.06.09 15:22:51

Hi hermitderkohle

Wenigstens hast auch du deinen Humor noch nicht verloren, vor 2 Jahren wäre das wirklich eine feine Sache gewesen.

Gruß Fritz

[Fritz77]

Antwort auf Beitrag Nr.: 37.344.127 von ricky2009 am 08.06.09 15:50:52

Hi Ricky

Nice to see they are on track again with such a high quality homepage to sell one promisingly product of the once large array of products.
You are sure that is the new page of VMCS??
Looks real good to me compared with the condition of the preceding one during the last year.
Imo VMCS was very near the insolvency, and now it is a good feeling to see them at last survive.
So I am waiting for the sales to follow.
Hope you do not mind me trying it next time in my mother tongue again.

Regards Fritz

[ricky2009]

Antwort auf Beitrag Nr.: 37.346.439 von Fritz77 am 08.06.09 19:40:22

Hi Fritz,

No, this is not the new website of VMCS. It's the new website of MedicalMD. Visualmed is now trying to sell their systems through resellers, who hold a license. I know of the following resellers: Visualmed Distribution Inc., Integrated Cancer Care Corp., Rational Health Systems and MedicalMD.

Visualmed is trying to cut down on cost by selling their products through resellers. All costs (marketing/sales, implementation etc.) are for the reseller. Visualmed now only gets a percentage of the turnover. Therefore the break-even point for Visualmed has come down to some $900.000. See their latest PR.

Greetings.

[Fritz77]

Antwort auf Beitrag Nr.: 37.347.012 von ricky2009 am 08.06.09 20:27:14

Hi ricky

Thank you for correcting the error in my ideas, I already wondered why VMCS got a internet performance under a different name and thought MedicalMD was a subsidiary of VMCS, as they only offered one of the former products.
But well a very promissing page and it looks like we are the lucky ones as it is going on that way, else I am sure without the resellers the here on the thread in thoughts already buried patient VMCS would also be below the ground in real.

Regards Fritz

[ricky2009]

Antwort auf Beitrag Nr.: 37.347.382 von Fritz77 am 08.06.09 21:05:36

Hi Fritz,

In his latest PR, mr. Gerard Dab was referring to another reseller of the Visualmed Clinical Information System and modules: Integrated Cancer Care Corp. Well, I found their website and it looks very promising. It seems that Integrated Clinical Care Corp. (what's in a name?) is a collaboration between Cardinal Health, McGill University Faculty of Medicine and medical informatics specialist. They don't refer to Visualmed directly, but if you read carefully you will find referrals to the Royal Victoria Hospital (where the Visualmed CIS was developed), the 3 hospitals where the complete CIS is running (El Paso Texas, Kansas Surgical and Battle Creek Michigan) etc. etc.

ICC Corp. aims at the oncology-facilities and has, thanks to the enormous market-position of Cardinal Health, a direct sales channel to hundreds of hospitals and oncology-clinics. This is a huge step in the right direction.

Greetings.

[ricky2009]

Antwort auf Beitrag Nr.: 37.491.858 von ricky2009 am 30.06.09 11:49:10

Sorry Fritz,

I forgot to post the link:

www. iclinicalcare.com

Greetings.

[Fritz77]

Antwort auf Beitrag Nr.: 37.491.858 von ricky2009 am 30.06.09 11:49:10

Hi Ricky

You are better informed than we are thank you for the link.
At least there is still some hope for VMCS to survive as they gave the selling into the hand of more experienced partners.

As far as I am informed here in Austria there is also some work done about better communication between the different involved persons working with medical files and the necessary network.

I can only hope the VMCS software systems are competitive and that also the oncology software will be sold by the help of Cardial Health's leading position as often as possible.
I am not that good informed as you are, so I hope we here on W.O. will also get some read from you in future.
Thank's in advance.

Fritz

[Depotmanager04]

Antwort auf Beitrag Nr.: 37.503.087 von Fritz77 am 01.07.09 20:25:45

Guten Abend, nichts für ungut; aber warum ist er besser informiert?

Gruß Depot...

[Fritz77]

Antwort auf Beitrag Nr.: 37.503.169 von Depotmanager04 am 01.07.09 20:36:53

Hi Depotmanager

Hast du die verschiedenen Firmen die jetzt die Produkte von VMCS vertreiben inklusive ihrer Homepage hier gepostet ?
Soweit ich es verfolgt habe nicht.
Ricky scheint sich hier näher mit der Thematik zu beschäftigen und sowas führt zwangsläufig zu mehr Informationen.
Weiters erleichtert ihm gegenüber uns sicher auch die Sprache hier die Recherche, da finde ich es nur vernünftig ihn zu bitten weitere Informationen die er findet hier mitzuteilen.

Es kann natürlich trotzdem sein das du mehr recherchierst als er, ich mache es auf jeden Fall aber nicht, freue mich aber wenn ich sehe das sie noch nicht ganz hinüber sind und ich noch warten kann den schwarzen Anzug aus den Kasten zu holen.

Gruß Fritz

[Depotmanager04]

Antwort auf Beitrag Nr.: 37.513.517 von Fritz77 am 03.07.09 11:56:25

Hi Fritz77; danke für deine Antwort.

Hinsichtlich der Firmen hatte ich nichts eingestellt. Wenn es über Internet-Recherchen gegangen ist bei Ricky, dann ist das schon ok und natürlich hilfreich.

Allen (noch)Investierten einen schönen Sommer...

[Fritz77]

Antwort auf Beitrag Nr.: 37.526.148 von Depotmanager04 am 06.07.09 19:07:41

Hi Depotmanager

Mir ging es nur um die Infos von Ricky den das VMCS sowas von aus den letzten Loch pfeift das der schwarze Anzug schon bereit stehen sollte ist allen noch investierten die sich seit Jahren ärgern sicher bewusst.
Aus eigener Kraft geht da wohl gar nichts mehr und da wird auch kaum wer mehr wissen über eine Firma die man nicht mal mehr per Email erreichen kann.
Das es durch verschiedene Firmen die soweit ich es beurteilen kann einen guten Eindruck auf mich machen weiterhin einen Vertrieb der Softwaremodule gibt finde ich zumindest erfreulich.
Ob es eine Überlebenschance gibt kann ich leider nicht beurteilen.
Ich gehe nach wie vor davon aus das wir für unser Leichtgläubigkeit und fehlende Eigenrecherche höchst wahrscheinlich den Preis zahlen werden.
Auf jeden Fall auch dir einen schönen Sommer, bei uns in Österreich gibt es den heuer bis jetzt leider nicht.

Gruß Fritz

[ricky2009]

Antwort auf Beitrag Nr.: 37.536.410 von Fritz77 am 08.07.09 20:31:09

Hi Fritz,

Seems to me that everybody missed a PR, that could have a great impact on Visualmed's future income:

http://www.mcgill.ca/newsroom/news/item/?item_id=107640


Medical.MD has formed a strategic relationship with McGill University Health Center. McGill wants to integrate MedicalMD's Electronic Health Records in a province-wide system, providing all Quebeckers with their state-of-art product, called MedforYou.

This could be huge. Quebec has some 7,6 million people. Let's assume that 10% will sign up: 760.000 x USD 25,- (???) = USD 19 million. MedicalMD is a reseller of Visualmed's products and VisualMed will only get 15%. Still, 15% of 19 million is a cool $ 2.850.000.

Not bad! Let's wait for more news on this deal.

Greetings.

[Fritz77]

Antwort auf Beitrag Nr.: 37.560.454 von ricky2009 am 13.07.09 13:16:16

Hi ricky

Again thank you for informing us and I think as well that nobody noticed the PR, as I also stopped some time ago to do active research on VMCS, as too much was promised in former times.

Read the article and well we can' t know how many people will subscribe, but as you tell some money could get earned there.

As long as VMCS can survive and MedforYou starts and stays growing I am happy to be in as I still got more time than money;-)

In the end the conceptions of VMCS imo pose the medical future as long as VMCS can stay alive long enough and as long as the concepts stay competitive.
The further development of medicine seems to me to be on their side.
Thanks for the read.

Regards Fritz

[hermitderkohle]

Antwort auf Beitrag Nr.: 37.586.726 von Fritz77 am 16.07.09 16:57:50

Über die zukünftigen gewinne von Visualmed müssen wir uns wirklich keine Gedanken mehr machen.
Der Profit aus den bestehenden Modulen, so denn welcher kommen sollte, wird bei den Vertriebsfirmen verbleiben: so kann man ihn direkt auf die Beteiligten verteilen und muß nicht noch mit den dummen Aktionären teilen.
schaut euch die neuen Firmen an, da sitzen ehemalige Visualmed Leute drin.

Gruß

HmdK

[erch]

Antwort auf Beitrag Nr.: 37.636.899 von hermitderkohle am 23.07.09 23:39:29

Ich fürchte, Du hast Recht, hermitderkohle.

Wegmitderkohle!

[Fritz77]

Antwort auf Beitrag Nr.: 37.636.899 von hermitderkohle am 23.07.09 23:39:29

Hi hermitderkohle

Das sehe ich nur bis zu einem gewissen Grad so wie du schreibst.
VMCS bleibt prozentuell geregelt wie von Richy gepostet mit 15% beteiligt und spart so zumindest die Vertriebskosten und die Kosten für ein erfolgreiches Marketing, das denen ohnehin nie gelungen ist.
Ob es reicht werden wir noch sehen, aber wenn sie in die Gewinnzone kommen ist das doch schon mal ein Anfang und ohne diese Schritte wäre das Licht wohl schon aus.

Gruß Fritz

[meveric]

Auf jedenfall hat heute jemand

Um 09.51 Für 0,032 Stücke 94.700


gekauft!

Das sind immerhin über 3'000.- Euro.

Also es gibt auch Anleger die hätten jetzt so einen gesetzt

[binda]

und heute wieder in
eine Order:

FRA

Aktuell
0,063

Zeit
30.07.09 14:32:36

Diff. Vortag
+96,88 %

Tages-Vol.
9.450 €

Geh. Stück
150.000

mmmmh

[binda]

muß heißen:

..und heute wieder in einer Order zu 0,063€

[meveric]

Ich denke da hat nur jemand auf den falschen Knopf gedrückt und den Order ausgelöst.

[ricky2009]

Antwort auf Beitrag Nr.: 37.686.332 von meveric am 31.07.09 13:26:29

Hi Fritz,

Did you read Visualmed's last (august 3rd) PR? Here it is:


Canada's Leading University Health Centre Adopts Intelligent PHR
Opens the Way for New Generation Medical Information Technology
Press Release
Source: VisualMED Clinical Solutions Corp.
On Monday August 3, 2009, 3:30 pm EDT
Buzz up! 0 Print.Companies:VISUALMED CLINICALVISUALMED CLINCL SOL
MONTREAL--(Marketwire - 08/03/09) - VisualMED Clinical Solutions Corp. (The "Company") (Pinksheets:VMCS - News) (Frankfurt:VA6 - News) announces that the McGill University Health Centre (MUHC) is deploying a web-based intelligent Personal Health Record that will be made available to some of its 700,000 patients as an interactive Patient Portal.

Related Quotes
Symbol Price Change
VA6.F 0.0410 0.0000


{"s" : "va6.f,vmcs.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""} This major breakthrough is expected to help change the direction of medical informatics and usher in a new era of medical meaningful use focused on the needs of patients. Over the years McGill has been a consistent leader in medical innovation as exemplified by its new $1.9 billion Health Centre Project, reputed to be the largest of its kind in the world.

The move reflects the new direction of healthcare informatics as leading policy makers and experts move to introduce a new generation of meaningful use clinical information technology more focused on patients and their families.

Dr. Jeffrey Barkun, Director of General Surgery and Chief Clinical Officer of the Informatics Transition at the MUHC, says, "MedforYou is an essential complement to the electronic patient record being implemented in our hospitals today."

MUHC Director General and CEO Dr. Arthur Porter noted, "Giving Quebecers a Web-based logbook in which to track their health and a host of features that can inform and influence their lifestyle choices is a new way for the McGill University Health Centre to make a difference in people's lives."

Canadian internet health information Company Medical.MD EHR, a leader in the development of meaningful use applications, will be providing its proprietary Personal Electronic Health Record called MedforYou. to the MUHC.

In the United States, the Obama Administration is also leading the way with steps to use a significant portion of the stimulus package (ARRA) to help physicians purchase clinical informatics tools that offer meaningful use with genuine outcome benefits for patients.

"These types of advanced medical technologies can no longer be ignored," says VisualMED chairman Gerard Dab. "We believe that this new trend will finally benefit our proprietary technologies." With some of our recent licensing agreements including those for the Chinese market, our technologies have taken on a much broader, global scope, and management is working to expand further these kinds of distribution channels.

The complete MUHC press release can be found at: http://www.muhc.ca/media/news/item/?item_id=107640

A complete broadcast of CTV news can be watched at http://montreal.ctv.ca/servlet/an/local/CTVNews/20090708/mtl…

ABOUT VISUALMED

Very interesting news I would think!

Greetings.

[ricky2009]

Antwort auf Beitrag Nr.: 37.795.223 von ricky2009 am 17.08.09 15:23:48

Hi Fritz,

Did you watch the video, explaining what it means to all McGill patients?

CTV Montreal
View larger image


A view of a page in www.medforyou.com .(July 7, 2009)
MUHC announces test of online medical records tool
Updated: Wed Jul. 08 2009 7:08:32 PM

ctvmontreal.ca

The MUHC says patients will soon be able to track their medical appointments, work outs and diets online thanks to a new program that administrators are comparing to Facebook.

Medforyou.com was developed by local company Medical.MD. The MUHC has put a call out for 300 volunteers to help test the site between July and September.

It hopes the site will go live in October. It estimates a subscription will cost $50 a year.

Program details

Like an advanced electronic calendar, it will allow patients to get an overview of their medical schedules and other details.

Official surmise it will be especially helpful for those with demanding health situations.

The program is independent of Quebec's plan to computerize all medical records.

The designer of the program is Philippe Panzini, whose work in the film industry with software development earned him an Academy Award.


I'm not sure what it means in terms of revenue for Visualmed. A subscription costs $50,- a year, of which 15% goes to Visualmed, i.e. $7,50. You can do the math. Will they get 250.000 subscribers, 700.000 or more than 1,2,3 million? In that case, you're happy to be a Visualmed shareholder!

Greetings.
Ricky

[erch]

Hat jemand Kenntnis über die Höhe der (Bank-)verbindlichkeiten von VMCS?
Erstaunlich ist doch, dass die Geldgeber - außer den Besitzern von Aktien - noch mitspielen.

[ricky2009]

Antwort auf Beitrag Nr.: 37.853.584 von erch am 26.08.09 11:03:40

Dear Erch,

My German is not very good, but I think you are asking why the banks are still financing Visualmed?

The answer is: they don't. Visualmed never borrowed a single penny from any bank. That seems to be the problem with a lot of small investors in this company: they don't read the financial statements.

Until april 1st 2008, Visualmed had losses of appr. $32 million. These losses were financed with paid-in capital of appr. $30 million. Paid-in capital consists of government grants, advances against sales of Visualmed-products, raised share capital etc. etc.

So, the good news is: the banks can not pull the plug. As there are no debts (only to related parties), Visualmed is going to stay!

Good luck to you!

[meveric]

Wow. Ging ja wieder mal etwas bei Visualmed.

Wie schon sicherlich 100mal erwähnt. Stell ich das heute nochmals rein. Damit alle nochmals sehen was die Bude vorher gemacht hat. Eigentlich nichts.

Sorry für die Google Übersetzung.


VisualMED Clinical Solutions Corp (VMC)
Wir waren im US-Bundesstaat Nevada am 7. September 1999 unter dem Namen Ancona Mining Corp (Ancona) aufgenommen als Bergbau-und Explorationsunternehmen. Nach ersten enttäuschenden Ergebnissen im Bergbau-Exploration, haben wir sehr kleines Geschäft und zeigte sehr geringe Aktivität, ohne die Rentabilität. Am 23. September 2004, nach Erhalt, dass unsere Beratung Bergbau Eigenschaften, die nicht gehalten wurden, um wirtschaftlich attraktiv sein, haben wir uns auf dem aufstrebenden Gebiet der klinischen Informationssystemen und geben Sie eine vertragliche Vereinbarung geschlossen, sich grundsätzlich an die Vertriebsrechte an eine Reihe von Kauf klinischen Software-Module sowie einige kleinere Bürogeräte und alle ausgegebenen und ausstehenden Stammaktien von VisualMED Marketing Inc., ein inaktives Unternehmen ohne Gewinn von Visual Healthcare Corp (früher bekannt als VisualMED Clinical Systems Corp), ein Unternehmen aus Nevada (VHCC). Wir beziehen uns auf diese Anlageklasse Kauf-Transaktion als Kauf. Wir vollzogen die Akquisition bereits am 13. Oktober 2004, und als Gegenleistung für die erworbenen Vermögenswerte, ausgegeben wir, was dann belief sich auf 80% der Stammaktien an VHCC. Als Folge der Übernahme haben wir uns das Recht zur Nutzung, Vermarktung, Installation, Support-und Upgrade der klinischen Software-Module erworben werden. Unsere Rechte zur Nutzung, Vermarktung, Installation, Support-und Upgrade sind die Module weltweit, mit Ausnahme, dass ein Teil des US-Marktes sowie der chinesischen und der japanischen Sprache Märkte, in die VHCC hat ähnliche Vereinbarungen mit anderen, nicht eingetragen im Zusammenhang mit Unternehmen.

[Goetterdaemmerungen]

Antwort auf Beitrag Nr.: 37.922.263 von meveric am 04.09.09 18:20:33

Warum versuchen bestimmte Leute immer Hoffnungen und Wünsche von anderen Menschen zu zerstören. Ich glaube du hast genau so wenig Ahnung von dem was die wirklich tun wie wir Investierten.Es ist schon schlimm genug das viele klein Anleger auf so Leute wie Investor Alert rein gefallen sind aber so einen Mist kann ich mir nicht mehr anhören. Schönen Gruß noch.Ich hoffe du kannst zu schauen wenn die Aktie durch startet!!!

[Fritz777]

Antwort auf Beitrag Nr.: 37.924.149 von Goetterdaemmerungen am 04.09.09 22:32:49

Hi GD

Du solltest das nicht so eng sehen, wenn jemand ein paar Zeilen schreibt zerstört er doch keine Hoffnungen, das schaffen nur die Firmen mit nicht eingetroffenen Geschäftsaussichten.

Gruß Fritz

P.S.:Habe einen Siebener mehr da ich mich für einige Zeit aus verschiedenen Gründen bei W.O. abgemeldet hatte.

[meveric]

Antwort auf Beitrag Nr.: 37.924.149 von Goetterdaemmerungen am 04.09.09 22:32:49

Weil man Hoffnung und Wünsche von Realität trennen muss.

Ich will keine Hoffnung und Wünsche von anderen zerstören. Ich bin ebenfalls wie andere hier in Visualmed investiert und hoffe unde wünsche mir jeden Tag, dass da noch etwas läuft.

Aber viele NEWS haben wir in letzter Zeit von der Firma nicht erhalten. Ich habe weder einen Quartals- noch Halbjahresabschluss gefunden.

Und die Webseite von Visualmed ist immer noch so nichtssagend wie seit Beginn.

Ich versuche meine Hoffnung und Wünsche nur zu begründen, stosse aber bei meinen Nachforschungen eher auf Indizien, die diese Hoffnung und Wünsche kleiner werden lässt.

Wenn Du von der Firma mehr wissen solltest als ich und wir, freuen wir uns über jede positive Neuigkeit.

Kann gut sein, dass die Aktie plötzlich durchstartet. Darüber würde ich mich natürlich mit Euch freuen. Aber so lange wir nichts mehr von Visualmed hören, müssen wir realistisch bleiben und den roten Schandfelck im Depot einfach übersehen.


@Fritz

Schön etwas von Dir zu lesen, hoffe bei Euch ist alles i.O.?

Wünsche einen schönen Abend allerseits.

[Fritz777]

Antwort auf Beitrag Nr.: 37.933.463 von meveric am 07.09.09 19:08:06

Hi Meveric

Habe dir eine BM geschrieben.

Freundlichen Gruß Fritz

[meveric]

Hallo Fritz

Und ich habe Dir zurückgeschrieben.

Wünsche allen einen schönen Tag.

[erch]

Leute, denkbar ist doch, dass das Papier in 10 Jahren oder nie weiter kommt! Sieht das jemand anders?

[2008]

Antwort auf Beitrag Nr.: 38.067.022 von erch am 28.09.09 09:20:27

du bist vielleicht ein pessimist
das erfährst du spätestens in 10 jahren
ich warte übrigens schon beinahe schon 4,5 jahre
mfg

[hermitderkohle]

Leute, die Bude ist so gut wie dicht und ihr Produkt ist Software! Computerprogramme die bisher kaum jemand haben wollte und die mittlerweile höchstwahrscheinlich veraltet sind.
Die einzige Hoffnung ist doch, das wieder (falsche) Gerüchte aufkommen die es den alten Deppen (uns)ermöglicht, die Papiere an neue Deppen zu verkaufen. Aber alles über 10 ct. halte ich für unrealistisch.

[Fritz777]

Antwort auf Beitrag Nr.: 38.087.343 von hermitderkohle am 30.09.09 16:24:33

Wieso soll das unrealistisch sein mit Kursen über 10 Cent, vor zwei Jahren war ein Cent wohl genauso unrealistisch, oder nicht?
Ist nicht immer so einfach mit den Deppen, sollte VMCS mal wieder hochgehen ist man warscheinlich der Depp wenn man um 10 Cent verkauft, denn der Anstieg wird dann auch einen Grund haben, der vielleicht noch mehr erwarten lässt.
Doch in einem Punkt stimme ich dir zu Deppen waren wir schon.

Gruß Fritz

[ricky2009]

Hi,

Who's selling at these prices? Someone who is tired of waiting? I think it's worthwile to wait a few more days. This month Medical.MD finishes testing Medforyou, the online electronic health record, developed with help of McGill MUHC.

Furthermore,ICC Iclinicalcare is up and running, trying to sell Visualoncology etc. in North America.

Let's see what happens in the next few days.

Greetings.

[erch]

Do you get something for your postings?

[2008]

steige hier aus mit wannsinnsgewinnen
einstieg 1,006 ausstieg 0,049
viel glück den noch investierten
mfg

[binda]

Noch ist der Aufwärtstrend intakt...

[Fritz777]

Antwort auf Beitrag Nr.: 38.224.788 von 2008 am 21.10.09 18:15:05

Hi 2008

Danke für die Glückwünsche.
Nach Verlust von mehr als 95% des investierten Kapitals hat sich der Ausstieg für dich leider nicht mehr besonders gelohnt.

Gruß Fritz

[2008]

Antwort auf Beitrag Nr.: 38.228.011 von Fritz777 am 22.10.09 06:09:46

der mikrige erlös reicht gerade mal für weihnachtsgeschenke der kinder

viel glück
ihr werdet es brauchen !!!

[ricky2009]

Antwort auf Beitrag Nr.: 38.224.788 von 2008 am 21.10.09 18:15:05

I think you will regret that!

[Fritz777]

Antwort auf Beitrag Nr.: 38.232.494 von 2008 am 22.10.09 15:50:27

Hi 2008

Für sehr viel mehr würde es bei mir bei einem Ausstieg auch nicht reichen, vielleicht noch ein Bier, oder zwei Biere extra, um den schalen Geschmack loszuwerden.
Glück kann man natürlich immer brauchen, hier wie auch anderswo.
Weiterhin alles Gute

Fritz

[Fritz777]

Antwort auf Beitrag Nr.: 38.233.719 von ricky2009 am 22.10.09 17:23:03

hi ricky

Thanks for writting here to keep the little rest of the thread a bit informed, as I have so little time for investigations about VMCS and your mother tounge also makes it less time intensiv to keep in touch with the development of the different products sold by several companies around VMCS, as I could imagine.

Regards Fritz

[meveric]

Hallo Leute

Da ist ja richtig etwas los im Visualmed Thread.

Nur die Aktie kommt nicht mehr vom Fleck. Von wo hat Ricky immer diese Infos? Visualmed liefert ja schon lange nichts mehr an die Aktionäre, weder Zahlen noch NEWS habe ich gesehen. Wenn man in Google nach Visualmed sucht, findet man eher unseriöse Börsenbriefe und andere komische Seiten als etwas schlaues über Visualmed.

Naja. Viel verlieren kann ich ja nicht mehr. Darum kann ich die Dinger auch einfach liegen lassen.

Wünsche einen guten Start ins Wochenende.

[2008]

Antwort auf Beitrag Nr.: 38.233.719 von ricky2009 am 22.10.09 17:23:03

I have this already the last 4 years

[Depotmanager04]

[Fritz777]

Antwort auf Beitrag Nr.: 38.252.769 von Depotmanager04 am 26.10.09 14:54:32

Hi Depotmanager

Lustig, bis auf die Alpträume.

Gruß Fritz

[erch]

Antwort auf Beitrag Nr.: 38.241.523 von meveric am 23.10.09 15:58:40

"Visualmed liefert ja schon lange nichts mehr an die Aktionäre, weder Zahlen noch NEWS"

Tja, meveric, das wundert mich auch.
Gibts da nicht Gesetze, die so was zur Pflicht machen?

"Wenn man in Google nach Visualmed sucht, findet man eher unseriöse Börsenbriefe" Erinnere uns nicht an solche Schundblätter!

[hermitderkohle]

Antwort auf Beitrag Nr.: 31.084.960 von binda am 08.08.07 19:16:48

Scheit sichum die letzten Zuckungen des Patienten Visualmed zu handeln.
Bin gespannt, wann endlich der Stecker gezogen wird und ich dieses in allen Belangen unrühmliche Unterfangen in die Ablage der schlechten Erfahrungen legen kann.

Nie wieder Börsenbriefen glauben, sich nicht mehr in Foren von der Euphorie anderer anstecken lassen, und nie wieder mit Fremden Wetten abschließen!

Ich melde mich wieder, wenn wir uns zu virtuellem Butterkuchen und Kaffee treffen,nachdem wird Visualmed zu Grabe getragen haben.

Bis dahin

hermitderkohle

[ricky2009]

Antwort auf Beitrag Nr.: 38.359.360 von hermitderkohle am 10.11.09 19:03:11

Hi,

Testing of MEDforYou was completed successfully:

http://www.medforyou.com

In 2 weeks the electronic health record (EHR) will be available for all Canada and USA. The MEDforYou EHR is based on the VisualMED interference engine and VisualMED will receive 15% of all turnover from exploiting the MEDforYou EHR.

Greetings.

[hermitderkohle]

Antwort auf Beitrag Nr.: 38.371.498 von ricky2009 am 12.11.09 09:56:50

Too little, too late!

[Fritz777]

Antwort auf Beitrag Nr.: 38.371.498 von ricky2009 am 12.11.09 09:56:50

Hi ricky

Thanks for still posting informations, but as you can see the longterm holders are a bit frustrated over here.
Personally I can only say all informations are welcome from my side.
In fact the meaning of 15% of the revenue only depends on the revenue that will be made by medforyou, so let us see in future if this is good or bad news, as I have time to stay waiting with my shares.

Best regards
Fritz

[hermitderkohle]

Antwort auf Beitrag Nr.: 38.377.923 von Fritz777 am 12.11.09 21:29:58

Since even Invertor Alert won't touch Visualmed shares in exchange to spread bogus Visualmed news, Gerard Dab has found a new way to mislead the stupid German investors: ricky 2009!

[erch]

hmdk, den Eindruck habe ich auch!

[Fritz777]

Antwort auf Beitrag Nr.: 38.393.197 von hermitderkohle am 16.11.09 11:35:53

Hi

Seit doch nicht so.Unsere nahezu wertlosen Teile haben wir immer noch und was soll schon passieren außer das die die paar Cent die sie noch wert sind auch noch an Wert verlieren.

Angewiesen bin ich nicht auf das bisschen Restgeld und da lasse ich sie liegen und freu mich wenn Ricky uns informiert das vielleicht doch noch nicht alles verloren ist.

Ist doch auch eine nette Abwechslung.Wer von uns macht sich schon noch die Mühe hier nach irgendwelchen Nachrichten oder Geschäftsverbindungen, oder was auch immer zu suchen.

Der Ricky ist denke ich nativer Englischsprecher und macht sich die Mühe mit uns auf deutschsprachigem Terrain in Kontakt zu treten, da kann man doch auch ein wenig nett sein.

Gruß Fritz

[meveric]

Hallo Leute

Euch hier habe ich schon fast vergessen

Nein natürlich nur ein Scherz.

Wie kann man Euch vergessen? Der rote Schandfleck in meinem Depot wird mich immer wieder an diese Investition erinnern. Er hat auch was Gutes. Ich habe ein paar lustige und freundliche Leute kennen gelernt. Naja. Hat mich zwar etwa gleich viel gekostet wie ein Puffbesuch mit einer spendierten Runde Champagner aber was solls.

Zudem habe ich natürlich noch nicht vergessen dass noch jemand Käse von mir zugute hat. Werde ich natürlich noch schicken, sorry dass es so lange gedauert hat. Aber ich wollte auf kühlere Tage warten, im Sommer wäre vermutlich nur "Raclette" geschmolzener Käse, angekommen.

Ja das mit Visualmed ist ein wenig ein Trauerspiel. Zum Glück läuft es im Moment bei meinen anderen Investitionen ein wenig besser.

@Fritz
Hoffe Dir geht es gut. Wünsche eine behagliche Weihnachtszeit und bis bald wieder einmal.

Lieber Gruss

Meveric

[Fritz777]

Antwort auf Beitrag Nr.: 38.414.856 von meveric am 18.11.09 22:04:54

Hi meveric

Danke der Nachfrage.Geht mir zum Glück sehr gut, arbeite nur zu viel, aber ab nächstem August geht es für ein Jahr in Karenz, da ist jetzt viel zu tun.

Würde ich viel mehr Aktien wie Visual Med im Depot haben hätte ich wohl schon aufgegeben, aber noch zuckt der Patient ein wenig.

Mal sehen ob der Patient immer noch lebt, oder diesmal zur Sicherheit der Herzstich gesetzt wird.

Gruß Fritz

[erch]

abschreiben oder vererben?

[naiv1]

Antwort auf Beitrag Nr.: 38.453.260 von erch am 25.11.09 15:19:14

...mund abwischen und positiv denken, habe auch 3000 euronen verloren

[Fritz777]

Antwort auf Beitrag Nr.: 38.453.260 von erch am 25.11.09 15:19:14

Hi erch

Nur was vererben?

Gruß Fritz

[ricky2009]

Antwort auf Beitrag Nr.: 38.516.193 von Fritz777 am 05.12.09 22:48:02

Hi Fritz,

While strolling down the internet, I found some more reassuring news about Visualmed:

Ontario to pay physicians up to $30,000 to adopt EMR

Follows the American plan of up to $64,000 per provider

MONTREAL, QUEBEC, December 4th, 2009 – VisualMED Clinical Solutions Corp. (The “Company”) (NASDAQ OTC: VMCS.PK) (Frankfurt: VA6.F) announces that Ontario will go ahead with plans to fund Electronic Health Records for medical practice. The Ministry of Health of the Province of Ontario has earmarked $236 million to MAPS the adoption of Electronic Health Records by the province’s physicians.

The aim is to provide Electronic Health Records for some 5,700 family physicians over the next three years. The government is stepping in to provide incentives to purchase clinical systems in much the same way as the new Obama Administration in the United States, where the American Recovery and Reinvestment Act (ARRA) has made some $36 billion of federal funds available to reimburse Healthcare IT purchases by providers.

“The Ontario initiative, the first of its kind in Canada, is a demonstration that the Obama policy on medical practice automation is having an impact beyond the U.S.” says VisualMED Chairman Gerard Dab. “We expect that our distributors will leverage the VisualMED technology, widely regarded, flexible and scalable, in providing systems to Ontario physicians. Financial incentives are bound to have a major impact on our industry,” concludes Gerard Dab.

The Company continues to expand its distribution channels in the United States, where it expects to leverage existing sites into a larger client base, supported by the funds made available in the Stimulus package (ARRA). Recent events such as the special EHR symposium of the American Society of Clinical Oncologists held in November show the impact of ARRA on provider interest in clinical automation. VisualMED licensee Integrated Clinical care Corp (www.iclinicalcare.com) was among the 15 vendors participating in defining the ASCO position on oncology specific Electronic Health Records.


ABOUT VISUALMED
VisualMED Clinical Solutions Corp. licenses cutting edge healthcare application technology from its extensive portfolio of proprietary clinical and medical solutions that help hospitals and healthcare authorities improve the efficiency of managing patients care, increasing personnel efficiency, bringing down operating cost while improving outcomes.
Some of the applications that its technologies enable such as fully automated and well tested Computerized Physician Order Entry with powerful decision support components and self populating automated Tumor Registries, are core solutions in the new agenda to MAPS better patient care, greater safety and reduce risks due to medication errors. Information on our company and its products is available on our web site at www.MAPS.com.

FORWARD- LOOKING STATEMENTS

Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.

Contact:

VisualMED Clinical Solutions Corp.
Tel: [phone]

SOURCE: VisualMED Clinical Solutions Corp.


So, Visualmeds' opportunities are increasing!!! Keep up the good spirit.

[ricky2009]

Antwort auf Beitrag Nr.: 38.516.193 von Fritz777 am 05.12.09 22:48:02

Hi Fritz,

And another message, from a dutch site:

Dear Sir
We will be posting the 2008 financials later this week.
Best Regards

..................................................................................................

Thank you for sending the e-mailmessage regarding developments Ontario.

You must be aware that your shareholders are still waiting for the results which are still not published.The only information we receive is about possible developments and no real facts.

Kind regards

Well, I can wait some more days. Let's hope that mr Dab 'sticks to his promise this time!!!!

Greetings.

[Fritz777]

Antwort auf Beitrag Nr.: 38.526.172 von ricky2009 am 08.12.09 10:47:22

Hi ricky

Thank you for the informations, as I am waiting here since years, made all the mistakes an investor can make with a stock and the value has dropped that much I see no sense for sellings anymore, but on the other hand I wouldn' t spent money to buy me more shares from VMCS.
Looks like Canada is a place with possible chances to survive for VMCS, or even comme up again, which is in fact hard to believe for me at this time, but if they don't make it I wont moan too much.

Regards Fritz

[erch]

"We will be posting the 2008 financials later this week."
Soso. Fahrlässigen Mist verbreiten die, sonst nichts.
Wenn die ihre Geschäfte so gewissenhaft führen, wie ihre PR-Arbeit, dann ist alles klar.

[erch]

Und immer noch nicht die angekündigten Informationen.
Das nennt man "Management by Champignon":
Alles im Dunkeln lassen und ab und zu eine Ladung Mist drüberwerfen!

[hermitderkohle]

Antwort auf Beitrag Nr.: 38.592.729 von erch am 18.12.09 08:08:53

Du tust ja gerade so, als ob Visualmed noch unternehmerisch tätig wäre, dabei werden die Reste gerade von Subunternehmen, gegründet von ehemaligen Visualmedlern, verhökert.

[Fritz777]

Antwort auf Beitrag Nr.: 38.602.348 von hermitderkohle am 19.12.09 14:23:19

Hi hmtk

Solange die Mutter dabei nicht verhungert ist es imo noch die beste Lösung, bezogen auf den Konkurs als Alternative.

Gruß Fritz

[ricky2009]

Antwort auf Beitrag Nr.: 38.612.822 von Fritz777 am 21.12.09 21:17:55

Yep, Fritz, very disappointing, but no news from Visualmed. I picked up the message however, that a management-letter will be published before X-mas.

Greetings.

[Fritz777]

Antwort auf Beitrag Nr.: 38.616.033 von ricky2009 am 22.12.09 12:11:33

Hi Ricky

Right, not much time left until X-mas for an announcement.
As I had only little hope to hear something positive it is not that disappointing to get no read.

Regards Fritz

[ricky2009]

Antwort auf Beitrag Nr.: 38.625.872 von Fritz777 am 23.12.09 16:15:39

Hi all,

Is someone over there on mr. Dab's mailing list? Here's the letter that was promised earlier:

January, 5th, 2010


Dear Shareholders,

As we have now left 2009 behind us, one of the most trying years in the history of business, it is with a sobering sense of gratefulness that I can report that our company has managed to weather the storm and come through both technologically and financially intact. We were able to generate revenues, further reduce debts, sign new commercial agreements, and initiate new lines of businesses in order to align ourselves with the priorities of the coming healthcare revolution in the United
States.

This was a year that saw the most severe financial meltdown in generations, unprecedented paralysis of commercial credit, the collapse of entire asset classes such as housing and equities and the disappearance of countless companies big and small. We have survived and also made progress, thanks to drastic cost reduction,
the continuing commitment of our team, and success in reducing and rescheduling debts. All debts are no recourse and do not require liens against either equity or technology. This is positive for the long term stability of the company.

We are now putting all of our focus on managing an extensive portfolio of intellectual properties, which we will extend through the acquisition of commercial rights to complementary medical technologies that we will license out to distributors and
value-added resellers. Management believes in leveraging our science expertise into providing sound product concepts, based on our strong technologies, to our distribution channel.

The company will also bring new types of clinical products to its licensees in such areas as intelligent medical imaging, infection control, public health applications, and mass clinical tools for cell phones. In certain cases these applications already
exist but cannot be made to be effective without the support of an integrating platform such as that of VisualMED.

Building royalty streams by providing clinical solutions licenses to a wide array of commercial companies will now be the business model we will adhere to with discipline. We will be seeking solely royalty payments from licensees and will not take equity positions nor seek any arrangements that will get us involved in the
operations of other businesses. We will not get involved in the management and business affairs of our licensees´ operations other than to provide them with suitable academic and scientific support, two areas where we have proven ourselves to be
world class. We were successful in creating a uniquely advanced technology but did not see through its commercial development which we now outsource to third parties. We will now get paid for the right to use our technology or for adding our applications to their own offerings.

Our financial position has improved in 2009 although economic conditions did not make the selling of clinical applications easy as American medical facilities suffered financially; many decided to sit and wait for more concrete details on how they would benefit from the subsidies promised by the new administration.

In the coming year we intend to continue seeking royalty agreements with new partners and to pursue business opportunities with energy and determination. We aim to consolidate measures that will support the future growth of the company including maintaining low overhead and operating expenditures. Our technology remains far ahead of the competition and will remain so for years to come, due to the extremely high barrier to entry. New entrants attracted by the Obama revolutions will not be able to avoid the many years of clinical testing in real conditions in order to attain product validation. Our close to $50 million investment in research and clinical testing retains much of its value as we look for novel ways to benefit from its high quality.

We have avoided the worst, reshaped a new business model and succeeded in preparing the future with new methodologies and clear orientations. It remains to thank many of you for your continuing interest, support, suggestions and ideas and wish you the best in the New Year.

Thank You

Gerard Dab

Chairman and CEO
Tel. [phone]


Looking good, looking good. Finally some turnover from existing contracts, cost down and a bright future when hospitals in USA start spending on clinical information systems.

[binda]

Antwort auf Beitrag Nr.: 38.674.010 von ricky2009 am 06.01.10 11:52:36

Thank you very much. It sounds fantastic.


As we have now left 2009 behind us, one of the most trying years in the history of business, it is with a sobering sense of gratefulness that I can report that our company has managed to weather the storm and come through both technologically and financially intact. We were able to generate revenues, further reduce debts, sign new commercial agreements, and initiate new lines of businesses in order to align ourselves with the priorities of the coming healthcare revolution in the United
States.

[ricky2009]

Antwort auf Beitrag Nr.: 38.674.010 von ricky2009 am 06.01.10 11:52:36

I'm sorry, something went wrong. Again:


January, 5th, 2010


Dear Shareholders,

As we have now left 2009 behind us, one of the most trying years in the history of business, it is with a sobering sense of gratefulness that I can report that our company has managed to weather the storm and come through both technologically
and financially intact. We were able to generate revenues, further reduce debts, sign new commercial agreements, and initiate new lines of businesses in order to align ourselves with the priorities of the coming healthcare revolution in the United
States.

This was a year that saw the most severe financial meltdown in generations, unprecedented paralysis of commercial credit, the collapse of entire asset classes such as housing and equities and the disappearance of countless companies big and small. We have survived and also made progress, thanks to drastic cost reduction,
the continuing commitment of our team, and success in reducing and rescheduling debts. All debts are no recourse and do not require liens against either equity or technology. This is positive for the long term stability of the company.

We are now putting all of our focus on managing an extensive portfolio of intellectual properties, which we will extend through the acquisition of commercial rights to complementary medical technologies that we will license out to distributors and
value-added resellers. Management believes in leveraging our science expertise into providing sound product concepts, based on our strong technologies, to our distribution channel.

The company will also bring new types of clinical products to its licensees in such areas as intelligent medical imaging, infection control, public health applications, and mass clinical tools for cell phones. In certain cases these applications already exist but cannot be made to be effective without the support of an integrating platform such as that of VisualMED.

Building royalty streams by providing clinical solutions licenses to a wide array of commercial companies will now be the business model we will adhere to with discipline. We will be seeking solely royalty payments from licensees and will not take equity positions nor seek any arrangements that will get us involved in the operations of other businesses. We will not get involved in the management and business affairs of our licensees´ operations other than to provide them with suitable academic and scientific support, two areas where we have proven ourselves to be
world class. We were successful in creating a uniquely advanced technology but did not see through its commercial development which we now outsource to third parties. We will now get paid for the right to use our technology or for adding our applications to their own offerings.

Our financial position has improved in 2009 although economic conditions did not make the selling of clinical applications easy as American medical facilities suffered financially; many decided to sit and wait for more concrete details on how they would benefit from the subsidies promised by the new administration.

Meanwhile I can share with you some salient financial information. First, regarding the results for 2009, I am able to provide some guidance and a general picture while we wait for the financial statements to be completed later this month. Revenues for
2009 are expected to have remained close to last year’s at approximately $1.2 million down from $1,381,485 in 2008. Operational expenses stood at around $400,000 as we have been able to shift the responsibilities for technical support and service to our licensees. Another amount of approximately $800,000 was spent to reduce debt load, for total expenditures for the year at approximately, $1.2 down from $4,668,913 in 2008. When the P&L is finally tallied, losses for 2009 will be down to six figures instead of in the millions.

Total revenue for the previous year, 2008, stood at $1,381,485 up from $355,812 for the same period in 2007, with total expenses at $4,668,913 down from $15,174,536 with a net loss of $3,355,718 down by almost $11.3 million from the previous year’s losses of $14,692,602. Total liability and stockholder deficit stood at $167,488, down from $467,873 from the previous year. Thanks to our licensees´ progress, the list of establishments having adopted applications running on our technology has now reached a critical mass of some 14 locations. (See attached 2008 Financial Statements
and notes).

In the coming year we intend to continue seeking royalty agreements with new partners and to pursue business opportunities with energy and determination. We aim to consolidate measures that will support the future growth of the company including maintaining low overhead and operating expenditures. Our technology remains far ahead of the competition and will remain so for years to come, due to the extremely high barrier to entry. New entrants attracted by the Obama revolutions will not be able to avoid the many years of clinical testing in real conditions in order to attain product validation. Our close to $50 million investment in research and clinical testing retains much of its value as we look for novel ways to benefit from its high quality.

We have avoided the worst, reshaped a new business model and succeeded in preparing the future with new methodologies and clear orientations.

It remains to thank many of you for your continuing interest, support, suggestions and ideas and wish you the best in the New Year.

Thank You

Gerard Dab

Chairman and CEO
Tel. [phone]

[ricky2009]

Antwort auf Beitrag Nr.: 38.674.046 von binda am 06.01.10 11:56:28

Hi Binda,

Yep, great news. They survived the development stage. Finally they have turnover from existing contracts. I am convinced that this is only the beginning:
- in the USA the ARRA-funds have become available for hospitals to invest in Clinical Information Systems. Visualmed's reseller in the USA is: www.iclinicalcare.com
- in Canada we are awaiting a PR from McGill on the MedforYou Electronic Health Record. Look at www.medforyou.com

Financial position is okay! All losses (31 million USD) were financed by paid-in capital. So, no bank-loans, no chance of going bankrupt. I own quite some shares of VisualMed and I will keep them to see what will happen next.

Greetings.

[Fritz777]

Antwort auf Beitrag Nr.: 38.674.198 von ricky2009 am 06.01.10 12:11:11

Hi ricky

Can you please post the link to the mailer of Dab?
Was near the point to sell as in your postings from today I missed any numbers from Dab, but now I think the chance is bigger than the risk with my shares from VMCS.
Still looks like we still need to remain here for a longer period if we want to harvest the fruits of our investment.

Thanks for the informations
Fritz

[meveric]

Ich weiss das ich mir keine Freunde mache wenn ich das schreibe. Aber ich muss es loswerden.

So einen Bullshit wie da der Herr Dab wieder einmal abgegeben hat, habe ich schon lange nicht mehr gehört.

Sieht für mich eher nach einem unprofessionellen Gequasel von einem Betrüger aus weder von einem Geschäftsführer. Jedes Jahr die gleichen Floskeln. Was hat die Kriese mit Visualmed zu tun? Läuft es nicht gerade in Kriesen bei der Pharma- und Medizinbranche immer super? Werden alle krank und depressiv, wie nach 9/11 bricht noch eine Vogel- oder Schweinegrippe aus und mann wird depressiv.

Hmmm.

Hinzu kommt der Webauftritt der Firma, welche jeder 2. Klässer in 10 Minuten besser hinkriegen würde. Keine Produkte, keine Kontaktaufnahme, keine Angaben, Keine schlauen Referenzen, einfach alles was man auf einer Webseite nie machen sollte, wurde dort gemacht.


Ich bin einfach immer noch der Meinung, dass wir einem Sunnyboy mit Kuckident-Lächeln auf den Leim gegangen sind, welcher unser Geld verjubelt.

Kundenkontakte knüpfen
(heisst so viel wie: ins Puff gehen)
Aufträge aquirieren

(heisst so viel wie: mit Hillery und Chantal am Pool sitzen und Sekt schlürfen)

Erfolgserchung pünktlich präsentieren
(heisst so viel wie: Ach Jonny. Du weisst doch dass ich in der Schule scheisse war. Kannst du mir da für ein paar Leute irgend einen Scheiss mit Zahlen, die nicht schlechter sind als im letzten Jahr, im Netz veröffentlichen, damit diese wieder für ein Jahr ruhe geben? Danke und Peace Jonny. Wenn Du das erledigt hast, schicke ich noch Chantal hoch.)

Blablabla.

So und nun seit mir nicht böse. Freue mich natürlich auch über ein Kursfeuerwerk.

Gruss und schöner Tag wünsche ich.

[hermitderkohle]

Kann dir nur recht geben, Meveric!

Erstmal alles auf die Wirtschaftskrise schieben, vielleicht vergessen die Deppen ja, daß Visualmed schon vor der Krise den bach runter gegangen war.

Der Rest liest sich wie folgt:

Wir habe ein System entwickelt, das wohl keiner haben wollte und/oder das wir aufgrund unserers schlechten Marketings nicht verkaufen konnten. Jetzt sind wir so gut wie pleite und versuchen zumindest unsrer Gehälter für eine Weile zu sichern, indem wir andere unsere Idee nutzen oder verkaufen lassen.
Grundsätzlich haben wir 50.000.000 in den Sand gesetzt und hoffen irgendwie, irgendetwas davon wiederzusehen, wenn nicht auch egal, solange wir im Jahr 400.000 für uns rausziehen können.

It remains to thank many of you for falling for my IA scam and buying shares of our company so I can pay myself a rediculous salary for beeing an incompetent CEO!

Alles Käse!


apropos Käse....

[ricky2009]

Antwort auf Beitrag Nr.: 38.674.839 von Fritz777 am 06.01.10 13:39:31

Hi Fritz,

Hope you are still here! I didn't write you in the past months, because there wasn't much to tell. The introduction of the Patient Portal (Medforyou)in cooperation with McGill (MUHC) has been delayed for almost 5 months.

But there's news:

https://www.unani.ca/unani/unani.html

The portal (now called Unani) will be introduced March 15th, next monday. This is a break-through, both for Medical.MD/McGGill and Visualmed. As you know, Visualmed will receive a 15% royalty stream of all subscription revenues by Medical.MD for the use of Visualmed's technology.

Greetings.

[hermitderkohle]

Antwort auf Beitrag Nr.: 39.110.873 von ricky2009 am 11.03.10 09:42:26

Let us rejoice and sing: a real URL! Now that is great news. To bad even IA won't touch Visualmed anymore, so Dab has to find other means to spread the word, since he is sitting on a heap of wothless stock. Along comes ricky2009...

[ricky2009]

Antwort auf Beitrag Nr.: 39.118.995 von hermitderkohle am 11.03.10 21:54:37

For those interested:

Media Advisory - MUHC launches sophisticated web-based health and wellness tool
MONTREAL, March 15 /CNW Telbec/ - On Monday, March 15, the McGill University Health Centre will announce a significant development in Unani.ca - the first consumer-minded personal electronic health record in the Canadian marketplace that combines the expertise of an academic health centre with that of an award-winning information-technology developer. Representatives of the media are invited to attend a press conference:


Where: The Montreal General Hospital's Livingston Hall (L.6.100)

When: 10 a.m., March 15, 2010

Who: The Hon. Arthur T. Porter, Director General and CEO, MUHC
Pierre Ducros, Chairman of the Advisory Board, Medical.MD.
Dr. Jeffrey Barkun, Director of General Surgery; Chief Clinical
Officer of the Informatics Transition, MUHC
Philippe Panzini, Chief Technology Officer, Medical.MD

The press conference will also be broadcast live on the web at: www.webampsolutions.com/muhc

For further information: Rebecca Burns, Communication Coordinator, MUHC Public Affaires and Strategic Planning, [phone], [e-mail]

[ricky2009]

Antwort auf Beitrag Nr.: 39.151.053 von ricky2009 am 16.03.10 16:26:29

Mar 15, 2010 - 10:45 EST
MUHC Co-develops Sophisticated Web-based Health and Wellness Tool - Unani.ca Personal Electronic Health Record Available Today

Article ToolsEmail this articlePrint this article Smaller | Larger TextShare thisFace Book Digg Stumble Upon Del.icio.us Newsvine Reddit Buzz up!
Story Tools MONTREAL, March 15 /CNW Telbec/ - The McGill University Health Centre (MUHC) announced today that anyone with an Internet access and a desire to manage his or her health and well-being can now subscribe to Unani.ca.
Co-developed with Quebec-owned Medical.MD, Unani.ca is the first consumer-minded personal electronic health record (PEHR) in the Canadian marketplace that combines the expertise of a world-class academic health centre with that of award-winning information-technology developers. The launch of Unani.ca 1.1 comes on the heels of a successful beta test undertaken in July 2009.

"As one of the world's foremost academic health centres, the McGill University Health Centre's mission is to treat complex medical conditions and carry out research and teaching that will have a meaningful impact on people's quality of life," said the Hon. Arthur T. Porter, MUHC Director General and CEO. "With Unani.ca, we bring a new dimension of support to the general population. Whether a person is healthy, managing a chronic condition such as Diabetes or helping a family member make a positive lifestyle change, Unani.ca provides a user-friendly Web-based platform where health and lifestyle information can be aggregated, tracked and shared."

Unani 1.1 is easy to navigate thanks to an interface that even the most novice of computer users would find straightforward, an integrated step-by-step tutorial, intuitive menus and shortcuts. Distinct from medical electronic health records being implemented by government or hospital medical records, Unani.ca is a lifestyle tool designed from the ground up with the consumer in mind.

"The MUHC's vision and collaboration have been indispensable as we've developed and refined this unique product," said Pierre Ducros, Chairman of the Advisory Board at Medical.MD. "We are proud to have had the support of world-class health experts to bring this first version of Unani.ca to the market, and look forward to a continued relationship as we add new and exciting features in the coming months."

<< Unani.ca 1.1's features include: - Multilingual user interface allows subscribers to switch instantly between English and French.

- Medical data allows lists of health conditions, medications, allergies, intolerances, vaccinations, therapies, life style choices and family history information to be compiled and cross-linked.

- Charting provides an at-a-glance view of a person's vital signs over time.

- Document storage is a secure repository for any type of document, from medical imaging and lab results to a fact sheet.

- Fax allows subscribers to receive a document by facsimile directly to their account.

- Agenda offers an address book for contacts, a calendar to manage appointments and a journal for personal notes.

- Print allows subscribers to format data, medical or other, into a single document that can either be sent via e-mail or printed on paper.

>> "I believe that a more informed person is a healthier person," said Dr.

Jeffrey Barkun, Director of General Surgery and Chief Clinical Officer of the Informatics Transition at the MUHC. "Historically, that information has come from sitting down with a physician, however, the times have changed. It's important for individuals to also take a leadership role and Unani.ca offers them that opportunity. Rather than telling their physician what's ailing them from memory, people can bring a digital snapshot of their health to the table and even make lifestyle changes before a physician's intervention is required.

That's significant!" In June 2008, the MUHC began collaborating with the consumer IT experts at Medical.MD on the state-of-the-art PEHR. MedforYou 1.0 was released in July 2009 for beta testing within the MUHC community. Within ten days, nearly 400 participants had signed on and began using the system. Around the same time, TELUS Health Solutions started discussions to onboard the PEHR on TELUS health space, powered by Microsoft HealthVault; the first pan-Canadian electronic platform devoted to managing consumer health.

"We applaud MUHC's leadership in making consumer-centric health care a reality by providing a personal health record tool for their patients and constituents to use to manage their health and that of their family," said Marc Filion, Chief Operating Officer and General Director, TELUS Health Solutions. "In the future, when Unani.ca is on-boarded to TELUS health space, consumers will benefit from an enhanced platform that will expand their ability to import and exchange medical information electronically, such as test results, with their healthcare provider, allowing them to take full advantage of the functionality to manage their health."

Features planned for Unani.ca in 2010 include applications for wireless devices such as the iPhone, iPad and BlackBerry, other languages and a module designed to manage the specific health needs of women.

"The MUHC has every reason to be proud of Unani.ca. Marrying high-tech sophistication with �ber-user-friendliness puts this personal electronic health record in a class of its own. Moreover, it allows the MUHC to extend its health education across the community, reaching youth and adults alike," concluded Arthur T. Porter.

[ricky2009]

Antwort auf Beitrag Nr.: 39.151.076 von ricky2009 am 16.03.10 16:27:54

McGill launches web program to let people create their own one-stop medical file
By Peter Rakobowchuk (CP) – 9 hours ago

MONTREAL — The day is not too far off when your cellphone, iPhone or Blackberry will ring to remind you to take your medication.

That's one of the eventual goals of a new web tool launched Monday by the McGill University Health Centre. The secure program, known as Unani.ca, allows anyone with Internet access to maintain a list of personal health conditions, medications, allergies and family medical history.

In short, it allows you to build your own medical file.

Dr. Jeffrey Barkun, the MUHC's director of general surgery, says that rather than tell a physician what's ailing you from memory, you can now carry around that digital file.

"It's a health organizer - a tool whose time has come," he said.

"It's a way of managing all the information you have, put it into some type of capsule, and communicate it to a doctor."

Barkun says it would be especially useful for people with diabetes, or such chronic illnesses, who want to be able to keep all their medical information together in one place.

He adds that giving people access to their electronic health record might also compel them to make lifestyle changes, even before they're forced to do so by a doctor.

"Frankly if we concentrated more on keeping people well, I would have less to do," quipped MUHC director-general Arthur Porter.

He says the system has already been tested and is freely available.

"Because the system is so easy and so intuitive, for someone who has a little computer skills, once you get in, it's very easy to use," Porter added.

The MUHC co-developed Unani.ca with Quebec-owned Medical.MD. Philippe Panzini, a co-founder of Medical.MD, said in an interview that the website is not for "cyberchondriacs."

"We believe most people will put valid information in the system," he added.

Panzini said a lot of "nice touches" will eventually be added to the program -and he used interaction with cellphones as an example.

"Like reminding you automatically - maybe tell you on your cellphone - (that) it's time to take that pill, because some people have a lot of pills to take and it's a difficult thing to do," he said.

Panzini predicted that, within the next year or so, the online health information system will be connected with doctors, hospitals and clinics.

"You will receive automatically your blood tests in the system - and your doctor's notes and your prescriptions," he said. "This is the direction we're going towards."

Health officials stress that the health information platform would be distinct from medical electronic health records being implemented by government, or from hospital medical records.

Panzini also said all the personal information is encrypted and stored in a data centre which is "as secure as humanly possible".

He noted a similar personal health information system currently exists at Sunnybrook hospital in Toronto.

[hermitderkohle]

Auffällig, daß der Name Visualmed in diesem Bericht nicht einmal erwähnt wird. Das sind ja großartige Neuigkeiten!

[Fritz777]

Antwort auf Beitrag Nr.: 39.110.873 von ricky2009 am 11.03.10 09:42:26

Hi ricky

Sorry I am out, hope you can make some money here with your long wind.
Thank you for all the informations and sorry if other people speaking my mother tounge do not show the appropriate respect as you are the only one to inform the rest of the board here.

Regards and good luck with VMCS
Bergler

[hermitderkohle]

Die letzten Nachrichten haben ja für ein wahres Kursfeuerwerk gesorgt! Den nächsten "News" werde ich, wie auch ihrem Überbringer, natürlich den gehörigen Respekt zollen.

Gruß

HmdK

[ricky2009]

Antwort auf Beitrag Nr.: 39.389.520 von hermitderkohle am 23.04.10 10:33:21

My German Friends,

Still selling your shares for as little as a few cents?

Do some research:

www.visualmedsolutions.com

Read the financial report 2009:

http://www.visualmedsolutions.com/VH_Pages/VH_news.htm

Yes, a profit of $248.000!!!!!

And now it's all starting over again:
- reseller Medicalmd in Canada has 3 products that are making headway (and money, 15% goes to Visualmed)
- reseller ICC in the USA is gaining ground (15% of turnover goes to Visualmed), now that ARRA is shaking up the market.

So, Visualmed has become profitable, even when turnover is still a modest 1 million plus. But....every dollar extra turnover means one dollar more profit.

Be clever, don't sell your shares for pennies. Keep them (or even average down) and hold them and make some money!!!!

[erch]

Hi ricky!
Thank you for the good information!
Please let me ask you: What is the reason for you to hold us informed? Are you getting paid for it? Do you have stocks by yourselve?

[meveric]

Heute habe ich nicht schlecht gestaunt, als Visualmed das letzte mal mit einem Preis von EUR. 24.- gehandelt worden sein sollte. Schön wäre es.

Ich habe den Geschäftsbericht 2009 einigermassen durchgelesen.

Es steht viel zu viel unwesentliches geschrieben. Wenn Visualmed ihre NEWS und Webseite mit so viel Text und Nachrichten pflegen würde.

Wie ich aus dem Bericht entnommen habe, hat Visualmed bereits etwa die 5 Kapitalerhöhung durchgeführt. Der Cashbestand liegt nur noch etwa bei 11'000? Da liegt doch schon bald wieder eine Kapitalerhöhung an der Tagesordnung.

[ricky2009]

Antwort auf Beitrag Nr.: 39.607.679 von meveric am 31.05.10 11:20:05

Hi all,

New contracts:

ARRA Financial Incentives Drive Demand for VisualMED smart EHR


Medical Facilities Sign Agreements Worth $2.6 Million
LAS VEGAS, NV, Jun 29, 2010 (MARKETWIRE via COMTEX) -- VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6.F) announces that it has received in the past three weeks firm orders for its Clinical Information System from independent private medical facilities worth an aggregate amount of 2.6 million.
The deals are multi-year rental agreements that will see the deployment of the Company's signature smart Electronic Health Record, with full CPOE, decision support and medical alerts, over the next 3 months. A significant part of the implementation support and help desk will be outsourced for greater speed and efficiency.

Starting in April the Company has been receiving increasing requests for quotes as medical facilities seek to meet the 2011 deadline for the first and largest disbursement to physicians under ARRA provisions. The key for physicians to secure these payments is meeting the meaningful use criteria which can only be demonstrated by using a true intelligent CPOE such as the ones VisualMED has been offering for many years.

"Thanks to the new reforms our time has come," says Chairman Gerard Dab. "We are now becoming a mainstream product line that helps physicians meet new regulatory standards. Providers have only five years to implement systems that offer meaningful use before they face punitive measures, and there is a shortage of expertise in the marketplace to do so."

VisualMED appears to be benefiting from the new regulatory environment created by the Healthcare Information Technology provisions of the American Recovery and Reinvestment Act (ARRA), which has earmarked close to $40 Billion to promote the widespread adoption of systems that correspond to federal norms of meaningful use, such as those owned and marketed by the Company since 2006.

Medical institutions are under increasing pressure to adopt such technologies. There is an industry-wide rush to identify systems that can help physicians qualify for federal ARRA reimbursement grants. This has led to an increased demand for products and services from companies that can deliver the rich medical content and suitable interoperability required.

The Company continues to work with its network of licensees and will seek to expand its network of strategic alliances. It expects to be profitable for a second consecutive year and has continued to contain operating costs.

ABOUT VISUALMED

VisualMED markets smart EHR with Clinical Information Systems (CIS) and Computerized Physician Order Entry that meet the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010.

We offer a powerful technology platform both scalable and interoperable, developed at a cost of some forty million dollars and tested over many years in tertiary care and ambulatory environments.

Our solutions help medical facilities reduce mortality and morbidity due to medical errors, increase provider efficiency and bring down operating costs. Their key clinical components are a core solution in the new agenda to promote greater patient safety and reduce risks due to medication errors.

Detailed information on our company and its products is available on our web site at www.visualmedsolutions.com

FORWARD-LOOKING STATEMENTS

Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.

So, a cool 2.6 million. Alive and kicking!!!!!!!!!!!

Bye.

[binda]

Antwort auf Beitrag Nr.: 39.755.347 von ricky2009 am 30.06.10 09:07:45

Liest sich verdammt gut.

"Thanks to the new reforms our time has come," says Chairman Gerard Dab. "We are now becoming a mainstream product line that helps physicians meet new regulatory standards. Providers have only five years to implement systems that offer meaningful use before they face punitive measures (Strafmaßnahmen), and there is a shortage of expertise in the marketplace to do so."


Medical institutions are under increasing pressure to adopt such technologies. There is an industry-wide rush to identify systems that can help physicians qualify for federal ARRA reimbursement grants. This has led to an increased demand for products and services from companies that can deliver the rich medical content and suitable interoperability required


Die Zukunft gehört Visual.

[binda]

Kam die News gestern nachbörslich??

[ricky2009]

Antwort auf Beitrag Nr.: 39.755.755 von binda am 30.06.10 10:18:04

Hi Binda,

You know, the problem was that when most investors bought shares in Visuelmed Clinical Solutions in 2005/2006 there was no real market for intelligent Electronic Health Records with Clinical Decision Support. Now there is! Every hospital/clinic and private practice has to adopt an EHR before end 2015 or they will be punished by Medicaid and Medicare. There are more than 12.000 facilities, a huge market. The USA Government has adopted the American Recovery and Reinvestment Act (ARRA) in 2009 and is paying a large part of the investment in intelligent systems. ARRA is starting now!

Visualmed Clinical Systems will be a winner. Mind my words.

Greetings.

[binda]

Die Nachricht scheint drüben gut anzukommen, es trauen sich wieder welche zu kaufen

Intraday
1 Monat

[ricky2009]

Antwort auf Beitrag Nr.: 39.760.732 von binda am 30.06.10 22:58:20

Hi All,

This comes as no surprise:

"Greetings to all

Please find enclosed a press release that announces our first post Reform Act deals with private clinics in the US. As you can imagine with the large subsidies of up to 64,000 per physicians more of these deals are the pipeline.
Best Regards"

Gerard


Gerard Dab
Chairman and CEO
VisualMED Clinical Solutions Corp
Tel. [phone]
www.visualmedsolutions.com

[ricky2009]

Antwort auf Beitrag Nr.: 39.761.763 von ricky2009 am 01.07.10 09:39:50

Hi All,

I received this letter from mr. G. Dab:


VisualMED Clinical Solutions Corp.

VisualMED in the U.S. market: Some Critical Success factors

Dear Shareholder:

Nobel Prize laureate Paul Krugman, a Princeton University economist and influential New York Times columnist, told journalist Charlie Rose in a recent interview that the real threat to the economy was the long-term Federal structural deficit, and that at the core, the crux was in solving the intractable Social Security deficit caused by rising healthcare cost.

Therein lies the real secret of the health reform act and ARRA dollars for physicians. The motivation for ARRA and the health reform act go beyond basic humanitarian consideration and represent measures intended to help reduce these deficits.

It will be interesting to see how the new regulations are enforced. In many other industries it has been demonstrated time and again that the most effective measures to lower cost are those that promote greater quality and the implementation of quantifiable quality assurance programs.
In practical terms this requires the type of automation that only VisualMED and a handful of companies are capable of delivering.

If meaningful use is enforced as intended, then many providers will be forced to follow best practice solutions like those we offer. To understand the potential financial impact, suffices to consider the following:

• It has been estimated that some 40% of hospital expenses are the result of medical errors, adverse drug interactions, readmission due to incomplete procedures, readmission due to avoidable complication, and neglect or lack of home care, all of which can be significantly reduced by using a smart clinical system.
• Most clinical vital signs measured by patients at home are not properly transmitted.
• Most clinical vital signs, if transmitted, are not received by an automated clinical repository that can provide real alerts and interpretation.
• Most patients do not use their medications as intended and the resulting inefficiency contributes to the cost factor. Few systems exist that can intervene in a non-invasive manner. VisualMED is exploring the creation of a network for instant collection and interpretation of home-based vital signs.
• Currently in America, according to a Newsweek magazine article published in 2007, close to 300,000 Americans die each year from drug errors, three times the number of 98,000 estimated in 2000 by the Washington based IOM. The IOM recommended the use of smart computerized order entry (CPOE) as a tool that could avoid half of all adverse drug events.
• Recent articles suggest that one patient in eight is victim of an adverse drug event (ADE) or other potentially lethal error.
• Iatrogenic errors have been steadily climbing as a major cause of mortality.
• A great deal of diagnostic information generated by smart machines and automated labs ends up being lost or used wrongfully because physicians are not connected.

All of the above creates high organizational stress and puts tremendous financial pressures on health care organization and the federal agencies that more than half of all medical bills in America.

We are one of the few vendors that offer tested and proven solutions. The current flow of orders and request for information we are receiving comes from early adopters who understand the need to prepare for the new health order brought in by the administration. The more savvy health managers understand that this is a fundamentally bi partisan issue and that there will be no turning back.

The American economy may no longer be in a position to support double digit cost escalation. The US spends almost 50% more than France and Britain as percentage of GDP but ranks well below these two comparable countries in quality and outcomes.

These are main driving forces that make up our critical success factors. Our business will be developing in the wake of public policy.

Thank you for your continuing interest in the company,
Best Regards


Gerard Dab
Chairman and CEO
VisualMED Clinical Solutions Corp
Tel. [phone]
www.visualmedsolutions.com

[ricky2009]

Antwort auf Beitrag Nr.: 39.839.778 von ricky2009 am 19.07.10 09:33:05

More news from mr. G. Dab on recent developments in the US-market:

Greetings

Please find below an article on a new 27 billion appropriation for digital records rules.
VisualMED provides an inexpensive and physician user friendly solution for that market which you will see may be even more lucrative for VisualMED than our flagship Smart EHR with CPOE.

Regards,


Gerard Dab
Chairman and CEO
VisualMED Clinical Solutions Corp

Tel. [phone]
www.visualmedsolutions.com


HHS releases digital-records rules
By: Jennifer Haberkorn and Kim Hart
July 15, 2010 04:26 AM EDT

The Obama administration’s release of long-awaited standards for digitizing medical records finally gave the green light to information technology companies that have been waiting to cash in on billions in stimulus dollars.

Between the American Recovery and Reinvestment Act of 2009 and health care reform legislation, about $27 billion has been set aside to help doctors and hospitals convert patient medical records to digital files. Big tech companies started beefing up their own health software businesses to take advantage of the opportunity.

But most health care providers waited to buy the expensive equipment while the administration finalized rules on reimbursements for costs related to implementing the systems. The Department of Health and Human Services released 864 pages of regulations Tuesday.

Computerizing medical records, in theory, will cut costs and reduce errors. For companies with large health care divisions, such as McKesson, Cerner, Microsoft, Google, Siemens and General Electric, the regulations mean billions of dollars in potential revenue.

“There’s been a lot of uncertainty in the provider community about what kind of equipment they should be purchasing, so they’ve been holding back from buying anything,” said David Main, chairman of the health care regulatory practice at Pillsbury Winthrop Shaw Pittman. “Now they can make plans to buy.”

But that doesn’t mean all hospitals and doctors will jump on the digital record bandwagon right away. Physicians complain the software programs are too complex and take too much time to fill out, especially in fast-paced environments like emergency rooms.

And all the software products have to go through a certification process, and it’s not yet clear how companies can dispute failing grades. Regardless of the kinks, providers will face penalties if they don’t adopt the new technology by 2015, a timeline some say will cause gridlock.

Don May, the American Hospital Association’s vice president for policy, says the pressing timeline could impose a burden on infrastructure.

“Everyone is going to vendors at the same time,” he said. “Even if [the hospital] is ready today, they may have to wait 18 months before the vendor goes out to implement it. “What we’ve created is this market that’s going to be like 495 at rush hour,” he says, referring to the Capital Beltway.

[Goetterdaemmerungen]

Antwort auf Beitrag Nr.: 39.839.790 von ricky2009 am 19.07.10 09:36:43

Warum wird Visualmed in Deutschland gehandelt und in Amerika läuft seit Anfang August nichts mehr. Wer kennt die Antwort!!!!

[erch]

Ich leider nicht, aber die Frage ist gut!

[ricky2009]

Antwort auf Beitrag Nr.: 39.996.428 von erch am 17.08.10 12:19:57

Hi there,

What do you mean? Last week some 300.000+ shares were traded on OTC.
The answer you want to hear is this: nobody is selling substantial amounts of shares at these prices. Watch the news coming out on Visualmed Clinical and hold on to your shares.
Better times ahead!

[ricky2009]

Antwort auf Beitrag Nr.: 39.998.058 von ricky2009 am 17.08.10 15:54:23

Hi all, here's visualmeds latest PR:

Press Release Source: VisualMED Clinical Solutions Corp. On Monday August 9, 2010, 5:41 am EDT
LAS VEGAS, NV--(Marketwire - 08/09/10) - VisualMED Clinical Solutions Corp. (The "Company") (Pinksheets:VMCS - News) (Frankfurt: VA6.F) is now offering its content rich highly-efficient safety and drug compliance system to pharmacies and drugstores. A full range of pharmacy-specific applications is now available for deployment, and will help drugstores consolidate relationships with clients and referring physicians.

Using the Visual Pharma application, pharmacists can provide better health management services to patients, including tracking medication compliance and home care monitoring, especially for the elderly.

Visual Pharma is easy to install and use. It provides drugstores with a cost-effective system to keep track of all patient and physician requirements, and to handle renewals and safety alerts. It can flag errors in medications and warn of Adverse Drug Event possibilities. "Drug Stores can make a credible and verifiable claim that they provide higher safety standards for their clients, thereby strengthening the relationship with patients and their referring providers," says Chairman Gerard Dab.

The system actually puts participating drugstores at the center of a new wired link connecting pharmacists, physicians, patients and their families in a single network. Physicians may send prescriptions directly to the drugstore for pickup. Visual Pharma has the ability to automatically capture and analyse data from home care devices allowing the pharmacist to alert physicians or families in case of abnormal readings.

"We are responding to the needs of various stakeholders. Pharmacists have long expressed the need to have access to a wider range of clinical information. Families have been looking for solutions in getting better care of their elder members," adds Mr. Dab.

"Visual Pharma is already being evaluated by drugstore groups and the company looks forward to securing some $10 million worth of business over the next 12 months. Implementation is light, timeline is less than a month and the training phase is measured in days. Pricing is right and drugstores can recoup their investment in 12 to 18 months," concludes Mr. Dab.

With Visual Pharma, drugstores can expect to see increased patient referrals from physicians in their community.

Patient Care from home

A special feature allows patients at home to use linked-in devices to send readings about their blood pressure, sugar levels, heart rates and other vital signs. The data is captured with no human intervention through embedded network connections. A data file maintains these readings, while anomalies are automatically flagged to both the physician and the drugstore. Now, older patients who wish to stay in their own homes instead of a medical facility can be regularly monitored through their drugstores.

Quick implementation

The learning curve for Visual Pharma is minimal: two to five hours for drugstore employees and pharmacists. Patients don't need to learn anything about the system as transmission of readings is automatic. Information already stored at the drugstore or at physicians' offices in older systems is automatically downloaded and reformatted.

ABOUT VISUALMED

VisualMED markets highly usable smart Clinical Information Systems (CIS) with EHR and Computerized Physician Order Entry that are at the core of the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010.

We offer a powerful technology platform with a broad array of rich embedded clinical data, both scalable and interoperable, and whose high level of usability has been tested over many years in tertiary care and ambulatory environments.

Our solutions help medical facilities increase provider efficiency, bring down operating costs, demonstrate meaningful use for ARRA grants and subsidies, and reduce mortality and morbidity.

Detailed information on our company and its products is available on our web site at www.visualmedsolutions.com

FORWARD-LOOKING STATEMENTS

Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.

Contact:
For further information: Gerard Dab CEOVisualMED Clinical Solutions Corp.Tel: [phone]

[binda]

"Visual Pharma is already being evaluated by drugstore groups and the company looks forward to securing some $10 million worth of business over the next 12 months. Implementation is light, timeline is less than a month and the training phase is measured in days. Pricing is right and drugstores can recoup their investment in 12 to 18 months," concludes Mr. Dab ( Monday August 9, 2010 )
1 Monat ist jetzt rum...



08.09.10
frankfurt
Zeit Kurs Volumen
15:34:04 0,033 30000
15:32:24 0,031 25000
14:12:20 0,03 1500
11:32:25 0,029 1000
09:14:17 0,031 20000
09:10:12 0,03 10000

[hermitderkohle]

Antwort auf Beitrag Nr.: 40.121.091 von binda am 08.09.10 20:30:32

Jetzt mal rasant verdoppelt, mein lieber Schwan!

[ricky2009]

Antwort auf Beitrag Nr.: 40.220.219 von hermitderkohle am 27.09.10 23:30:35

Hi all, another update from G. Dab:

Greetings

You will find in this report from KLAS below two interesting information.
First, medical facilities are moving ahead making acquisition of EMR, a movement
based on the promise of ARRA monies for physicians.
Second these same facilities are now looking for partners like VisualMED
that have the product and capability to help them achieve meaningful use.

Our own sales funnel has been growing rapidly ever since the passage of
the health reform bill five months ago, demand has finally materialized.
You may notice that the very few large facilities that could purchased EMR
did so in 70% of the case from CERNER and EPIC, two still small companies,
offering serious clinical solutions turning away from the giants such as Siemens
IBM and GE which used to command the hospital dollars.
These are further indications that our time has come.

The only factor slowing our growth at this point in time is the
fact that facilities, like many other small businesses in the US, find it difficult to
access credit to pay for their acquisition. We have begun negotiating on
their behalf with foreign lending institutions, it looks like we can get very favorable terms.
Best Regards
Cheers

Gerard Dab
Chairman and CEO
VisualMED Clinical Solutions Corp
101 Convention Center Drive, 7th floor
Las Vegas, Nevada, 89109
Tel. [phone]
[e-mail]


New KLAS report: CIS Purchase Decisions: Riding the ARRA Wave

Report highlights:

* EMR sales reached a seven-year low in 2008 due to the economic downturn; however, purchases nearly doubled in 2009 reflecting the increased attention EMR systems have received since the American Reinvestment and Recovery Act announcement.

* Organizations not only want a truly integrated system that clinicians will actually use, they are looking for a vendor that can be a consistent and reliable partner in their efforts to reach meaningful use.

* Seventy percent of the 2009 new large hospital EMR purchases in the report were integrated solutions from Epic and Cerner.

For purchasing and other information regarding this report, please visit the KLAS Web site or contact your KLAS representative at 800-920-4109.

[erch]

aktuell bewegt sich was; gepushte Schummelkäufe oder reine Spekulation oder Insiderinfos - keine Ahnung.
Wenn das konkreten Hintergrund hätte, ginge ich von weiteren Kurssteigerungen aus. Dann müsste man schnell nachlegen; dass dazu zunächst mal kaum einer Mumm hätte, spricht für fundamentale Gründe hinter der aktuellen Bewegung.

[erch]

Frühjahr 2009 gab es schon mal so eine Phase - die war aber kurz ...

[hermitderkohle]

Antwort auf Beitrag Nr.: 40.239.462 von erch am 30.09.10 13:04:22

Also wenn es irgendwelche Gründe gäbe die für eine Kursteigerung sprächen, dann hätte Mr. Dab die schon mit Krokant und Sahnehäubchen von Ricky auftischen lassen. Bisweilen gibt es aber nur die Info, dass sich die Rahmenbedingungen zum Vorteil von Visualmed geändert hätten. Verkäufe? Verträge? Fehlanzeige! Von daher ist die Zockerbude in Vegas gut aufgehoben, denn da stirbt die Hoffnung nie.

[Goetterdaemmerungen]

Antwort auf Beitrag Nr.: 40.239.462 von erch am 30.09.10 13:04:22

Grundsätzlich bin ich auch überascht das der Titel noch lebt. Aber auf Grund das in jedem Land momentan alle Gesundheitssysteme auf dem Prüfstand stehen besteht immer noch eine gute Chance auf Gewinne. Was hat man denn zu verlieren!!!! Einsatz 2000,00 E und schwub hat man ca. 30.000 Tausend Aktien. Und wenn nur gezockt wird ist doch egal. Fundamentales
ist heute zu Tage sowieso rar. Gruß an alle die der Aktie treu geblieben sind und bleiben.
Mal sehen was passiert!!

[erch]

Kurzes Strohfeuer wieder vorbei?

[binda]

Antwort auf Beitrag Nr.: 40.279.103 von erch am 07.10.10 08:46:13

rauf runter

wenn man den 2 jahreschart anschaut sieht man jedoch einen zaghaften aufwärtstrend. auch das handelsvolumen hat sich erhöht.
jedoch noch lange nicht zufriedenstellend.Zitat von Götterdämmerung: Aber auf Grund das in jedem Land momentan alle Gesundheitssysteme auf dem Prüfstand stehen besteht immer noch eine gute Chance auf Gewinne
sehe ich auch so. Gruß binda

[Goetterdaemmerungen]

Antwort auf Beitrag Nr.: 40.279.159 von binda am 07.10.10 08:53:49

Mir hat mal jemand gesagt wenn im Kursverlauf ein schönes W entsteht dann steigt die Aktie!!!! Bis jetzt hat der Jemand wohl Recht.

[erch]

Ich sehe kein W.
Ich sehe eher das letzte Zucken im Oberschenkel, bevor dieses Teil unter 2 Cent zu haben sein wird.

[erch]

ricky2009 - dont you get money any more for good news?

[pegasusorion]

Antwort auf Beitrag Nr.: 40.301.652 von Goetterdaemmerungen am 11.10.10 21:40:06

Dein Name is ja nich schlecht, aber es dämmert nich oder????

Stell das Ding glatt und investier in ein vernünftiges Papier!

[Goetterdaemmerungen]

Antwort auf Beitrag Nr.: 40.497.872 von pegasusorion am 11.11.10 07:03:44

Nicht nur der Name ist gut ! Ich kann ja auch nichts dafür das Obahma ein wennig schwächelt.Es hängt eben viel an dieser Gesundheitsreform ab.Aber so wie ich hat Obahma
bwstimmt auch ein As im Ärmel oder zwei?? Naja ich hoffe bei euch dämmerts auch bald.
Macht was ihr wollt ich bleibe investiert, kann nicht viel verlieren oder der Laden gehört mal mir. Egal schönen Gruß.

[binda]

GREENWAY ACQUIRES IMAGING TECHNOLOGY
October 21, 2010, Carrollton, Ga. – Greenway Medical Technologies, Inc. today announced that it has acquired imaging technology and certain other assets from VisualMED
http://www.greenwaymedical.com/dynamicData/news/pdf/288/Gree…


----------------------------------------------------------------------------------------------

In the News
October 26, 2010
Greenway Medical Bolsters Its Health Software With Visual MED DealBy Timothy Hay
10/26/2010

Greenway Medical Technologies Inc. said doctors using its software will be able to easily add medical images to digital patient records, following the company's recent acquisition of technology from Visual MED Inc.

Terms of the deal weren't disclosed.

Both Greenway Medical and Visual MED are venture-backed companies, according to Greenway spokesman Greg Fulton. Visual MED, based in Charlotte, N.C., will continue on with its other lines of business, which involve creating imaging software for several different segments of the health-care industry, he said.

Visual MED hasn't provided details about its investors or its fund-raising history. An attempt to reach the company wasn't successful.

Greenway offers software to individual doctors and small practices, rather than hospitals, Fulton said. The company's system enables digitizing patient records, but it also handles a medical clinic's back-end operations, including billing and scheduling, he said.

Acquiring Visual MED means Greenway can now enable doctors to affix images--for example MRIs or X-rays--to digital patient records.

Founded in 1998, Carrollton, Ga.-based Greenway has raised more than $90 million from investors including Investor Growth Capital, Pamlico Capital and Wachovia Capital, VentureWire records show. Fulton said individual investors have also backed the company.

Other software companies have offered to acquire Greenway, but the profitable company has spurned all offers, Fulton said. Instead, Greenway is looking to acquire other companies or their technology, he said.

The company told VentureWire in 2006 that it aimed to go public. Fulton declined to comment further about the plan.

Greenway has 400 employees, he said. Valuation was not disclosed.


Übersetzung von Englisch nach Deutsch
In the news
26. Oktober 2010
Greenway Medical stärkt seine Gesundheitssoftware mit Visual MED Deal
Von Timothy Hay
10/26/2010

Greenway Medical Technologies Inc., sagte, dass Ärzte, die diese Software verwenden, nach der kürzlich erfolgten Übernahme der Technologie von Visual MED Inc, in der Lage sind, auf einfache Weise, digitale medizinische Bilder Patientenakten anzulegen.

Die Bedingungen der Transaktion wurden nicht bekannt gegeben.

Beide Greenway Medizinische und Visual MED sind Venture-backed-Unternehmen, nach Greenway Sprecher Greg Fulton. Visual MED, in Charlotte, NC basiert, wird weiterhin auf mit seinen anderen Sparten, die Schaffung von Imaging-Software beinhalten für verschiedene Segmente des Gesundheitswesens Industrie, sagte er.

Visual MED hat keine Einzelheiten über ihre Investoren oder ihre Fundraising-Geschichte zur Verfügung gestellt. Ein Versuch, das Unternehmen zu erreichen war nicht erfolgreich.

Greenway bietet Software an einzelne Ärzte und kleine Praktiken, anstatt Krankenhäuser, sagte Fulton. Das Unternehmen ermöglicht die Digitalisierung Patientenakten, aber auch Griffe einer medizinischen Klinik Back-End-Betrieb, einschließlich der Abrechnung und Disposition, sagte er.

Visual MED zu erwerben bedeutet, durch Greenway können Ärzte jetzt Bilder anlegen - zum Beispiel MRT oder Röntgenaufnahmen - die digitale Patientenakte.

Gegründet 1998, Carrollton, Ga.-basierte Greenway hat mehr als 90.000.000 $ von Investoren wie Investor Growth Capital, Pamlico Capital und Wachovia Capital erhöht, zeigen VentureWire Datensätze. Fulton sagte einzelnen Anleger haben auch die Unternehmen gesichert.

Andere Software-Unternehmen haben angeboten, Greenway zu erwerben,stattdessen hat das profitable Unternehmen alle Angebote verschmäht, sagte Fulton. Im Gegenteil, Greenway ist dabei andere Unternehmen oder deren Technologie zu erwerben, sagte er.

Das Unternehmen erklärte VentureWire im Jahr 2006, dass es an die Öffentlichkeit gehen wollen. Fulton lehnte weitere Kommentare zu den Plänen ab.

Greenway hat 400 Mitarbeiter, sagte er. Bewertung wurde nicht bekannt gegeben.

[binda]

“We are excited to announce this technology acquisition, as it gives our customers a low-cost way to manage the multitude of images and reports they encounter on a daily basis,” said Tee Green, Greenway president and CEO. “While we continue to pride ourselves on having built our award-winning PrimeSUITE EHR solution from the ground up, this acquisition sends a clear message that we intend to acquire industry-leading technology where strategically advantageous,” Green said.

[Johnmil]

Antwort auf Beitrag Nr.: 40.616.042 von binda am 30.11.10 15:29:44

Dear Binda,
Please check the name! This Visual Med is not "our" VMCS (The CS at the end of the name is important). And you missed the most important: the JV on 14/07/2010 with the RIDE Group Holding, but nobody may know it yet, so don't tell to anybody else, PR should come soon, they just were forgotten, ....(http://www.rideempire.com/strategic-alliance.php). And many, many contracts are at the final stage. And not only America but also China could become a nice client. It's just a matter of time and patience. Sleep well.
John

[erch]

Thank you, John, for correcting!

Leute, "sleep well" klingt zwar wie "gute Nacht", aber ich glaube, das war positiv gemeint ...

[binda]

Antwort auf Beitrag Nr.: 40.616.860 von Johnmil am 30.11.10 16:44:53

Schade

[Johnmil]

Antwort auf Beitrag Nr.: 40.619.480 von binda am 30.11.10 22:06:56

Don't worry, it's better it was not our VMCS. Our VMCS needed money to finance the contracts, the JV with the new partner makes our situation looking still better than before. But nothing is sure till we know more details from Herr Dab himself. However, the change is now greater that after new information will be released, we will regret not to have bought more shares ....
Have sweet dreams (und das ist positiv gemeint ...)

[erch]

Hi Johnmil! Do you think, Dab is interested in good share-value? If he is, why does he not put out good and clear information? I can only explain this, if the good facts are not sure enough, not real facts. For years now is the situation like now.

I hope, Dab knows, that he definitely has to give bad information also, if necessary.
But he does not tell anything clear; only making "hope".

[Johnmil]

Antwort auf Beitrag Nr.: 40.643.617 von erch am 03.12.10 18:49:23

Erch, Mr Dab and the Ride group should have a nice amount of shares in the holding. The holding has about 20 % of the shares of VMCS. So of VMCS is doing well, they can earn a lot of money. If Ride became a JV partner, it means they smell money. The situation is not any longer the same as a year ago. We can only hope that they don't play a dirty game, but that's negative thinking. That kind of thinking has only one reason, a lack of communication and information. I don't think it will take long before we'll know more, but not long means one, two or three months. I wonder if this will be pre-announced with any strong movement in volume and price. In any case it's rather a very special situation, it gives the feeling of an all or nothing situation. It should be all, but human mind often fears. Let's call it exciting, dangerous and hopeful, something like poker instead of investment. Those who don't play, can't win and that's the game...

[hermitderkohle]

Dab, aka Ricky seems to have a new name now...

[Johnmil]

This business seems to become very hot. Similar companies like VMCS were getting big money from the bigger guys. In the spotlight: Aetna´s acquisition of Medicity, only a basic medical decision support platform, for an amount of half a billion and the merger of Alls with Eclipsys was a deal of one billion...
Nor mr. Dab nor Ride can tell anything more about the JV because not all the details are yet settled. According Ride we'll get more news in the beginning of next year, according Mr. Dab he will give us more information about the JV, together with the year end results (1/07/09 - 30/06/10) in the next few days ....But we all know that when Mr. Dab is talking about days these could be weeks ... In any case something is coming very soon. Is a price below one $ for VMCS a gift or not, is it only the beginning or the end? Let us hope that some uncertainties will be clarified in the very near future.

[Goetterdaemmerungen]

Antwort auf Beitrag Nr.: 40.697.163 von Johnmil am 12.12.10 20:14:34

Mein englisch ist nicht so gut !! Ich kann das alles nur halb oder gar nicht verstehen.

Kannst du das auch auf deutsch schreiben.

Thank you.

[hermitderkohle]

Keine Sorge, wenn Du der Sprache mächtig bist, findest Du nur den üblichen alten Wein in neuen Schläuchen, lediglich von einem neunen Visualmed Botschafter ausgeschüttet: Es tut sich tolles auf dem Markt, unglaubliche Joint ventures sind passiert und deshalb ist es nur noch eine Frage der Zeit...bla,bla,falsel, laber Rhabarber. na dann mal Prost.

[binda]

Research Report
Hotstocked.com has a complete research report available for VMCS stock. Download VMCS report. Date: Nov 21, 2010
Price: Free
Pages: 5
Document Type: Adobe Acrobat Reader
Download VMCS report

[meveric]

Antwort auf Beitrag Nr.: 40.720.659 von binda am 16.12.10 11:58:51

Mich gibt es da ja auch noch.

Schön war das letzte Jahr. Viel Hat Visualmed wieder nicht hingekriegt. Eines finde ich aber ganz komisch....

Hotstocked.com

Warum veröffentlichen diese jetzt eine Empfehlung zum Verkauf? Also viel tiefer als wir bereits sind kann ja das Teil gar nicht mehr fallen. Sie schreiben auch, dass hier Manipulation betrieben wird... hm hm .. Aha. Ich glaube ich kenne keinen Pennystock bei dem das nicht betrieben wird und allem voran sind es meistens Buden wie Hotstocked die das noch unterstützen.

Kann mir gut vorstellen, dass Visualmed plötzlich durch die Decke geht. Ein paar NEWS, ein völlig überverkaufter Titel der nicht mehr weiter runter will und ein paar Pusher genügen schon, für einen grösseren Ausbruch.

Tod ist der Titel noch nicht. Denn diese Visualmed Leute betreiben Kurspflege auf höchstem Niveau und lassen sich immer wieder ein kleines Schmankerl einfallen, welches die Visualmed Gemeinde wieder etwas hoffen lässt.

Abgeschrieben habe ich den Titel schon lange im Depot. Aber etwas gutes hatte dieser Kauf trotzdem. Seit daher bin ich nie mehr auf eine solche Mistbude hereingefallen. Und wenn ich Aktien von einer solchen Firma gekauft hatte, dann war es ein kalkulierter Zock.

Nunja. vielleicht startet Visualmed ja im nächsten Jahr noch durch und führt die Pennystock Liste an

Mich würds freuen.

Wünsche einen guten Rutsch und bis Bald.

[Goetterdaemmerungen]

Antwort auf Beitrag Nr.: 40.766.744 von meveric am 28.12.10 09:05:21

Visualmed clinical solutions wechselt das Börsensigement ??????????????????????

[binda]

Zitat von Goetterdaemmerungen: Visualmed clinical solutions wechselt das Börsensigement ??????????????????????

[binda]

Endweder ist das hier ganz viel heiße Luft, oder die kriegen doch noch die Kurve.
Ich weiß es nicht. Risiko

Gruß binda



Marketing Strategy and Recent Developments

During 2009, VisualMED completed a key restructuring that saw the significant reduction of operating expenses and a move to become a flow-through revenue generating company through licensing, marketing, distribution and sale of its technologies by third parties.

Our technology is running in 7 healthcare facilities, and our threshold for critical market penetration of 12 facilities is now being pursued by an array of licensees and authorized resellers.
One of the most important segments of our activities has been licensed to Greenwich Science Partners Inc, an Alberta holding and its affiliate Integrated Clinical Care Corp. a Nevada Corporation, to whom some of our research and development efforts have been outsourced, and from which 12.5% of all revenues flow to VisualMED.

In the same vein we have licensed some Canadian rights to VisualMED distribution inc of Montreal including the management of our academic center solution VisualOncology at McGill University affiliate Segal Center of the Sir Mortimer B. Davis Jewish General Hospital.
VisualMED Distribution continues to explore opportunities in Italy. Canadian executive health specialist Plexo Inc continues to have exclusive Canadian rights in the executive and employee health market. Other licenses have been granted to companies such as Omnitech, Medical.MD, Mtuitive and Cardinal Health..
The ASCO organization (American Society of Clinical Oncology) is a major venue for Integrated Clinical Care Corp., and the company is currently in the process of closing some 5 agreements with doctor owned clinic in the United States, backed by the success of the technology at the ASCO annual EHR showcase and subsequent industry validation.

The sales effort will continue to target regions where current legal regulations encourage the adoption of our clinical management modules. These markets are being aggressively pursued through the creation of sales consortiums that bring together local healthcare consultants, hardware vendors and local systems integrators. We are proud to report that current installations continue to operate at full capacity with zero downtime at all of our client facilities.
Negotiations are still ongoing with several hospital management groups in Europe. We have begun the slow process of establishing a relationship with the new Italian government, and physicians and local authorities of two Italian provinces. The French healthcare shareable Electronic Medical Record initiative has been put on hold during the political transition in that country, however we hope to form new relationships with the new government.

http://www.visualmedsolutions.com/VisualMED%20Annual%20repor…


http://www.visualmedsolutions.com/PRESS%20RELEASE%20VMCS%20F…Medical facilities sign agreements worth $2.6 million
LAS VEGAS, NV, June 28th 2010

[ricky2009]

Antwort auf Beitrag Nr.: 40.809.463 von binda am 06.01.11 11:42:09

Hi Binda,

Seems like you all missed the most important developments from past weeks:

Visualmed filed its Annual List and raised its share-capital:

Action Type: Amendment
Document Number: 20100919363-84 # of Pages: 1
File Date: 12/10/2010 Effective Date:
Previous Stock Value: Par Value Shares: 100,000,000 Value: $ 0.00001 Par Value Shares: 15,000,000 Value: $ 0.00001 Par Value Shares: 10,000,000 Value: $ 0.00001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 1,250.00 New Stock Value: Par Value Shares: 350,000,000 Value: $ 0.0001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 35,000.00

Action Type: Reinstatement
Document Number: 20100918220-45 # of Pages: 1
File Date: 12/10/2010

So did Visual Healthcare a few weeks ago:

Action Type: Annual List
Document Number: 20100769821-46 # of Pages: 1
File Date: 10/13/2010 Effective Date:
(No notes for this action)

Action Type: Registered Agent Change
Document Number: 20100758286-29 # of Pages: 1
File Date: 10/07/2010 Effective Date:
(No notes for this action)

Action Type: Amendment
Document Number: 20100758289-52 # of Pages: 1
File Date: 10/07/2010 Effective Date:
Previous Stock Value: Par Value Shares: 200,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 200,000.00 New Stock Value: Par Value Shares: 600,000,000 Value: $ 0.0001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 60,000.00

What does it all mean? It means that Visualmed and Visual Healthcare is benefitting from the uptick in business investment. New shareholders will step in.

[ricky2009]

Antwort auf Beitrag Nr.: 40.810.208 von ricky2009 am 06.01.11 13:02:03

We know that Visualmed has signed a Joint Venture Agreement with Ride Group Holding. Not sure if Ride Group Holding will take a share in Visual Healthcare as well. A few weeks ago Mr. G. Dab wrote an e-mail to stockholders:

Greetings

I am forwarding the news letter below regarding Aetna´s acquisition of Medicity, a basic decision support platform for an amount of half a billion, a purchase price described in various articles as full or eye popping. Medicity offers limited application for decision support and information sharing. It cannot support full automation of the clinical environment yet it fetched an impressive price.
Many of you have written to me indicating that by searching the likes of Twitter they had uncovered the fact that VisualMED was involved in similar strategic alliances involving the sale of equity. I am held back from commenting under the constraints of non disclosure agreements yet I cannot deny information brought to my attention from outside sources. Therefore I will be sending a letter to shareholders to that effect in the next few days so they can assess for themselves the impact of these development on company valuation in the future. This letter will be sent once we post our year end results on the website. Kindest Regards to all

Cheers


Well, we're still waiting for the FS 2010 and his letter to shareholders, but "there's something cooking".

Greetings.

[Nick65]

Frage? Was muss geschehen, dass ich meine 3 €/Stück wiedersehe?

Jahrelang die Augen zu machen und das Ding vergessen hat bisher nichts gebracht.

[Goetterdaemmerungen]

Leider investiert man bei Aktien in die Zukunft. Bei mir sieht es nicht anders aus. Habe aber später meinen Kurs runter gemittelt aber Verlust
bleibt Verlust. Verkaufen bringt jetzt aber auch nicht mehr viel. Aber
ich glaube immer noch an eine Trendwende. Weil vorher war kein Potenzial
da aber mittlerweile kann sich da was entwickeln haben. Das ist meine
Meinung und darin liegt auch meine Hoffnung.

[oedinger1]

Auf dem Hollandischen Wallstreetweb wirt regelmassig geschrieben uber VMCS.
Es wirt geschrieben das in diesem monat die jahres zahlen uber 2010 bekannt werden, und das sich so ein und anderes tut.

http://wallstreetweb.nl/community/viewtopic.php?p=90988#9098…

[chriwass]

Antwort auf Beitrag Nr.: 40.990.827 von oedinger1 am 06.02.11 15:29:03

Hi Mittleidende, auch ich bin ein Gefangender dieser revolutionierender Aktie,
hat mir auch ein kleines Vermögen gekostet, leider bis heute konnte ich es noch nicht ausgleichen.
Wie sagt doch ein schönes Sprichwort,"Die Hoffnung stirbt zum Schluß" ich werde Sie halten bis zum Schluß.
Aber wenn die Nachbarn in Holland mehr Wissen habe, nehmmen wir es gerne an, oder?

Gruß an die Gemeinde

Chriwass

[oedinger1]

Ubernommen von Wallstreetweb,

Geplaatst: Do Feb 10, 2011 5:21 pm Onderwerp:

--------------------------------------------------------------------
Dear Sir
We will be filing and posting our 2010 results no later than February 15th.
I appreciate your desire for more information about some of our joint ventures but I cannot
answer to one inquiry but I will send out a general letter to all the time of filing.
You may have noticed that we have made steady improvements in our operations in the past three years
and I expect the trend to continue in 2011. You will surely have noticed that medical automation is being
gradually brought into the limelight.
Thank you for your interest
Best Regards

Gerard Dab

[oedinger1]

http://www.otcmarkets.com/stock/VSHC/company-info

und

http://www.otcmarkets.com/stock/VSHC/financials

[ricky2009]

Hi,

Someone sold some Visualmed shares today at a little over 2 eurocents. Must be mad! Financial Statements 2010 and some more details on the Joint Venture with RIDE Group are expected today/tomorrow.

[binda]

Zitat von ricky2009: Hi,

Someone sold some Visualmed shares today at a little over 2 eurocents. Must be mad! Financial Statements 2010 and some more details on the Joint Venture with RIDE Group are expected today/tomorrow.

Das wäre ja klasse, wenn heute schon was käme.

Gruß binda

[binda]

Hatten wir hier, glaube ich, noch nicht:


Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Audited Financials Not Available
Latest Report Feb 09, 2011 Quarterly Report http://www.otcmarkets.com/otciq/ajax/showFinancialReportById…

CIK 0001121130
Fiscal Year End 6/30
OTC Market Tier OTC Pink Limited

[binda]

Joint Venture with RIDE Group
Hier ein paar Details von der RIDE-homepage, wie ein JV abläuft:

http://www.rideempire.com/images/stories/RIDE-JointVenturePr…

[binda]

Dear Sir
We will be filing and posting our 2010 results no later than February 15th.



Naja, steht ja nicht dabei,in welchem Jahr.

[Goetterdaemmerungen]

Antwort auf Beitrag Nr.: 41.048.191 von binda am 16.02.11 10:16:07

Das Börsensigment spricht ja für sich. Aber trotzdem ist da was im Busch!!

Seit dem Visualmed in dieses Sigment gewechselt ist gab es nie solche Umsetze.

Und ich wiederhole es nochmal die Aktie lebt !!!!!!!!!!!!!!!!!!!

[binda]

Zitat von ricky2009: Hi,

Someone sold some Visualmed shares today at a little over 2 eurocents. Must be mad! Financial Statements 2010 and some more details on the Joint Venture with RIDE Group are expected today/tomorrow.

Hi ricky,
I miss a comment from you, to your posting .

Nothing happened what you wrote on the 14th February.

Who is mad now?

Binda

[ricky2009]

Antwort auf Beitrag Nr.: 41.151.515 von binda am 04.03.11 23:02:50

Hi Binda,

Yes, you're right. But mr. Dab is letting us down once again. Don't know what's holding him up. Found this correspondence with mr. Dab on a dutch forum:

Dear Mr DAB,

Again shareholders have to conclude that the info they receive from Visualmed is not
correct. You have promised results/PR before at least 15 februar 2011. There is nothing published sofar and it is the 17th of Februar!

Kind regards

Antwoord:


Dear Sir

Again you are right but we are in a major restructuring and we have to think through the repositioning of the company now that there is at last a real market for our products.
At this point in time, the financials we are completing are the Quartelies up to Q2 , 2011 that are now due and that need to be filed with the year end.
I can however share with you some elements of facts:
We are still one of the most advanced and best performing clinical system,
We have lowered our cost of delivery to users by 90% over the past three years.
We have offers to acquire part of the company as most people are now aware at an excellent valuation,
We are also seeking new strategic partners in the US,
We maintain a low burn rate, less than low six figures,
We have successfully retired a great deal of current and accumulated debts,
American public policy and medical practice standards continue to favor Visual|Med more than ever,

Details on all these issues will be available in our Quarterly filings.

Thank you for your interest

Kind regards


Gerard Dab
Chairman and CEO
VisualMED Clinical Solutions Corp
50 West Liberty Street, Suite 880
Reno, Nevada 89501
Tel. [phone]
[e-mail]

Binda, let's see what happens in the next few days.

[ricky2009]

Antwort auf Beitrag Nr.: 41.152.445 von ricky2009 am 05.03.11 12:42:45

Hi Binda,

See VisualMED's website, under NEWS:


SUBSEQUENT EVENTS
Since June 30, 2010, the Company has entered into a number of significant negotiations with new strategic partners. In particular, it has entered into an agreement with Ride Empire Corporation in order to raise up to $53 million in new capital designed to expand activities and to finance customers. In exchange for this financing, the Company could issue as much as 40% in additional equity.
As a result, the Company has seen fit to undertake significant steps to reduce its outstanding debt load. On October 29, 2010, the Shareholders resolved by a 62.4% vote to increase the authorized shares of the Corporation from 125,000,000 to 350,000,000 shares.
We have since begun striking much of the short-term and long-standing debt from our books, converting long-standing Notes held against us into shares of the Company As of March 1, 2011, 166,605,700 common shares have been issued, the vast majority of which are restricted under rule 144 and cannot be traded.

[ricky2009]

Antwort auf Beitrag Nr.: 41.159.932 von ricky2009 am 07.03.11 17:58:10

March 13th. 2011


Dear Sir
In response to your questions and that of some of our fellow shareholders, let me state the following:

We have just posted our results for 2010, and the first 6 months for fiscal 2011 will follow in the next two days. It is clear that the company has continued to make significant progress over the course of the year. We have continued to compress expenses and limit losses to a minimum. Thanks to this conservative policy, we have achieved our main objective to continue to own and control 100% of our $50 million plus intellectual property, which remains unencumbered and free of all liens even after the difficulties encountered in the last few years.

We have many new signed licensing agreements with private clinics but most of these will not be reflected in GAAP revenues until later in the year. We have also adopted a series of radical measures and innovations in order to remain well positioned for the coming transformation of healthcare delivery in the US. These include an upgrade to a more flexible platform, an innovative product line for American drug stores and for the first time we will be in a position to offer physicians a free app at almost no cost to us.

We continue to attract considerable attention from both industry players as well as from institutional investors. We have entered into agreements that would see significant capital injection into the company, at a valuation level that is higher than the current price of the stock. Our market appeal remains strong in view of the massive undertaking that will be required to reform and modernize the crumbling healthcare industry in the US. Conventional wisdom is that this cannot be achieved without automation and smart systems like ours.

This has brought new scrutiny by various parties looking at the company and we have been advised to reduce our current debt load in order to be in line with post crisis concerns over debt in the US. In the second quarter of 2011, before the completion of the Ride/VisualMED private placement memorandum, we had to bite the bullet and settle most of the company’s debt load by converting debt to equity, most of which will remained restricted.

Our agreement with Ride Empire, as documented by the public filing of a private placement memorandum in December, calls for issuance of convertible loans of up to a maximum of $53 million in exchange for a maximum dilution of 40% of the company in the form of restricted shares.
I believe that 2010 saw the transformation of the business from a science company, albeit a brilliant one, to a more prosaic organization, one that can adjust product offerings to actual market conditions. We are focusing more on what doctors want and not what we think they need.

We are expanding our offerings in cooperation with our affiliated companies. One of the most important is the development of a free-standing platform for general practitioners that will be available online and will allow them to track basic patient care in a way that will save them a significant amount of time and positively impact their bottom line.

This is a turning point for the company. We will be able to offer a free application as a genuine loss-leader, in order to rapidly augment the number of our registered users. This has been rendered possible by transposing applications on some of the newer convergence platforms, where we can recruit new users at practically zero installation cost.

At the other end of the spectrum, some of our system-wide complex applications for major hospital environments continue to be developed with the support of major institutions such as the Segal Cancer Center and Plexo Inc. We have undertaken the certification process for meaningful use, as defined by the Department of Health and Human Services in the United States, even though the rules continue to be less than clear.

In fact the regulatory establishment as well as medical organizations have yet to clarify in real terms how and when doctors will be reimbursed for modernizing their practices. At the recent HIMSS conference, there was much conflicting information, and the general mood from our prospective clients was to wait and see. This explains in part our lower revenue figure for 2010.

I fully realize that the lesser revenue figure for 2010 will disappoint some investors. It should be noted that after years of haemorrhaging red ink, our number one mission remains to maintain the integrity of the company and exclusive ownership of our intellectual property.

The Quarterly Reports for Q1 and Q2 2011 will continue to show modest revenues, but will explain in more detail the nature of some of the financing agreements that we have entered into.

As we move along in 2011, some of the investments that we are contemplating demonstrate once again that there is genuine shareholder value accrued in the company, and strong interest in the company’s potential once healthcare reform gets underway.

Hoping this note provides additional perspective, I remain

Yours Truly

Gerard Dab
Chairman and CEO

[binda]

Antwort auf Beitrag Nr.: 41.197.367 von ricky2009 am 14.03.11 11:19:54

Thanks ricky


We have just posted our results for 2010


Where? I could`nt find them.

[ricky2009]

Antwort auf Beitrag Nr.: 41.197.572 von binda am 14.03.11 11:40:53

Visualmed's website (www.visualmedsolutions.com), see the NEWS section.

The 2010 revenues were rather disappointing at $389.000. Only a small loss, as they have cut back on their cost. I'm looking forward to the quarterly results of december 31st, as they will tell me more about recent developments under ARRA.

Most interesting is the deal with Ride Empire, injecting $53,000,000 in the company by means of a convertible bond. So, Visualmed has no debt, they own a technology that's valued at appr. $50,000,000 and have the cash now (thanks to Ride) to grow. Demand for their Electronic Health Record / Clinical Information System is picking up, so the future seems very bright.

Let's hope that mr. Dab will do all the necessary filings to upgrade Visualmed's standing at OTC Markets (he has done so recently for Visual Healthcare!!!) and issue a press release on these new developments. Only few people are following this company, which explains the rediculously low valuation of the stock at only a few cents. I think that will change soon enough.

Greetings.

[binda]

March 13th. 2011

Dear Sir
In response to your questions and that of some of our fellow shareholders, let me state the following:

We have just posted our results for 2010, and the first 6 months for fiscal 2011 will follow in the next two days.

Yours Truly

Gerard Dab
Chairman and CEO

I didn`t believe it, but.....


NEW (Posted on March 17, 2011) VisualMED Quarterly Report Q1 2011.1A

Overview
During Q1 the Company has seen fit to undertake significant steps to reduce its outstanding debt load. We have since begun striking much of the short-term and long-standing debt from our books, converting long-standing Notes held against us into shares of the Company.
We refer to the twelve month period ended June 30 2010, as fiscal 2010, and the twelve month period ended June 30, 2009, as fiscal 2009.
At June 30, 2010, the Company had a working capital deficiency of $2,014,708 as compared to a working capital deficiency of $2,299,783 for fiscal 2010, and has incurred losses of $32,124,020 since inception.
We had a loss of $8,186 for Q1 2011 as compared to losses of 20,559 in fiscal 2010. We incurred approximately $55,000 in professional expenses and filing fees. This sharp increase in professional fees is due to a one-time bulge in legal fees of some $50,000 paid out to our legal counsel who represented the company in extensive negotiations with Ride Empire.
Operating expenses for Q1 2010 were $75,716.
http://www.visualmedsolutions.com/docs/VisualMED%20Quarterly…


NEW (Posted on March 178, 2011) VisualMED Quarterly Report Q2 2011.1A

Overview
During Q2 the Company continued with its drive to reduce its outstanding debt load. On October 29, 2010, the Shareholders resolved by a 62.4% vote to increase the authorized shares of the Corporation from 150,000,000 to 350,000,000 shares.
We continue to strike much of the short-term and long-standing debt from our books, converting long-standing Notes held against us into shares of the Company.$1,587,157 were retired in this way during the quarter, in order to comply with the demands of financial markets.
We refer to the three month period ended December 31 2010, as Q2 2011, and the three month period ended 2010, as Q1 2011.
At December 31, 2010, the Company had a working capital deficiency of $398,972, a major reduction as compared to a working capital deficiency of $2,014,708 for Q1 2011, and has incurred losses of $32,079,081 since inception.
We had losses of $5,061 for Q2 2011 as compared to losses of $8,186 in Q1 2011.
Operating expenses for Q2 2010 were $82,038,largely due to the fact that we incurred approximately $60,000 in professional expenses and filing fees, principally related to becoming current in our reporting obligations. However, this still represents a significant reduction as we streamline operating procedures.
http://www.visualmedsolutions.com/docs/VisualMED%20Quarterly…

[hermitderkohle]

32 Millionen bisher in den Sand gesetzt, der Umzug in die Wüsten- und Zockerstadt Las Vegas ist daher mehr als passend. Wer jetzt noch an Visual Med glaubt, kann es auch wieder mit dem Weihnachtsmann probieren.

[hermitderkohle]

Ist die Bude jetzt komplett platt?

[erch]

Keine Neuigkeiten?
Kein Geld mehr für ricky?

[binda]

06.07.2011 16:54
(31 Leser) 12345

(0 Bewertungen)
Schrift ändern:
AFX News · Mehr Nachrichten von AFX News · Archiv

VisualMED Clinical Solutions Issues June Quarter Revenues Outlook

OTTAWA (dpa-AFX) - VisualMED Clinical Solutions Corp. (VMCS.PK) announced that it is expecting its revenues for the quarter ended June 30th, 2011 to rise to an amount between $890,000 and $965,000.

The company stated that these banner figures do allow the Company to provide further guidance regarding year end revenues for the entire exercise which is expected to reach as much as $1.2 million to $1.3 million.

Copyright RTT News/dpa-AFX

© 2011 AFX News

[binda]

Final year end results will be released during the last week of August. The Company is planning to hold a conference call immediately after filing 2011 year end results. This conference will be open to all investors and will address the 2011 financial results. Contact information will be provided on company website.

Company Chairman, Mr. Gerard Dab attributes the rising revenue trend to early adopters who desire to move forward ahead of the curve in seeking advanced medical informatics. The administration has been particularly proactive in pushing for better quality of healthcare delivery to patients in American healthcare facilities. For the first time general market conditions appear to favor the kind of advanced medical technology VisualMED offers
http://de.advfn.com/nachrichten/VisualMED-Provides-Quarterly…

[binda]

June 14, 2011 Letter from the Chairman

http://www.visualmedsolutions.com/Dear Shareholder

I thought I would provide a compendium of some of the questions I have recently been asked by fellow shareholders.

Many have pointed out that our March 31st results did not suitably reflect the kind of revenues we should expect from prior deals. This is not entirely wrong and it is certainly a reality that the lag time between signing and moving ahead with a project can be quite frustrating at times. This is further complicated by the GAAP rules for revenue recognition standards.

We are now well along the fourth quarter and it looks like we will be able to book more substantial revenues in this very quarter considering the progress on some projects and license deals. You may also revisit the strong revenue guidance provided in a recent Visual Healthcare news release and realize that much of that work has been contracted out for execution to VisualMED.

Therefore when adding this to the revenues of the current implementation underway and some licensing revenues owing, we will definitely be in a position to book over $1 million for the current quarter which will more than make up for the lag time effect and achieve the highest yearly revenue in years but this time without the red ink incurred in past years.

I have also received questions about whether the recent weakness in the stock may be caused by parties who have recently received shares from our debt reduction plan. First let me point out that there has not been much volume to support any hypothesis of this sort. Furthermore, it should be remembered as I have stated before publicly, that practically all the new shares, that is over 90%, have been issued to affiliates and insiders who are not permitted to trade more than 1% per quarter and only when filing a personal form 4 disclosures to that effect. No such form has been filed. Also there is no short position that would point out to an insider trying to go around the regulation which of course would not be legal.

As I recently wrote to one of our fellow shareholders, we must be all too aware that negative sentiment on the company has been significant and may continue to prevail until such time as the company will again show top line growth higher than its previous best numbers. And we are about to reach that goal, so I do not see why insiders would lose confidence at this juncture after waiting patiently for so long just at a time when medicine finally begins to move into the 21st century.

I am also being asked about the status of the Ride deal. It is a large scale private placement endeavor that I set up and structured as a framework for raising non dilutive capital in the company. These types of deals are complex, take time and are conditioned by both business opportunities and money conditions. Most of the money is destined to fuel an acquisition drive designed to purchase blocks of business that would provide rapid accrual of revenues and income. That is accretive on a per share basis. It is a puzzle that may require more time but in the meanwhile it has certainly demonstrated the company’ s potential value and how it continues to attract significant interest as well as its ability to negotiate serious agreements with major players.

In conclusion, let me state that I will issue an official guidance news release on our expected fiscal 2011 revenues before the end of the month.
General conditions in the American healthcare industry are fast shifting in our favour. Even if Obamacare were to be challenged or reversed, the deed is done, the news is out there about meaningful use and it can no longer be ignored. It is now a matter of time until a jury condemns a medical facility to multimillion dollar crippling punitive damages for having failed to implement meaningful use. The courts have always been the final forum where Americans drive forward major social changes.

I hope these answers to questions from fellow shareholders will be useful and informative. Thank you for all useful comments, suggestions and support.

Sincerely,

Gerard Dab
Chairman of the Board and CEO

*****

Following the passage of the health reform law, one of the greatest challenges that will face the American health system and its providers will be the continuing struggle to improve patient safety in hospitals by the elimination of medical error.

In North America it is estimated that as many as 10% of patients admitted to hospital are subject to some form of medical error. Preventable medical errors have been estimated to cause as many as 200,000 deaths annually, with another 500,000 suffering some form of permanent injury. According to the Washington based Institute of Medicine a significant proportion of medical problems in hospital settings are medication errors, resulting in adverse drug events (ADEs), which can be averted by using electronic prescribing combined with decision support tools at point of care. Other problems associated with inadequate hospital procedures can be averted by the use of intelligent clinical information systems that provide streamlined automated work flow management tools.

Considerable progress in Patient Safety can be achieved by using new generation smart computer software providing facilities with functional electronic prescribing, computer physician order entry (CPOE) and clinical decision support. Studies in live North American hospital environments indicate that the application of CPOE technology can reduce these types of errors by more than 50% - and, in some cases, by up to 86%.

As health care costs rise faster than can be sustained by regional and national governments, Health Departments recognize that long term solution will not be possible without better health care information management, management that can best be addressed by the implementation of state-of-the-art integrative solutions such as those marketed by VisualMED Clinical Solutions Corporation. This site provides additional information on the problem of medical error, the use of CPOE technologies to reduce error, VisualMED Clinical Solutions Corp, and the VisualMED family of healthcare solutions.

About the company and its products

VisualMED Clinical Solutions Corp., since 1999, markets and distributes clinical management solutions that help hospitals and healthcare authorities reduce medication errors, increase personnel efficiency and bring down operating costs. One of its key decision support components is a core solution in the new agenda to promote greater patient safety and reduce risks due to medication errors which are at the core of meaningful use.


The VisualMED smart EHRs and Clinical Information Systems (CIS) are unique software applications built to conform to the way doctors and nurses provide and document patient care. The VisualMED CIS is the only solution of its kind to have been wholly designed by practicing medical staff in terms of both workflow and user interface. State-of-the art design is at the basis of product scalability. Unique design features allow system decision support to conform to local practice. From a purely technical perspective, object-oriented design and table-driven programming allows for cost-effective development that can rapidly respond to advances in medicine and surgery and informatics, itself.


VisualMED Clinical Solutions Corp. is a publicly-traded company on the Nasdaq OTC (ticker: vmcs.pk) and on the Frankfurt Exchange (ticker: VA6.F).









VisualMED Clinical Solutions Corp.
101 Convention Center Drive, 7th floor
Las Vegas, Nevada 89109
Tel: [phone]



The debate on Meaningful Use






Follow the evolution of meaningful use concepts, standards and regulations with the Association of Medical Directors of Information Systems at http://www.meaningfuluse.org/


For more on meaningful use go to:

http://content.nejm.org/cgi/content/full/362/12/1153

http://www.emrandehr.com/2010/01/25/another-meaningful-use-w…

http://www.himss.org/EconomicStimulus/

[binda]

heute in usa höchstes Handelsvolumen überhaupt

[Neuling77]

hat hier noch jemand ernsthafte Hoffnungen?

[binda]

August 4, 2011

Reno, August 4th, 2011 – Visual Healthcare Corp. (the “Company”) (NASDAQ OTC: VSHC) announces that it will be stepping up the delivery of its home care applications for seniors and the disabled which it announced last year as a major product initiative. The ability to provide reliable monitoring and medical care for seniors in their home is expected to emerge as a major trend in the search for savings in the bloated US healthcare system.


The sudden reversal of spending patterns to follow new US budget cuts is certain to impact Medicare and Medicaid. These come at a time when demographic pressures of an ageing population make it increasingly difficult to continue providing easy access to a wide range of expensive medical facilities as in the past.


‘We are seeing the emergence of a multi-billion dollar market for smart home care applications like ours that can not only monitor heart function, blood pressure, sugar levels, fever and oxygen source at home, but more importantly can also have it transmitted to a smart clinical system that will be reading the signs and providing suitable alerts in real time. These transmission protocols will require no human intervention and will be working through automated routes such as the GSM network,’ says Chairman Gerard Dab. ‘The ability to treat seniors at home will generate some of the serious savings required by policy makers.’


The Company is already providing smart distributive and inferential technologies to healthcare providers. Provider organizations and their suppliers are part of a new generation of caregivers who will increasingly rely on our proprietary enabling platforms, real smart clinical tools and adapted mobile devices to improve ambulatory care and keep patients out of expensive hospital stays.


In order to bring to market the most complete set of solutions, we are working closely with our strategic allies including affiliates VisualMED Clinical Solutions Corp., VisualMED Distribution Inc., and International Rational Health Systems Inc.


According to its Chairman, the Company has now increased its sales expectations in the home care market from one to three million dollars for Calendar 2012.

http://www.visualmedsolutions.com/

Visuelle Healthcare Corp (das "Unternehmen") (NASDAQ OTC: VSHC) gibt bekannt, dass es wird verstärkt die Auslieferung der häuslichen Pflege Anwendungen für Senioren und Behinderte, die es im vergangenen Jahr angekündigt, als eine große Produktoffensive. Die Fähigkeit, eine zuverlässige Überwachung und medizinische Versorgung für Senioren in ihrer Heimat bieten soll als ein wichtiger Trend bei der Suche nach Einsparungen in der aufgeblähten US-Gesundheitssystem entstehen.


Die plötzliche Umkehr der Konsumgewohnheiten, neue US-Budgetkürzungen werden sicher Auswirkungen auf Medicare und Medicaid haben. Diese in einer Zeit, demographische Druck einer alternden Bevölkerung es immer schwieriger, weiterhin einen leichten Zugang zu einer breiten Palette von teuren medizinischen Einrichtungen wie in der Vergangenheit machen zu kommen.


"Wir sehen das Entstehen einer Multi-Milliarden-Dollar-Markt für Smart-Home-Care-Anwendungen wie der unsrigen, die nicht nur überwachen, Herzfunktion, Blutdruck, Blutzuckerspiegel, Fieber und Sauerstoff-Quelle zu Hause sind, sondern vor allem auch haben sie übertragen, um eine intelligente klinische System, das Lesen wird das Zeichen und die Bereitstellung geeigneter Warnungen in Echtzeit. Diese Übertragungsprotokolle wird kein menschliches Eingreifen erfordern und wird durch automatisierte Routen wie das GSM-Netz zu arbeiten ", sagt Vorsitzender Gerard Dab. "Die Fähigkeit, Senioren zu Hause zu behandeln erzeugt einige der schweren Einsparungen von den politischen Entscheidungsträgern nicht erforderlich."


Das Unternehmen bietet bereits Smart-Verteilungs-und Inferenzstatistik Technologien im Gesundheitswesen. Provider-Organisationen und deren Zulieferer sind Teil einer neuen Generation von Betreuern, die immer auf unserer proprietären Plattformen ermöglicht, real intelligente klinische Werkzeuge und angepasst mobile Geräte verlassen, um der ambulanten Versorgung zu verbessern und zu halten Patienten von teuren Krankenhausaufenthalten wird.


Um die komplette Reihe von Lösungen auf den Markt zu bringen, arbeiten wir eng mit unseren strategischen Verbündeten einschließlich Tochtergesellschaften VisualMED Clinical Solutions Corp, VisualMED Distribution Inc. und International Rational Health Systems Inc.


Laut dem Vorsitzenden, hat das Unternehmen jetzt seine Umsatzerwartungen im Homecare-Markt von 1 Million auf 3Millionen Dollar für Kalender 2012 erhöht.

[ricky2009]

We refer to the twelve month period ended June 30 2011, as fiscal 2011, and the twelve month period ended June 30, 2010 as fiscal 2010.
At June 30, 2011, the Company had a working capital deficiency of $253,424 as compared to a working capital deficiency of $2,300,407 for fiscal 2010, and has incurred losses of $31,945,632 since inception.
We had a net income of $167,823 for fiscal 2011 as compared to losses of $35,056 in fiscal 2010. We incurred some $12,500 in professional expenses, depreciation and filing fees.
Operating expenses for fiscal 2011 were $1,290,483, up from $323,462 for June 30 2010 largely due to increased revenues and positive growth for the Company as healthcare markets move steadily toward automation.

This past year will prove to have been a watershed exercise in the long history of the company as we have for the first time ever managed to generate revenues without incurring the losses we had in the past. For the full year, VMCS turned out a profit of about $167K, its first profitable year ever after years of massive investments to develop and introduce the technology to the market place. We are getting clients in the private sector but we are also getting strong market validation from large corporate organizations now seeking our help and assistance in meeting the new regulations driven by new public policy. We are building on our history of alliances with major institutions and taking advantage of this experience.

These are some of the driving forces that explain in part the turnaround of our operations and our recent success. Our revenues are up more than 300% with most of the gains obtained in the last quarter and we expect a similar exceptional growth rate of 300% for the next exercise. We have emerged from the recession as a leaner company, one that is taking full advantage of new public policy to finally make money from our uniquely advanced technology and science businesses.

[Neuling77]

Na, das liest sich doch mal schick.... ich bin hier ja nun auch schon ewig investiert und hatte das Papier bereits abgeschrieben. Ich denke jetzt lege ich nochmal nach. Leider nur in Stuttgart möglich... Hab mal ne Order für bei 0,011€ reingestellt.... wer will, kann die gerne bedienen.

[binda]

VisualMED Files Year-End Disclosure Statement
Datum : 31/08/2011 @ 15h00
Quelle : MarketWire
Name : VisualMED Clinical Solutions Corp. (VMCS)
Kurs : 0.0101 0.0001 (1.00%) @ 15h41
Kurs Chart Reports Trades Level2


VisualMED Files Year-End Disclosure Statement

Visualmed Clinical Sltns (PC) (USOTC:VMCS)
Historical Stock Chart
1 Monat : August 2011 bis September 2011

VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6.F) announces that it has published its year-end disclosure statement and financial results. These are available on the OTC markets site as well as on the company website at www.visualmedsolutions.com.

The Company is pleased to report that Q4 came in as the best quarter in its history, leading to the most positive year to year results ever. The company is benefiting from the initial impact of coming health reforms in the US as we are finally undergoing an unprecedented acceleration of revenues barely two years after the passing of Obamacare and the first launch of meaningful use.

Revenues were significantly up for fiscal year 2011, surpassing earlier guidance at $1,543,510, with net income of $167,823, both spurred largely by the impact of current U.S. Administration's healthcare policies on the marketplace. It is clear that mounting pressure will continue to push forward the modernization of clinical facilities and we expect to more than double our current volume of business in the coming year.

"We are clearly benefiting from public policy which has had a marked effect on our ability to conduct our business, giving us some pricing power. We also benefit from our ability to lower operating cost. For the first time ever we have been able to provide services without incurring losses and therefore produce positive results," says Chairman Gerard Dab.

Gerard Dab will be hosting a company conference call to discuss company results, current business and future prospects on Wednesday, August 31st at 1 PM EDT (New York Time).

Please use the following Dial in number and access code.

Dial-in Number: [phone]

Access Code: 910071

All members of the public are welcome.

The full disclosure statement with financial results can be found at http://www.otcmarkets.com/otciq/ajax/showFinancialReportById…

ABOUT VISUALMED

VisualMED markets smart Clinical Information Systems (CIS) with EHR and Computerized Physician Order Entry that are at the core of the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010. We offer medical facilities and physicians a broad array of clinical applications with rich embedded clinical data, both scalable and interoperable, and whose high level of usability has been tested by over one thousand clinicians over many years in tertiary care and ambulatory environments. Our solutions help medical facilities increase provider efficiency, bring down operating costs, demonstrate meaningful use for ARRA grants and subsidies, and reduce mortality and morbidity. The Company's Suites of Medical Solutions operate on state of the art proprietary Software platforms with advanced analytical capabilities provided by Visual Healthcare Corp. (PINKSHEETS: VSHC).

Detailed information on our company and its products is available on our web site at www.visualmedsolutions.com

FORWARD-LOOKING STATEMENTS Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.

For further information, please contact:



Frederick Berlin

Operations manager

TEL: [phone]

or 514 582 5220

[binda]

Beiträge aus:
http://investorshub.advfn.com/boards/read_msg.aspx?message_i…

Hey all,

Just got off the conference call, I was as confused as you guys were before the CC. Dr. Dab and his son explained to me the different between VMCS and VSHC. VHSC owns the algorithm used in their applications, while VMCS links all the research data into the database the platforms use. Earlier in the year when they downgraded them to limited information, it was because a form they were submitting for the past year was following SEC forms whereas they were supposed to have submitted the Pink Sheet forms and therefore let to errors. To ensure that never happened again VSHC agreed along with Pink Sheets to submit the forms for review before they were accepted and uploaded. That's why there has been a delay. The CC was originally for today at 11:00AM but since they were delayed they have to wait for them to post before setting a CC for VSHC. I asked about how revenue booked is distinguished for each company and he said they have seperate contracts. It is almost as if they should be one company and quiet frankly I'm going to ask the CEO why he just doesn't merge them, boooking greater revenue and growing shareholder for both shareholders. I've stressed to Dr. Dab in the past that attention to detail is key as previously much market confidence was lost due to such errors. Management competence is paramount, I will continue to push for him to understand this as there should have been an update that would have prevented the confusion and lost of market confidence.



.......

For those who didn't pay very close attention to the call or couldn't read through the lines VSHC will be the large player here and be supplemented by it's investment in VisualMed. The technology alone per today's call along with my previous discussion with Gerard is where the true money will be made. The first large traunch of 2.5MM anticipated before the EOY will impact VSHC's bottom line only which will be huge here. In addition there are numerous other contracts for IP that are being discussed which will also impact VSHC going forward. I'll be buying as many as i can for cheap before others actually figure out where the money will be made here ). VMCS will be properly valued around .10 at the current time IMO analyzing the report, VSHC with the added IP/tech revenues is way undervalued.

[hermitderkohle]

Antwort auf Beitrag Nr.: 42.035.081 von Neuling77 am 02.09.11 10:37:02

Hallo Neuling,

ich hoffe, Du hast glück gehabt und keiner hat deine Order bedient...
Visualmed ist tot.

Gruß

Hermitderkohle

[Goetterdaemmerungen]

Toller Name, super Beitrag. Bla,Bla,Bla,Bla. Danke!!!

[binda]

Kurs : 0.018 0.0095 (111.76%) @ 20h57
VisualMED Physician-Designed Systems to Benefit From UK $20 Billion Hospital IT Fiascos
Visualmed Clinical Sltns (PC) (USOTC:VMCS)

VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6) announces that a major article in the New York Times analyzes the failure of old IT models and practices in the giant $20 billion dollar British Health IT program that ended in a resounding fiasco. The Times article describes the British program as "...an ambitious drive to computerize England's health records and let doctors, clinics and hospitals share patient information."

"The UK failure was predictable," says Chairman Gerard Dab. "The project was managed by British Telecom, who shunned physician input and paid the price." Implementation was turned over to engineers from major American and Japanese IT service corporations. Attempted input from medical schools and physicians was not welcomed. Imperial College of London was ignored when it recommended doctor-designed medical solutions from VisualMED.

A senior Physician from the University of Manchester, UK, has recently stated that the project has been moribund for years. He says that beyond the delays and mismanagement, there have been almost no successful implementations even of the seemingly simple applications such as e-Prescribing and e-Booking, let alone of EHRs.

The fatal engineering bias is confirmed by Dr. David J. Brailer, former national coordinator for health information technology in the Bush administration, who is quoted in the article as saying that "The experience in Britain is a warning to us. The thing that brought them to their knees was the confrontation with doctors."

Coming on the heels of Google's withdrawal from healthcare, the massive British failure makes it abundantly clear that going forward; institutions must turn to physician-driven solutions like those of VisualMED. These developments have begun to weaken the position of big IT service companies and this will translate into greater market penetration for the handful of physician-driven companies like VisualMED.

This helps explain the sudden progress of VisualMED in the past two years, a positive trend that shows no sign of slowing down as the Company's first quarter indicates. Revenues for the quarter show a marked increase of more than 400% over the same period last year.

"We are very encouraged by the recent turn of events. After years of being ahead of the curve, the market is finally moving in our direction," concludes Gerard Dab.

ABOUT VISUALMED

VisualMED markets smart Clinical Information Systems (CIS) with EHR and Computerized Physician Order Entry that are at the core of the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010. We offer medical facilities and physicians a broad array of clinical applications with rich embedded clinical data, both scalable and interoperable, and whose high level of usability has been tested by over one thousand clinicians over many years in tertiary care and ambulatory environments. Our solutions help medical facilities increase provider efficiency, bring down operating costs, demonstrate meaningful use for ARRA grants and subsidies, and reduce mortality and morbidity. The Company's Suites of Medical Solutions operate on state of the art proprietary Software platforms with advanced analytical capabilities provided by Visual Healthcare Corp. (PINKSHEETS: VSHC).

Detailed information on our company and its products is available on our web site at www.visualmedsolutions.com

FORWARD-LOOKING STATEMENTS Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised

http://de.advfn.com/nachrichten/VisualMED-Physician-Designed…

[binda]

As the name VisualMED Clinical Solutions Corp. (PINK:VMCS, VMCS message board) hints, the company provides clinical solutions, like a complete electronic patient record. Earlier this year, the company reported some impressive results, but the stock didn't take off so strongly as it did yesterday.
Yesterday, VMCS closed up 100% at $0.017. The volume was stunning 8.1 million shares. And all this happened due to a press release issued by the company before the markets opened.


The PR focused on an article about the failure of IT models and practices in the British Health IT program. Basically, the PR says the program failed because it didn't take input from medical schools and physicians. Gerard Dab, CEO of VMCS, stated: "We are very encouraged by the recent turn of events... ...the market is finally moving in our direction."

It seems this was enough to cause the huge interest on the market. The immediate reaction was even more fervent; in the morning, there were transactions in which VMCS was traded as high as $0.027. In the end, this was just a PR about the potential VMCS has. It makes the reserved reaction to the annual report seem strange.

In its report for the year and quarter ending June 30, 2011, the company recorded almost $1.3 million in revenue for the quarter and $221 thousand net income. Most of it generated in the last fiscal quarter. There is no guarantee VMCS will continue to grow, but if it does it may provide shareholders with some value.

http://www.hotstocked.com/article/20982/visualmed-clinical-s…

[binda]

VisualMED Provides Revenue Guidance on First Quarter
Datum : 18/10/2011 @ 15h28
Quelle : MarketWire
Name : VisualMED Clinical Solutions Corp. (VMCS)
Kurs : 0.0144 0.0024 (20.00%) @ 16h23
Kurs Chart Reports Trades Level2


VisualMED Provides Revenue Guidance on First Quarter

Visualmed Clinical Sltns (PC) (USOTC:VMCS)
Intraday Stock Chart
Heute : Tuesday 18 October 2011

VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6) is pleased to be able to announce today that it expects revenues for the first quarter of fiscal 2012 to be between $320,000 and $400,000. The mid-range of the current guidance would represent close to a 400% increase over the same period last year. The continued growth in revenue reflects the emerging trend away from engineering service companies to medical based vendors with real clinical solutions like those offered by VisualMED. If the first quarter performance trend is maintained in following quarters which are seasonally stronger, then the Company's previous guidance for fiscal 2012 would have to be revised sharply upward.

"It should be remembered that medical informatics is still quasi-virgin territory. We have major business initiatives that have taken long years to develop and are expected to mature this year and start producing revenues," says Chairman Gerard Dab. "Certain contract negotiations have extremely long cycles due to size and complexity of the decision process. Any one of them would have an instant multiplier effect on our performance."

The Company's main priority currently is to finalize certain deals that would see VisualMED medical content powering healthcare applications distributed over a wide array of national institutions in the United States, to hundreds of thousands of users caring for millions of patients. VisualMED advanced solutions, already among the lightest and most flexible in the industry, have been targeted by a number of provider-user partnerships as a likely candidate. This validates once more VisualMED's expertise and ability to leverage its established brand into major corporate relationships.

The Company continues to credit changing conditions in the healthcare market for its continuing performance.

ABOUT VISUALMED

VisualMED markets smart Clinical Information Systems (CIS) with EHR and Computerized Physician Order Entry that are at the core of the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010. We offer medical facilities and physicians a broad array of clinical applications with rich embedded clinical data, both scalable and interoperable, and whose high level of usability has been tested by over one thousand clinicians over many years in tertiary care and ambulatory environments. Our solutions help medical facilities increase provider efficiency, bring down operating costs, demonstrate meaningful use for ARRA grants and subsidies, and reduce mortality and morbidity. The Company's Suites of Medical Solutions operate on state of the art proprietary Software platforms with advanced analytical capabilities provided by Visual Healthcare Corp. (PINKSHEETS: VSHC).

Detailed information on our company and its products is available on our web site at www.visualmedsolutions.com

FORWARD-LOOKING STATEMENTS

Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.

For further information, please contact:



Frederick Berlin

Operations manager

[kuli2002]

Ups, ein lebenszeichen!? Kann sich jemand nen Reim drauf machen? Oder sind hier alle schon längst über alle Berge, und ich bin der einzige, der auf seinen Verlusten sitzt!

Bin gespannt, ob hier und in die Aktie wieder Bewegung kommt!

Viel Glück allen,

Kuli

[binda]

http://www.visualmedsolutions.com/index.htm

Dear Shareholder,

I am pleased to report that we have had the best quarter in our history, leading to the most positive year to year results ever as evidenced in our year-end annual report now publicly posted well in advance of the September 28 deadline. The numbers speak for themselves; we are finally undergoing an unprecedented acceleration of revenues barely two years after the passing of Obamacare and the first promulgation of meaningful use. Our company is deriving major benefits from public policy.

Our revenues are up significantly, and our market share although still minimal has begun to expand as we have started to deliver clinical solutions to new clients looking to modernize their medical facilities, to improve services to patients and lower costs of their operations. For the first time ever we are able to deliver services without incurring losses greater than what we can charge.

These positive developments are happening for us after a lengthy commitment to develop and maintain some of the most advanced and effective state-of-the-art intelligent medical applications, a commitment of nearly $50 million over close to a decade. Our Company has come through a long process while expecting regulations and public policy to push healthcare automation onto the last major industry to still be working with pen and paper.

Our outlook is now brighter than ever with a rising rush of early adopters who intend to stay ahead of the current and coming regulatory curve. Through 2010 and 2011, the news coming out of America points to a paradigm shift in the way the healthcare establishment views and uses healthcare informatics. Make no mistake, this movement is now irreversible and will continue to expand no matter which party wins the White House in the next election.

More recently, we have taken measures to make the company more attractive to major financial players who are increasingly looking at participating in the coming healthcare revolution. We were able to file with the SEC a bona fide prospectus for the issuance of investment grade bonds for as much as 50M, a singular initiative that demonstrates our continuing capability to play in the major leagues. We also moved resolutely to liquidate debt, improve the balance sheet and began to be once again a full reporting issuer on the OTC market.

One of the major initiatives in the coming year will be to continue seeking a breakthrough in large hospital organizations. What we face is an extraordinary reluctance on the part of large organizations, be it industrial corporations or hospitals, to adopt newer more nimble technologies for enterprise wide solutions. Most are still relying on obsolete mainframe and client server solutions, and have yet to embrace any of the newer technologies of the past few years be it cloud or mobile applications such as the ones we offer.

We have put in place an aggressive strategy for penetrating these larger organizations, centered on bringing mobile solutions to the ambulatory segment of hospital care. To that end, we will continue to multiply our strategic and tactical alliances. Since June 30th, we have become party to a joint venture comprising one of the world’s largest hospital networks and one of America’s leading telephone companies in order to explore mobile applications for ambulatory care. There is growing political traction for this type of marriage between large utilities networks and smart applications like ours that are rich in medical content.

In conclusion, this has been a banner year for us and we remain more solid than ever. We continue to be extremely competitive, still years ahead of most healthcare informatics companies when it comes to smart medical applications that actually improve quality of care and outcomes. It’s been a long haul, but as you can see, we have been fortunate in maintaining continuity of management and purpose, the integrity of our vision and we remain firmly committed to the cause. VisualMED is clearly here to stay.

I thank all of you for all the great support, ideas and suggestions that you have provided over the course of the past year.

Sincerely,


____________
Gerard Dab
Chairman of the Board



Der Annual Report ist also gar nicht mal so schlecht.

Das 1 Q für visual endete am 30.Sep. Bin mal gespannt, wann diese Zahlen veröffentlicht werden, und ob der leicht positive Geschäftsverlauf fortgeführt werden konnte.


Wäre echt der Hammer, wenn ich mit dieser Aktie noch Geld verdienen sollte

[binda]

Datum : 08/11/2011 @ 14h23
Quelle : MarketWire
Name : VisualMED Clinical Solutions Corp. (VMCS)
Kurs : 0.012 0.0034 (39.53%) @ 16h50
Kurs Chart Reports Trades Level2


VisualMED Launches New Patient Access Apps for Mobile Networks
Visualmed Clinical Sltns (PC) (USOTC:VMCS)
Intraday Stock Chart
Heute : Tuesday 8 November 2011

VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6) announces today the launching of a new generation of Patient Access smart applications that will bring major improvements to the way patients communicate with their providers. These new products have evolved from the highly effective remote access capability previously deployed with our clinical information systems in hospitals and clinics. A set of enabling technologies make it easy for patients and physicians to communicate and make home care safer and more affordable.

The applications are designed to be used on mobile handsets and will make it possible for patients and their families to get connected to their hospital records as well as allow the care team to follow patients after discharge. Confidentiality of clinical information is protected by the highest encryption standards.

"While provider facilities are still slow in adopting full CIS solutions, much progress is being made in connectivity through mobile networks," says Gerard Dab, Chairman & CEO. "We are paying more attention to this simpler and more lucrative segment of the market. Installation costs are minimal and revenue stream is recurring," says Gerard Dab.

The company expects to generate as much as five million in additional revenues over the next two years in leveraging its unique medical content solutions into this fast-growing multi billion market segment. "We continue to lead in bringing innovative and cost-cutting clinical solutions into the mobile revolution," concludes Mr. Dab.

ABOUT VISUALMED

VisualMED markets smart Clinical Information Systems (CIS) with EHR and Computerized Physician Order Entry that are at the core of the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010. We offer medical facilities and physicians a broad array of clinical applications with rich embedded clinical data, both scalable and interoperable, and whose high level of usability has been tested by over one thousand clinicians over many years in tertiary care and ambulatory environments. Our solutions help medical facilities increase provider efficiency, bring down operating costs, demonstrate meaningful use for ARRA grants and subsidies, and reduce mortality and morbidity. The Company's Suites of Medical Solutions operate on state of the art proprietary Software platforms with advanced analytical capabilities provided by Visual Healthcare Corp. (PINKSHEETS: VSHC).

Detailed information on our company and its products is available on our

[binda]

Datum : 10/11/2011 @ 14h20
Quelle : MarketWire
Name : VisualMED Clinical Solutions Corp. (VMCS)
Kurs : 0.013 0.004 (44.44%) @ 16h47
Kurs Chart Reports Trades Level2


VisualMED First Quarter Results Meet Guidance and Expectations

Visualmed Clinical Sltns (PC) (USOTC:VMCS)
Historical Stock Chart
1 Monat : October 2011 bis November 2011

VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6.F) announces quarterly results for the first quarter of fiscal 2012. A full disclosure statement and financial results will be available on the OTC Markets site as well as on the company website at www.visualmedsolutions.com.

Revenues were on the high side of previous guidance at $416,000 with net income of $91,264, as the Company continues to benefit from the current U.S. Administration's healthcare policies and a market place that is evolving towards the kind of products we offer. It is clear that mounting fiscal pressure will continue to push forward the modernization of clinical facilities and we expect our business to continue growing accordingly.

"We are very heartened by the progression of business, and the next quarter is going to prove quite important for us. Also we have entered into an agreement with a Swiss financial institution to secure a 15 million dollar fund strictly dedicated to provide direct vendor financing to our clients," notes VisualMED Chairman and CEO Gerard Dab. "This means we can finance client leasing and or acquisition with a faster turnaround than is currently the norm with lenders."

Being able to provide direct financing solutions to healthcare facilities should help the company secure otherwise hard to get accounts who in these uncertain times are hesitant to tap into their own credit facilities with traditional lenders.

"We had a strong quarter and are in line to achieve the same king of growth that made last year a banner year. We continue to diversify, especially bringing to market simpler and cheaper product lines," concludes Mr. Dab.

ABOUT VISUALMED

VisualMED markets smart Clinical Information Systems (CIS) with EHR and Computerized Physician Order Entry that are at the core of the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010. We offer medical facilities and physicians a broad array of clinical applications with rich embedded clinical data, both scalable and interoperable, and whose high level of usability has been tested by over one thousand clinicians over many years in tertiary care and ambulatory environments. Our solutions help medical facilities increase provider efficiency, bring down operating costs, demonstrate meaningful use for ARRA grants and subsidies, and reduce mortality and morbidity. The Company's Suites of Medical Solutions operate on state of the art proprietary Software platforms with advanced analytical capabilities provided by Visual Healthcare Corp. (PINKSHEETS: VSHC).

Detailed information on our company and its products is available on our web site at www.visualmedsolutions.com

FORWARD-LOOKING STATEMENTS Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.

For further information, please contact:



Gerard Dab

514-582-5220

[binda]

VisualMED Will Provide Clinical Workflow Engine for Phase II Clinical Trials

Visualmed Clinical Sltns (PC) (USOTC:VMCS)
Intraday Stock Chart
Heute : Thursday 8 December 2011

VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6) announces it will be providing structured medical content to a provider of Software integration services serving major drug developers. The latter seek new forms of standardization designed to both reduce cost and save precious time to market. The use of standardized clinical workflow engine and analysis should have a positive impact in moving forward phase II clinical trials.

The deal is worth $2 M over 2 years for the company and involves mostly formatting and delivery of existing applications and rich medical content. It provides the Company with unprecedented opportunities to sell limited clinical information, a more flexible business model with shorter sale cycle.

"Drug companies are slowly coming around to using solutions that keep pace with the complexities involved in collating information, as we understand more about illnesses and the variable effects of treatment," says Chairman Gerard Dab. "VisualMED has been offering drug companies advanced tools such as one of the industry's best inference engines, medical content and clinical workflow management systems."

The Company intends to offer reduced fixed-term 3rd party licensing at extremely competitive rates for these types of offerings and will determine the appropriate value of this particular solution as it becomes clear how much time and money the pharmaceutical industry can save, in an environment where every day counts against future revenues due to patent limitation.

ABOUT VISUALMED

VisualMED markets smart Clinical Information Systems (CIS) with EHR and Computerized Physician Order Entry that are at the core of the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010. We offer medical facilities and physicians a broad array of clinical applications with rich embedded clinical data, both scalable and interoperable, and whose high level of usability has been tested by over one thousand clinicians over many years in tertiary care and ambulatory environments. Our solutions help medical facilities increase provider efficiency, bring down operating costs, demonstrate meaningful use for ARRA grants and subsidies, and reduce mortality and morbidity. The Company's Suites of Medical Solutions operate on state of the art proprietary software platforms with advanced analytical capabilities provided by Visual Healthcare Corp. (PINKSHEETS: VSHC).

Detailed information on our company and its products is available on our web site at www.visualmedsolutions.com

FORWARD-LOOKING STATEMENTS

Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.

For further information, please contact:



Gerard Dab

514-582-5220

[binda]

VisualMED to Benefit From New Incentives for Hospitals From Federal Government
Datum : 14/12/2011 @ 14h30
Quelle : MarketWire
Name : VisualMED Clinical Solutions Corp. (VMCS)
Kurs : 0.01 0.002 (25.00%) @ 23h00
Kurs Chart Reports Trades Level2


VisualMED to Benefit From New Incentives for Hospitals From Federal Government

Visualmed Clinical Sltns (PC) (USOTC:VMCS)
Intraday Stock Chart
Heute : Thursday 15 December 2011

VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6.F) announces it is pleased by U.S. Federal Government announcement of significant new financial incentives designed to encourage faster adoption of EHR by facilities and physicians. The new subsidies are meant to speed up the adoption rate of health IT smart products like the ones offered by VisualMED.

"This is great news for our company. Our client base is now entitled to even greater payments from Uncle Sam," says Company Chairman & CEO Gerard Dab. "These new incentive payments, which will be compounded with current programs such as the American Recovery and Reinvestment Act (ARRA), are expected to have a significant impact on both our sales growth but also on our pricing power."

The constant increases in government payments will help the company to reach its previously published strategic target for 2012 of more than doubling its top line. These powerful incentives demonstrate the Federal Government's commitment to bring smart automation to all medical facilities in America. This includes "... dragging laggards kicking and screaming into the 21st century," as Dr. David Brailer, the previous administration's medical informatics Czar, has intoned.

The U.S. Department of Health and Human Services' (HHS) new policy is to step up new incentives to hospitals and physicians' offices to speed the adoption of healthcare IT and improve healthcare. It has also been determined that this policy will contribute significantly to job creation, making it ever more politically palatable at the legislative level.

Under the current requirements, eligible doctors and hospitals that begin participating in the Medicare EHR incentive program this year would have to meet new standards for the program in 2013. If they do not participate until 2012, they could wait to meet the new standards until 2014 and still be eligible for the same incentive payment.

To encourage faster adoption, HHS will allow doctors and hospitals to adopt healthcare IT this year, without meeting the new standards until 2014. Doctors who act quickly can also qualify for incentive payments in 2011 as well as 2012.

Federal subsidies are also helping train more IT technicians to build and maintain the digital systems, declared HHS Secretary Kathleen Sebelius. The Obama Administration has launched four workforce development programs to help train a new healthcare IT workforce.

Currently, more than 10,000 community college students are enrolled in healthcare IT programs, and since November 2011, universities have graduated more than 500 postgraduate and masters-level healthcare IT professionals, with more than 1,700 students expected to graduate by July 2013, Sebelius said.

ABOUT VISUALMED

VisualMED markets smart Clinical Information Systems (CIS) with EHR and Computerized Physician Order Entry that are at the core of the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010. We offer medical facilities and physicians a broad array of clinical applications with rich embedded clinical data, both scalable and interoperable, and whose high level of usability has been tested by over one thousand clinicians over many years in tertiary care and ambulatory environments. Our solutions help medical facilities increase provider efficiency, bring down operating costs, demonstrate meaningful use for ARRA grants and subsidies, and reduce mortality and morbidity. The Company's Suites of Medical Solutions operate on state of the art proprietary Software platforms with advanced analytical capabilities provided by Visual Healthcare Corp. (PINKSHEETS: VSHC).

Detailed information on our company and its products is available on our web site at www.visualmedsolutions.com

FORWARD-LOOKING STATEMENTS Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.

For further information, please contact:



Gerard Dab

514-582-5220

[Mubu]

Ich halte die Aktie für sehr aussichtreich, der Gewinn sollte sich 2012 verzehnfachen, da die Krankenhäuser kosten einsparen müssen und ihre Systeme erneuern + die Förderung durch die Regierung, da sollte doch Visualmed einen guten Teil von abbekommen, gut für den Aktienkurs

[Goetterdaemmerungen]

Kein Handel mehr in Deutschland möglich !!! Wer kann mir das erklären. Bitte schnell!!

[Scar]

Antwort auf Beitrag Nr.: 42.527.902 von Goetterdaemmerungen am 28.12.11 22:31:48

Was mache ich jetzt mit meinen Aktien? Kann man die noch verkaufen?
Wahrscheinlich kann ich sie abschreiben.

[binda]

Zitat von Scar: Was mache ich jetzt mit meinen Aktien? Kann man die noch verkaufen?
Wahrscheinlich kann ich sie abschreiben.

Ruf Deine Bank an und lass die Verwahrungsart ändern.
In ein paar Tagen hast Du visual mit der amerikanischen kennnummer in Deinem Depot und Du kannst sie an der usotc handeln ( bei der comdirekt nur telefonisch, da pennystock).Das Ändern der verwahrungsart kostet natürlich Gebühren. Ich habe ca 20 Euro bezahlt.

Gruß binda

[binda]

Zitat von Goetterdaemmerungen: Kein Handel mehr in Deutschland möglich !!! Wer kann mir das erklären. Bitte schnell!!

An jeder Börse zahlt der emittent, in diesem Fall visualmed, Gebühren für das listing.
Ist das Unternehmen z.B. an 4 Borsenplätzen gelistet, fallen 4x Gebühren versch. Art an. Um Geld einzusparen, verabschieden sich, gerade Unternehmen, die nicht so liquide sind, von den Plätzen, an denen ihre Aktien nur ein geringes Handelsvolumen haben.

Im Rahmen eines Listings fallen unterschiedliche Gebühren an. Die folgende Tabelle zeigt eine
Übersicht der Gebühren für die Segmente Prime Standard, General Standard und Entry Standard
und das First Quotation Board der Deutsche Börse.http://deutsche-boerse.com/dbag/dispatch/de/binary/gdb_conte…
z.B.:
Zulassungsgebühr 3.000 €
Wertpapierzulassung
2.500 €
Handelsaufnahme
3.000 €
Jährliche Gebühr 10.000

Ich finde es gut, das visual über all dort spart, wo es möglich ist. Sollte das Geschäft wirklich super anlaufen, könnte eine Rückkehr an deutsche börsen möglich sein.

We will see

Visual ist High risk invest

[binda]

VisualMED to Gain Access to US Hospital Networks

Heute : Tuesday 7 February 2012

VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6) announces that its suite of medical intelligent software for hospitals has been adapted so that autonomous modules and applications can be used by clinical staff through the entertainment hardware which is to be found by the bedside of a growing number of facilities.

A number of institutions have been deploying an in-house network of bedside hardware at great cost so they can turn a profit by selling internet access and entertainment to their patients. As a result VisualMED can now sell separate patient care modules that will run on these networks, saving the hospital millions in installation cost.

The ability to deploy separate modules solves three issues in hospital clinical systems implementation. Physician and nurses can pick and choose which applications they feel ready to use rather than get swamped by a large "go-live" event; and, as a vendor, we can get a much quicker purchase decision as we are now able to sell lower-ticket solutions. Finally we can cut distribution costs by offering these modules online as they no longer require expensive implementation.

The Company has therefore begun to develop an alternate business model, one that is more in line with standard software licensing pricing practice, charging only for applications the hospital requires and according to the number of users. The company, with benefit from better margins, now expects to generate much faster revenues which could reach as high as the ten million mark in the first year. It should be noted that in the intelligent medical software and advanced clinical automation market segment, VisualMED still has very few competitors.

Looking back on 2011, it was a poor year in terms of economic growth but the Company managed to continue making inroads into the U.S. healthcare market. We operated largely with a positive cash flow and continued to avoid the multimillion losses that had marked past years.

The cost of healthcare continues to rise much faster than inflation and will become increasingly unaffordable under the pressure of an aging population. Unless radical measures are adopted, services will have to be cut or providers will need to seriously adopt technology solutions like ours. In order to improve quality, lower cost and bring efficiency, there is no other avenue than using available technologies like those offered by advanced medical knowledge companies like VisualMED.

Datum : 07/02/2012 @ 14h00
Quelle : MarketWire
Name : VisualMED Clinical Solutions Corp. (VSHC)

[ricky2009]

Binda, did you get this from mr Dab


Dear Shareholders and Stakeholders

Looking back on 2011, it was a poor year in terms of economic growth but the Company managed to continue making inroads into the U.S. healthcare market. We operated largely with a positive cash flow and continued to avoid the multimillion losses that had marked past years. We had a good fall quarter and will be posting our financials in the next few days.
The cost of healthcare has continued to rise much faster than inflation and will become increasingly unaffordable under the pressure of an aging population. Unless radical measures are adopted, services will have to be cut or providers will need to seriously adopt technology solutions like the ones we have pioneered. In order to improve quality, lower cost and bring efficiency, there is no other avenue than using available technologies like those offered by advanced medical knowledge companies like VisualMED.

We still face confused government policies in the US and doctor resistance. Nevertheless we are still gaining traction with selected private clinics as well as with larger longer term projects. We are also involved in serious strategic initiatives with major Fortune 500 industry players that will break new ground in patient-provider coordination and in the Holy Grail of future care, the much discussed "continuity of care".

Along similar lines, Medical.MD has had its first positive development in more than a year. Its Medforyou PHR application was the selected product in a public tender from the state of Maine to become the exclusive state sanctioned PHR to some 800,000 citizens. The tender involved some 10 vendors vying for the contract. Four other states are expected to follow Maine's lead. If this expansion of the deal does materialize in a timely fashion then Medical.MD would see estimated revenues of 145M over the first five year period.

The company has been trying to find new methodologies in order to tackle the more traditional and difficult space of hospital sales. We have begun to develop an alternate business model, one that is more in line with standard software licensing pricing practice, charging only for applications the hospital requires and according to the number of users. The company, with benefit from better margins, now could expect to generate much faster revenues which could reach as much as the ten million mark in the first year. It should be noted that in the intelligent medical software and advanced clinical automation market segment, VisualMED has very few competitors. We will look to piggy back on existing hospital networks whenever it proves feasible.

Looking back, 2010 was an amazing breakthrough year for us. I think in 2011 we were in a holding pattern as all year long the economic and political news in our largest markets were sorely negative. I hope that we have seen the worse and that 2012 will show positive results like most presidential election years in the past.

I would to conclude by thanking you for your continued interest and support.
Kind Regards

Gerard Dab
Chairman & CEO

[binda]

Antwort auf Beitrag Nr.: 42.717.277 von ricky2009 am 08.02.12 10:01:41

Thanks ricky,

sounds very optimistic

Along similar lines, Medical.MD has had its first positive development in more than a year. Its Medforyou PHR application was the selected product in a public tender from the state of Maine to become the exclusive state sanctioned PHR to some 800,000 citizens. The tender involved some 10 vendors vying for the contract. Four other states are expected to follow Maine's lead. If this expansion of the deal does materialize in a timely fashion then Medical.MD would see estimated revenues of 145M over the first five year period.

[kuli2002]

Antwort auf Beitrag Nr.: 42.717.899 von binda am 08.02.12 11:09:47

Olala, besteht hier doch noch hoffnung?

[binda]

Antwort auf Beitrag Nr.: 42.718.151 von kuli2002 am 08.02.12 11:43:22

Hi kuli,
hier findest Du die Finanzberichte u. News von visual:
http://www.otcmarkets.com/stock/VMCS/financials

visual macht Umsätze und mitlerweile kleine Gewinne, jedoch sind die Altlasten (Schulden) noch verdammt hoch. Doch sie werden Stückchen für Stückchen abgebaut.
Lies es Dir mal durch.

Ob Dab's Aussichten sich bewahrheiten, keine Ahnung.

Visualmed = High risk

[Neuling77]

Na, da scheint sich ja doch noch etwas Leben in der Bude zu befinden... mein Einstandkurs liegt immer noch bei 17c.... also ne schöne Depotleiche... die Volumen sind im zweiten Halbjahr 2011 wieder extrem nach oben geschossen.... sollte sich hier doch noch etwas positives ergeben?

[oedinger1]

Antwort auf Beitrag Nr.: 42.718.350 von binda am 08.02.12 12:14:17

http://www.wallstreetweb.nl/community/viewtopic.php?t=575&po…

[binda]

Antwort auf Beitrag Nr.: 43.009.309 von oedinger1 am 05.04.12 20:25:35

http://www.wallstreetweb.nl/community/viewtopic.php?t=575&po…

[binda]

Der Brief des Mr. Dab liest sich sehr positiv.
Ich habe ihn mal komplett hier reingestellt, damit sich jeder seine eigenen Gedanken dazu machen kann.





Dear Hans,

Let me state here that our future is brighter than ever before because the mobile revolution allows us to sells or give away useful clinical apps directly to help physicians, nurses and other caregivers do their job more efficiently.




No more blocking from grossly incompetent IT departments that keep doctors in the dark, no more CEOs and CFOs blindly handing over tens of millions to the Siemens of this world for antiquated CIS technology. Even Microsoft and Google could not break through into healthcare, but with the advent of smart phones, mobile companies will.




Samsung’s newest Android galaxy handsets are like a revolutionary mini tablet with super connectivity that can allow a doctor to use VisualMED unique clinical notes or our electronic prescription for pennies. $30 million wasteful 4 years long implementations will no longer stand in our way. Instead we have platforms in a cloud like the billion dollar marvel recently deployed by Verizon to support and connect smart applications.




You question whether or not Obamacare can have a determining effect on our progress in the US market. The deed is done. Obamacare whether or not it survives future challenges has already done the job of pointing out how so much of US health is in need of improvement. We welcomed Obamacare 2 years ago but now we have moved beyond that.




You may remember that as a rule, I don't give out too much news for fear of informing the competition, but I will here ignore my usual restraint and respond to your inquiry with a recall of where we stand today.

Over the years we worked with some of America's most influential corporation like Oracle and Cardinal Health, gaining entry to a number of leading providers, being accepted by nurses and physicians, only to lose the deal at the 11th hour.

Why?

Simply because of the level of corruption through hospital organizations. I cannot count the number of times we lost a deal because Siemens stepped in to block us. I mention Siemens because it is public knowledge, after they were fined $1.5 billion for corruption by a German court. Other IT companies were equally successful in blocking us using similar tactics. Look also at the number of hospitals that have defrauded Medicare and Medicaid.




You need to know that clinicians always liked our clinical apps and that it was only a matter of time until they were made available. I am not betraying any secret at this time in telling you how we plan to work with Mobile. We have a contractual teaming agreement with Verizon, which is keen to tackle the healthcare tech market, and we will be working closely with them on huge opportunities presented by newer concepts of transition care to reduce costly re admissions (40% of hospital costs) and genuine continuity of care. Only mobile can address these issues, but neither Siemens nor Big Blue can.




As demographic pressures slowly bring US healthcare to the brink of bankruptcy, governors and mayors will join big business in moving their spending to mobile solutions in order to bring down cost and morbidity.

The projects we are currently working on in the world of mobile are projected to be worth some 2 billion in revenue over the next five years with VisualMED’s share set at about 25% with impressive margins. Simple, effective, portable, over pre existing networks that we don't have to build.




I thought it was important to demonstrate for you how our business model has moved past the confines of Obamacare.

I must conclude by thanking you for your keen interest and continuing support

Kindest regards

[oedinger1]

Dear Raul

Your analysis of our tactical alliance with a mobile company is understandable but please take note that it does not preclude us from continuing to reach independent physicians and clinics.




You are certainly right in stating that we could just go it alone in a multi channel world pushing our content rich medical apps through Google ads, Twitter and the like. Yes we have the core competency in content and clinical workflow management automation, the very functionalities that go much beyond narrow definitions of meaningful use to save lives, time and money. And to go to your last point, how will Verizon prove to be different than our previous corporate alliances with industry giants like Oracle and Cardinal Health?





There is a enormous difference. These were near monopolies who embraced us in order to be politically correct and we still to this day have great appreciation for the technical and financial support they provided us with. But they did not have it in them to fight the good fight and brought us few clients.





It is my belief that Verizon will prove to be a different story with a better outcome. This for three reasons. First, they are a recent winner against a wide field of fierce competition always looking to attract clients away from their subscriber base. It's still a company on the make. Their substantial billion dollar investment dwarfs any such commitment from our past allies and they will have to make it into a productive asset. They clearly believe they can find growth by tackling healthcare automation and succeed where others have failed. Third they help us bring in multiple partners....they are much more team player than the others.





As we join alliances that include Verizon, we will still move ahead and distribute our new apps independently to end users, especially physicians, nurses and pharmacists. While we move on to attack entrenched institutional zombies with our new powerful allies, we continue to move ahead grabbing low hanging fruits.




Raul, we give up nothing, we stay the course, keep expenses low and maintain the integrity of the corporation without compromise until such time as markets will recognize our intrinsic value.

I hope I have clarified for you our perspective in entering yet again into new alliances.





Remember that in DC we have just learned that American health continues to see decline and no gain in productivity. We are still at ground Zero.....We have also learned that VisualMED is perceived by corporate America as a strong brand. This is based on our 8 year history and the strength of our academic validations.

Thanks again for your concern and support

Kind Regards

[oedinger1]

PR ABOUT PARTNERSHIP MARYLAND CENTER VISUALMED ITNELAFORM AND VERIZON


http://investorshub.advfn.com/boards/read_msg.aspx?message_i…

[binda]

Antwort auf Beitrag Nr.: 43.030.095 von oedinger1 am 12.04.12 14:21:39

Danke

http://investorshub.advfn.com/boards/read_msg.aspx?message_i…

BOWIE, Md., April 11, 2012 /PRNewswire-iReach/ -- The Maryland Center at Bowie State University recently formed a partnership with three market leaders in healthcare information and communications to develop a national research center that will apply the latest technologies in managing health information to enhance national capabilities to respond to domestic threats including natural disasters, pandemics and manmade catastrophes.
The Maryland Center, an affiliated foundation of the University System of Maryland, has as its charter to eliminate disparities, including those in health, and simultaneously enhance research and development on behalf of Bowie State University. Its new public/private partnership with VisualMED Clinical Solutions Corp., Intelaform, Inc. and Verizon Communications Inc. will create the National Emergency Preparedness and Response (NEPR) Research Center. This initiative is designed to respond to recommendations from public and private leaders for research centers to develop surveillance and response capabilities that coalesce national efforts to prepare for emerging threats.
The NEPR Research Center, to be housed by the Maryland Center on the campus of Bowie State University, will assist federal, state and private sector leaders in developing protocols and methodology to enhance the ongoing efforts in preparing and responding to national emergencies. The center will offer deployable systems developed by the joint capabilities of the private partners.
"This is the right time and the right place for this kind of project," stated Mickey L. Burnim, president of BSU. "With the creation of the NEPR Research Center, we are taking a significant step towards our vision of creating innovative public/private economic development partnerships that are beneficial to BSU, the state of Maryland, and our great nation."
"The NEPR Research Center has the potential to revolutionize emergency preparedness efforts, by creating unprecedented and uniform access to medical technology and information. For the first time, local, state, and federal agencies will have real-time access to essential, life-saving data in a highly integrated and usable form to prepare for and respond to national emergencies", said J. Randall Hoggle, PD, Chairman of the Board of Intelaform, Inc.
"We are excited about the NEPR Research Center initiative and look forward to a long-term partnership that will produce pioneering milestones in the emergency preparedness community," said Terry Lawlah, executive director of the Maryland Center at Bowie State University. "The Maryland Center will optimize our partner's ability to provide sustainable, scalable and stable capabilities in a collaborative and synergistic relationship."
"We wholeheartedly believe this partnership will prove to be one of the premier relationships of the 21st century, one which will improve the efficiency and effectiveness of our customers while adding incredible value to all stakeholders," stated Gerard Dab, CEO of VisualMED Solutions Corp.
About The Maryland Center at Bowie State University
The Maryland Center at Bowie State University, Inc is a non-profit organization that is an affiliated foundation of the University System of Maryland located on the campus of Bowie State University. As an affiliated foundation, the Center engages in and supports activities to further enhance the educational, research or service mission of Bowie State University. Through this collaboration, The Maryland Center and Bowie State work in concert to increase the research capacity of the University. For more information, visit www.themarylandcenter.org.
About Intelaform
Intelaform, Inc. is a global leader in emergency preparedness and response planning and deployment, medical and biosurveillance and a premier source for healthcare product monitoring and surveillance. Intelaform is a Delaware C-Corporation founded in 2007 as a spin out business of Health Pathways, Inc. with intellectual property from a series of global government agencies and private sector emergency preparedness and response projects and healthcare asset management and monitoring programs. Intelaform global headquarters are in Rockville, Maryland, USA. For more information, visit www.intelaform.com.
About Verizon
Verizon Communications, Inc., headquartered in New York is a global leader in delivering broadband and other wireless communications services to consumer, business, government and wholesale customers. Verizon Wireless operates America's most reliable wireless network, with nearly 109 million total connections nationwide. Verizon also provides converged communications, information and entertainment services over America's most advanced fiber optic network, and delivers integrated business solutions to customers in more than 150 countries, including all of the Fortune 500. A Dow 30 company with $111 billion in 2011 revenues, Verizon employs a diverse workforce of nearly 194,000. For more information, visit www.verizon.com.
About VisualMED
VisualMED markets smart EHR with Clinical Information Systems (CIS) and Computerized Physician Order Entry that meet the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010. VisualMED offers a powerful technology platform both scalable and interoperable, developed at a cost of some $40 million and tested over many years in tertiary care and ambulatory environments. VisualMED solutions help medical facilities reduce mortality and morbidity due to medical errors, increase provider efficiency, and bring down operating costs. The key clinical components are a core solution in the new agenda to promote greater patient safety and reduce risks due to medication errors. For more information, visit www.visualmedsolutions.com.
Media Contact: Cassandra Robinson of Bowie State University, 301-860-3505, [e-mail]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Bowie State University
Back to top
RELATED LINKS
http://www.themarylandcenter.org

[Depotmanager04]

Bin bei Visualmed schon lange raus mit Verlusten. Tummele mich weiterhin im Gold und Silbersektor.

Für Wagemutige hier mal mit Verlaub: Diskussionsnr.: 1.173.710
Golden Dory Resources

[Depotmanager04]

Antwort auf Beitrag Nr.: 43.048.963 von Depotmanager04 am 17.04.12 13:33:22

...achso, das ist keine Kaufempfehlung...

[binda]

Zitat von Depotmanager04: Bin bei Visualmed schon lange raus mit Verlusten. Tummele mich weiterhin im Gold und Silbersektor.

Für Wagemutige hier mal mit Verlaub: Diskussionsnr.: 1.173.710
Golden Dory Resources

Hi,ich lasse sie drin. Wenn was kommt ist gut, wenn nicht, dann eben nicht.

Gruß binda

[ricky2009]

Antwort auf Beitrag Nr.: 43.049.529 von binda am 17.04.12 15:08:44

Goodmorning German Friends, here's another one. And next week some more!

Maryland Center at Bowie State University Partners with Industry to Develop Community Based Care Transition Program

BOWIE, Md., April 18, 2012 /PRNewswire-iReach/ -- The Maryland Center at Bowie State University has formed a partnership with Intelaform, Inc., and VisualMED Clinical Solutions Corporation, market leaders in healthcare information and communications, to develop a Community-Based Care Transition Program (CCTP) for the state of Maryland.

Care transitions occur when a patient moves from one health care setting to another. In the instance, that people living with serious illnesses move from the hospital to home or a nursing center, they may be at risk for readmission to the hospital if they develop a complication. The Centers for Medicare and Medicaid Services (CMS), has launched an initiative to reduce hospital readmissions by 20% by 2013. To begin with, the agency plans to spend $500 million -or half of the $1 billion earmarked in the Affordable Care Act for improving patient safety- to help hospitals and their community partners decrease readmissions over a five year period ending in 2016.The Maryland Center Transition Care Program (The Program) will focus specifically on the needs of elderly patients transitioning from a hospital setting back to the home environment.

According to a 2007 report of the Medicare Payment Advisory Commission, readmissions to the hospital are estimated to cost Medicare approximately $15 billion, nearly $12 billion of which is for causes considered preventable. In Maryland, hospital readmissions are estimated to cost $300 million annually. The Program is designed to assist the patient during the critical transition period and thereby significantly decrease the number of preventable hospitalizations.

The Maryland Center, an affiliated foundation of the University System of Maryland, has as its charter to eliminate disparities, including those in health, and simultaneously enhance research and development on behalf of Bowie State University. Its new public/private partnership with VisualMED Clinical Solutions Corp., and Intelaform, Inc. will have as a primary goal the development of a CCTP. The initial program will focus on Maryland, and could be expanded across the entire National Capital Region.

The MD Center CCTP is the first of its kind in Maryland. The program will focus on five key areas for aging patients, cardiovascular, diabetes, urological, pulmonary, and dermatological and seek significant reductions in each.

This program is unique among CCTP programs in that it will provide patient surveillance and "concierge" services to transitioning patients and will integrate the latest technologies in managing health information to enhance the capabilities of all involved parties – hospitals, physicians, nurses, and other healthcare providers – to respond to the needs of the transitioning patient.

Intelaform will provide patient surveillance and concierge services, treatment management and patient care management systems to monitor and individually manage each patient's needs. VisualMED Clinical Solutions will provide mobile medical applications and the patient treatment infrastructure with secure access and tracking capabilities to enable real-time collection, aggregation, and sharing of information.

"As designed, this landmark program can be quickly replicated across the United States, reducing Medicare costs by billions of dollars and adding to the quality of life of millions of elderly patients and their families," said J. Randall Hoggle, PD, Chairman of the Board of Intelaform, Inc.

"The Transition Center is an innovative program with the potential to permanently transform transitional care for millions of the most vulnerable citizens in our community. The Maryland Center is proud to be a part of this historic partnership," remarked Terry Lawlah, executive director of the Maryland Center at Bowie State University.

"Transitional care and reduction of readmissions can truly be implemented in a safe and effective manner when using mobile medical and nursing applications" stated Gerard Dab, CEO of VisualMED Solutions Corp.

About The Maryland Center at Bowie State University
The Maryland Center at Bowie State University, Inc is a non-profit organization that is an affiliated foundation of the University System of Maryland located on the campus of Bowie State University. As an affiliated foundation, the Center engages in and supports activities to further enhance the educational, research or service mission of Bowie State University. Through this collaboration, The Maryland Center and Bowie State work in concert to increase the research capacity of the University. For more information, visit www.themarylandcenter.org.

About Intelaform
Intelaform, Inc. is a global leader in emergency preparedness and response planning and deployment, medical and biosurveillance and a premier source for healthcare product monitoring and surveillance. Intelaform is a Delaware C-Corporation founded in 2007 as a spin out business of Health Pathways, Inc. with intellectual property from a series of global government agencies and private sector emergency preparedness and response projects and healthcare asset management and monitoring programs. Intelaform global headquarters are in Rockville, Maryland, USA. For more information, visit www.intelaform.com.

About VisualMED
VisualMED markets smart EHR with Clinical Information Systems (CIS) and Computerized Physician Order Entry that meet the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010. VisualMED offers a powerful technology platform both scalable and interoperable, developed at a cost of some $40 million and tested over many years in tertiary care and ambulatory environments. VisualMED solutions help medical facilities reduce mortality and morbidity due to medical errors, increase provider efficiency, and bring down operating costs. The key clinical components are a core solution in the new agenda to promote greater patient safety and reduce risks due to medication errors. For more information, visit www.visualmedsolutions.com.

Media Contact: Ina Ramos Maryland Center at Bowie State University, 301-860-4306, [e-mail]

[binda]

VisualMED joint venture receives strong endorsement from State
Posted on June 26, 2012 by newsvisualmed


RENO, NV, June 26, 2012.VisualMED Clinical Solutions Corp. (The “Company”) (PINKSHEETS: VMCS) (FRANKFURT: VA6.F) announces that its public/private Partnership with The Maryland Center at Bowie State University, Intelaform, and Verizon has been endorsed by The State of Maryland in a letter http://newsvisualmed.files.wordpress.com/2012/06/govenor-oma…from the Governor to the Executive Director of the Center. The Governor expressed strong support for our joint venture, especially for the National Emergency Preparedness and Response which was recently installed at Bowie State.

VisualMED is working closely with its partners to create a model for health data collection, analysis and transmission in real time to help in all manners of emergency response. This model will be the first of its kind in the world and is expected to be adopted by other states. It is a watershed initiative and has received major Congressional support which underscores the national scope of its impact. Considerable Federal funding in the tens of billions is available to state and local governments for ensuring better health and public safety response capabilities in cases of national emergencies for a range of potential disasters.

VisualMED and the joint venture also remain active in our project to reduce costly readmissions to hospitals which are estimated to cost Medicare approximately $15 billion annually, nearly $12 billion of which is for causes considered preventable. In Maryland alone, hospital readmissions are estimated to cost $300 million annually. The Program is designed to assist the patient during the critical transition period and thereby significantly decrease the number of preventable hospitalizations.

The Maryland Center, an affiliated foundation of the University System of Maryland, (www.themarylandcenter.org) has as its charter to eliminate disparities, including those in health, and simultaneously enhance research and development on behalf of Bowie State. VisualMED Clinical Solutions will provide mobile medical applications and the patient treatment infrastructure with secure access and tracking capabilities to enable real-time collection, aggregation, and sharing of information in order to help reduce inefficiencies and increase safety and security.

http://definiteimage.com/visualmednew/index.php?option=com_c…

[ricky2009]

Goodmorning over there. Just read these 2 letters, from governor O'Malley of Maryland and democrat Steny Hoyer, and you know Visualmed is back. Just a matter of time (weeks?) until the markets realize whats happening here and Visualmeds share-price will explode. Dont think they will make it back to $4,00 (all time high), but somewhere between $1,00 - $2,00.

http://newsvisualmed.files.wordpress.com/2012/06/govenor-oma…

http://newsvisualmed.files.wordpress.com/2012/06/congressman…

[hermitderkohle]

Antwort auf Beitrag Nr.: 43.331.116 von ricky2009 am 28.06.12 14:20:29

Ricky, don't be ridiculous.Visualmed is pretty much dead and will stay that way. We have paid for Dab's (your?) salary, and now that all this money is gone, he will have to look for a real job, or lean back and glee about how he fooled the greedy investors. RIP VM.

[binda]

September,25 2012
VisualMED Annual Disclosure Statement for Fiscal 2012

http://newsvisualmed.wordpress.com/2012/09/25/visualmed-annu…

[binda]

Item XVI Management’s Discussion and Analysis or Plan of Operation.
Overview
We refer to the twelve month period ended June 30 2012, as fiscal 2012, and the twelve month
period ended June 30, 2011 as fiscal 2011.
At June 30, 2012, the Company had a working capital of $572,745 as compared to a working
capital deficiency of $53,424 for fiscal 2011, and has incurred losses of $31,458,763 since
inception.
We had a net income of $286,869 for fiscal 2012 as compared to net income of $367,823 in
fiscal 2011, partly due to the Company’s refocusing on a more modular approach to marketing
our products. This revision has already begun to pay dividends. We incurred negligible
professional expenses, depreciation and filing fees.
Operating expenses for fiscal 2012 were $1,115,884 slightly, up from $1,090,483 for June 30
2011.
This yearly Management Discussion and Analysis for fiscal 2012 must begin with a overview of
the special context in which we have been operating this past year. This has been the genuine
watershed year in which we have completed a three year long repositioning of the company into
a Medical Content business offering knowledge based applications through a wide array of
different industrial clients and allies. These new relationships have imposed new trade secrets of
extreme value to our company and go a long way in explaining delays in communications.
Yet these developments are so dramatic for our future and represent such an increase in
shareholder value that owners of large block of shares have voluntarily reduced their holdings in
order to help support improves share valuation. Thus 70 million shares have been cancelled
reducing the amount of issued and outstanding to less than 225 million from a peak of 294
million.
Our new business avenues are aligned with the likes of mobile operators like Verizon, Orange
and Vodafone to take part and benefit from the mobile revolution, especially in such diverse
areas as transition care, ambulatory, home care and Emergency relief and first response. We
have also been approached to provide smart potable solution in the field of public health issues
for various states, most notably Maryland where we have a public/private partnership with
Bowie State University, Verizon and two other partners.
The main focus of these relationships is to use cutting edge technologies to deliver applications
mandated by Obamacare policies as well as help all manner of public institutions meet serious
challenges such as reducing hospital readmissions (50% of cost), improving services to the Page!43!of!48
elderly population by promoting real home care, children's health, fighting rising obesity among
the young, collecting epidemic data for federal agencies, and bringing for the first time ever
medical support and knowledge in real time to citizens, policemen, firemen and guardsmen who
handle first emergency response.
We provide the medical knowledge, workflow engines and intelligence in these new more
efficient ways to deliver health services. No longer will we be isolated in being 20 years ahead of
our time. We have now broken up our system into specific components that can serve in limited
but effective purposes. This is chiefly responsible for our many new partnerships, which have
brought us broad based opportunities moving forward.
Management believes now in using these relationships to build up the number of users of our
applications across the board. We plan to give away limited but useful apps to the tens of
thousands of physicians who are part of our partners' networks. This is a business model which
will be our main focus as we have created some simple applications from our deep technology
bench. It should be noted that in recent years companies like ours have been valued on the
number of physician users and have been acquired for hundreds of millions by the likes of Aetna
life.
In conclusion, VisualMED is now deeply involved in major National initiatives such as
completing the country’s first National Emergency Preparedness Response network. The NEPR
will be tapping a variety of state, federal and private budgets , in conjunction with the University
of Maryland Health Systems, the Government of Maryland, Verizon, Intelaform, and various
branches of the federal government to put into place a system on a national scale, driven by the
VisualMED database, that will allow states to upload statistical health data on the population to acentralized repository.
The NEPR beyond its core use in emergency first response has also significant applications for
military safety issues as well as for Homeland security. Initial installations at Maryland’s Bowie
State University has attracted interest from branches of the Armed Forces and some of the
nation’s leading industrial contractors. It has been the focus of a noted article in Signal
Magazine.
Management believes that our company has now been repositioned to build lasting shareholder
value from new ways of conducting business with allies that are more modern and aggressive in
outlook than before.
Most of the Federal budgets being sought by our State allies have already been voted by congress
and will not be affected by the coming election. Our State sponsored Public/Private partnership
with Verizon and Maryland agencies has been strongly endorsed by both Governor O'Malley and
senior congress leader Hoyer (see attached letters in the appended documents)

[Tristanus]

Mit Bezug auf den "Patient Protection and Affordable Care Act" vom 23. März 2010 (Obamacare), der Wiederwahl Obamas, der finanziellen Einsparnotwendigkeit, der Annäherung von Kongress und Senat und der staatlichen Unterstützung, müsste der Kurs von VisualMed (VMCS) doch eigentlich in nächster Zeit explodieren. Oder ?!

[ricky2009]

Goodmorning,

let me update you on some recent developments. I know you guys are quite cynical over there, and you should, but things are turning around at Visualmed:

VisualMED Sees Major Growth of Its Partnerships and Business Lines After U.S. Election

Visualmed Clinical Solutions Corp. (PN) (USOTC:VMCS)


VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6) announces that following President Obama's re-election and a Democrat controlled Senate blocking attempts to roll back healthcare reform, the Company expects to see major growth in the sales and deployments of its business lines. This is backed by a clear political mandate for the White House to continue major reform programs in the U.S. healthcare sector over the next 4 years. VisualMED believes that its prospects have been buoyed by this election, with Democratic initiatives in healthcare promising to speed up the deployment of our most advanced solutions and validate our current business model.

The Company expects an immediate expansion of its Transitional Care solutions across many healthcare jurisdictions involving its powerful public/private partnership with the Government of Maryland and the University of Maryland. Pilot projects are in place for Transitional Care which until now has been completely neglected, leaving a void in the care process which the Administration intends to remedy. The Company has been working on Transitional Care for years and is almost alone in the marketplace to offer validated instruments in this completely new segment of the healthcare delivery process, valued in the near term in the tens of billions in the U.S. alone.

The Administration's commitment to provide better care for its veterans will also give a major boost to our mobile medical solutions which we have been developing in the past year. The mobile tracking solutions we currently offer through our joint venture with the State of Maryland, Intelaform and Verizon could greatly enhance remote location support for Veterans and therefore offer better care more efficiently, saving expense without cutting short-term acute care. This is the latest in patient tracking, improving medical outcomes, whose potential value in terms of revenue to the Company and its partners cannot be overestimated in this trillion dollar industry where everything must now change.

Also on track is VisualMED's private/public partnership for a National Emergency Preparedness Response program designed to provide medical support in real time to first responders at the scene of a natural disaster. National Emergency Preparedness has become a major priority at all levels of government, because of the threat of bio-terrorism and natural catastrophes.

All of these initiatives bring immediate expansion of the VisualMED brand and the line of products it provides. Increased funding and subsidies of new healthcare processes and technologies by the Federal Government are designed to force the medical industry to become more cost efficient while at the same time increasing the quality of care for patients.

[ricky2009]

and this press release was published yesterday

VisualMED Releases Transitional Care Solution for Reducing Hospital Readmissions

Visualmed Clinical Solutions Corp. (PN) (USOTC:VMCS)

Today : Wednesday 14 November 2012

VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6) announces that its Transitional Care solution has now been completed and is available for immediate deployment for both independent institutions as well as regional health agencies.

Transitional Care is a post release methodology aimed at reducing hospital readmissions, a national scourge that costs Americans more than $45 billion a year in additional medical bills. For the Federal government readmissions has become a key issue as 19% of all hospital patients are readmitted in less than 30 days after being discharged. The government considers readmissions a prime symptom of an overly expensive and uncoordinated health system.

The numbers surrounding this problem are serious. Nearly 6 million patients are readmitted within 30 days of release each year, costing Americans some $47.5 billion in additional hospital bills. This national average has remained steady at around 19 percent for several years. The same factors apply to Medicare patients. In an effort to reduce associated cost, next year more than 2200 hospitals will be financially penalized by Medicare for unwanted readmissions.

Hospitals face stiff penalties and are trying to remedy the problem, but are failing. A senior physician, Dr. Kenneth Sands, senior vice president for quality at Beth Israel, was recently quoted saying that "A lot of places have put in a lot of work and not seen improvement. It is not completely understood what goes into an institution having a high readmission rate and what goes into improving it." Hospitals need guidance, appropriate methodologies and ready solutions that VisualMED is now offering.

The reduction of readmissions by 50%, would provide recurring annual savings of $25 billion or half a trillion dollars over 20 years. VisualMED has the knowledge and proven technology to effectively reduce readmissions.

The Company was a pioneer in finding solutions, having produced a full manual on readmissions in 2010. Over the next five years we are looking at bringing Transitional Care to health agencies covering some 100 institutions. We will have competitive pricing, charging a one-time fee per unit plus annual support. Readmissions are so costly that most institutions will likely recoup our cost in six months time, an attractive ROI.

We bring in the tools, hire and train all requisite new personnel. It is a fresh start with social workers and nurses, and it is a turnkey solution requiring no retooling of existing practice which is a classic source of bleeding. As a consequence, the company will be in a position to protect healthy operating margins -- this is one of the key factors behind our determination to prioritize transitional care over acute care automation.

VisualMED is now in a position to further the aims of the Obama administration's public policy while generating solid revenue and returning the company to its historic valuation.

[ricky2009]

this mail is from CEO Gerard Dab, november 9th

Dear Shareholder

Please find below a response to a letter from a fellow shareholder who is wondering why we do not pursue more acute care opportunities with Verizon.The quick answer is that we do not want to loose the focus on Public Health and the available billions in immediate Federal funding which will prove to be be a must faster money maker for us than complex acute care. I explain this in the letter.


The investment in Nantl Health is excellent news, it confirms the general orientation of Verizon towards
healthcare in spite of their early setbacks in the field after spending over a billion on their secure health cloud.

Their investment company , Verizon Investment LLC means to help create future user of their platforms.

Just like Google before them, Verizon will need a critical mass of hundreds of applications providers to build their medical solutions business.

That said, our alliance with Verizon is focused on getting contracts from existing Federal programs which are obvious low hanging fruits for partnerships like ours. These programs running into tens of billions are about public health issues much more than actual clinical work like cancer care.

Remember that our JV with the State of Maryland is focused on transition care, monitoring of chronic conditions for the CDC,

National security issues such as Bio terrorism, bringing medical support to First Responders and helping the VA
monitor beneficiaries at a distance. These are all public health initiatives based on simple data point analytic and interventions driven by Federal and State initiatives. We also look forward to distribute simple apps to clinicians free of charge to increase our user base as a mean to drive our company valuation model.

These are public health fields where we have no real competition and no regulatory roadblocks.

We work with the likes of DOD, homeland security, CDC and other agencies that have huge budgets and means and a greater willingness to do the right thing. As for cancer care we have no plans at this point in time to engage Verizon in anything remotely involving some of our rocket science technology. Transition care is our ticket, we are alone....where as treating tumour staging
on mobile is still years away.

Dont forget Nantl is getting an investment, why not, but not a client yet.

Thanks for you interest and support as always

Kind Regards

Gerard

PS have you seen New jersey and Staten Island? You can see why our first response initiative is so important.

[ricky2009]

and another mail from CEO Dab, november 12th

Dear Shareholders
I am getting much inquiries following the election of President Obama.
Expectations run high about the coming impact of public policy on the
growth of our company. I am sending you a copy of my response to a fellow shareholder wanting to know why the importance of Transitional care and the underlying economics.
See below
Best Regards


Gerard Dab

Dear Sir

You ask me about the economics of transitional care in America. It's about saving lives, saving time and money. It's about reducing hospital readmissions, a national scourge that cost Americans more than 45 billion a year in additional medical bills.

For the Federal governments it's a burning issue. Next year more than 2200 hospitals will be financially penalized by Medicare for readmissions within one month of a patient being discharged.

These hospitals face stiff penalties and are trying to remedy but are failing. " "A lot of places have put in a lot of work and not seen improvement," says Dr. Kenneth Sands, senior vice president for quality at Beth Israel. "It is not completely understood what goes into an institution having a high readmission rate and what goes into improving" it.

Well, we at VisualMED, we know, we have been looking at the problem and have come up with a complete protocol based on pioneering work at the University of Kentucky. That is why we were chosen to lead the joint venture in Maryland that is tackling the issue there. Governor O'Malley want his state to claim national leadership in solving this problem.

One in five Medicare patients returns to the hospital within a month of discharge. The government considers readmissions a prime symptom of an overly expensive and uncoordinated health system.

Nearly 6 million patients are readmitted within 30 days of release each year, costing Americans some $47.5 billion in additional hospital bills. This national average has remained steady at around 19 percent for several years.

In other words assuming we should reduce 50% of readmissions, recurring annual savings would amount to 24 billion or half a trillion over 20 years to talk in budgetary terminology.

VisualMED has the knowledge and the technology, we wrote a full manual on readmissions 3 years ago. Over the next five years we are looking at bringing TC to health agencies covering some 100 institutions. If we charge a one-time fee of 3M per unit plus 300K per annum, most will recoup the cost in six months, a staggering ROI. We bring in the tools, hire and train all requisite new personnel. Its a fresh start with social workers and nurses, Its turnkey. No retooling of existing practice, a classic source of bleeding. Our profit margins could exceed 40%.You can see why it is such a better business than acute care automation.

We can finally further the aims of public policy while making a healthy revenue and bring back the company to its historic valuation.

Hoping this clarifies some of your questions, thank you for your continuing interest and support

--
Gerard Dab

[ricky2009]

It seems to me that Visualmed is back. Joint Ventures with universities, States, verizon, national institutions and more.

All í'm doing here is to bring you up to date, thats all.

No advice to buy or sell. Make your own choices.

And to "hermitderkole" i'd say: no need to respond. Relax

[Tristanus]

Antwort auf Beitrag Nr.: 43.821.751 von ricky2009 am 14.11.12 10:20:11

Thank you for the informations!

[kuli2002]

Antwort auf Beitrag Nr.: 43.821.436 von Tristanus am 14.11.12 09:21:25

Schönes Szenario, meinetwegen, bin dabei!
Aber ich war leider schon zu oft bei sowas dabei, als dass ich da Hoffnung hab.

Ein halber Euro wär ja auch schon was!

Allen, die hier noch istzen vile Glück,

Kuli

[Tristanus]

Antwort auf Beitrag Nr.: 43.826.437 von kuli2002 am 15.11.12 08:21:30

Ein halber Euro müsste hier ja wohl allemal drin sein, zumal einiges dafür spricht. Bin auch drin!

[hermitderkohle]

You'r right Ricky, there is no need to respond, since anyone can see that we are just reading the same BS we were reading 4 years ago, when Obama came into office. Let's see what has happend since then: oh yeah - nothing!

[Tristanus]

Die Umsetzung dauert halt ihre Zeit, auch wenn so manch einer schon ganz ungeduldig ist oder vieleicht sogar schon die Hoffnung verloren hat.

Man darf dabei nämlich nicht vergessen, dass der "Patient Protection and Affordable Care Act" (PPACA) erst im Jahr 2010 verabschiedet wurde und seitdem juristisch und politisch sehr umschritten war.

Der PPACA gilt als zentraler Bestandteil der Politik des wiedergewählten US-Präsidenten Barack Obama (daher auch OBAMACARE genannt).

Erst im Jahr 2012 wurde der PPACA vom Supreme Court of the United States nahezu vollständig bestätigt.

Hinzu kommt, dass zum PPACA unzählige Einzelregelungen gehören, welche über mehrere Jahre in Kraft treten, um ausreichend lange Übergangsfristen zu schaffen.

[Tristanus]

http://anarchistsoccermom.blogspot.de/2012/12/thinking-unthi…

Das schreckliche Geschehnis in Newtown Texas und dieser Blog-Beitrag zeigen doch mal wieder, wie wichtig ein für jedermann zugängliches, gut funktionierendes und bezahlbares Gesundheitsystem für die USA ist.

[Tristanus]

http://www.handelsblatt.com/panorama/aus-aller-welt/amoklauf…

[whoever77]

Moin Männer,
ik bin hier ja nun auch schon seit ca 7 Jahren investiert... also auch einer, der auf den Hype seinerzeit "reingefallen" ist... in 2010 und 2011 hab ich nochmal ein paar Stückchen nachgekauft und steh jetzt mit einem EK von ca 17c bei einem Buchertverlust von >99%... jetzt stellt sich natürlich die Frage, ob mann nicht nochmal nachlegt... ich glaub ich platziere mal ne Order (sieht so aus, als ginge das nur über die NSADQ/OTC oder sehe ich da etwas nicht richtig?)

@ricky
the latest news + the related story sounds interesting and reasonable. However, I am wondering how this road is being financed? Would be pls share some info on funding etc... basically I am interested to know who is paying all the bills at the moment... as I can't really see an existing order backlog!

Thanks!

[binda]

Zitat von whoever77: Moin Männer,
ik bin hier ja nun auch schon seit ca 7 Jahren investiert... also auch einer, der auf den Hype seinerzeit "reingefallen" ist... in 2010 und 2011 hab ich nochmal ein paar Stückchen nachgekauft und steh jetzt mit einem EK von ca 17c bei einem Buchertverlust von >99%... jetzt stellt sich natürlich die Frage, ob mann nicht nochmal nachlegt... ich glaub ich platziere mal ne Order (sieht so aus, als ginge das nur über die NSADQ/OTC oder sehe ich da etwas nicht richtig?)

@ricky
the latest news + the related story sounds interesting and reasonable. However, I am wondering how this road is being financed? Would be pls share some info on funding etc... basically I am interested to know who is paying all the bills at the moment... as I can't really see an existing order backlog!

Thanks!

Nur noch drüben Handel. Sind in D nicht mehr gelistet.

[whoever77]

Antwort auf Beitrag Nr.: 44.053.976 von binda am 23.01.13 14:33:16

danke... daran sieht man, wie lange ich mir diese depotleiche nicht mehr angeschaut habe...;-)

[whoever77]

danke! daran sieht man, wie lange ich mir diese depotleiche nicht mehr angeschaut habe...;-)))

[whoever77]

Moin Männer,

noch ne kurze Frage: Hat irgendjemand eine Idee, wieviele Mitarbeiter Visualmed hat?
Wenn ich mir die Finanzen ansehe, dann können das nichtmehr als ne Handvoll sein...?!?!?!

[binda]

Zitat von whoever77: Moin Männer,

noch ne kurze Frage: Hat irgendjemand eine Idee, wieviele Mitarbeiter Visualmed hat?
Wenn ich mir die Finanzen ansehe, dann können das nichtmehr als ne Handvoll sein...?!?!?!

14 Employees
http://markets.ft.com/research/Markets/Tearsheets/Business-p…

[whoever77]

oh mann - 14 MA ...! riecht nicht gerade nach ner fundamentalen Sensation...

danke für die info!

[binda]

Zitat von whoever77: oh mann - 14 MA ...! riecht nicht gerade nach ner fundamentalen Sensation...

danke für die info!

Naja, die sollen ja keine Häuser bauen

Its suite of software modules comprises a clinical information system that includes the complete electronic medical record, with a core computerized physician order entry (CPOE) module.

Es geht um die Software und dafür braucht man nur wenige schlaue Köpfe und ein paar die es an den Mann bringen.

[Tristanus]

Zitat von binda:

Es geht um die Software und dafür braucht man nur wenige schlaue Köpfe und ein paar die es an den Mann bringen.


Und zumindest eine Person, die endlich mal ein paar aktuelle News in Netz stellt. Die bisherige Informationsarbeit lässt nämlich einiges zu wünschen übrig!

[whoever77]

naja, 14 mann ist auch für eine softwarebude klein, wenn sie in einer höheren Liga spielen wollen. und dazu kommt noch, dass VMED die eigentlich IT-Architektur (Platform) nicht selbst macht, sondern von Visual Healthcare (WKN A0DPPZ) bezieht.

ich bin nicht sicher, ob ich als Krankenhausleiter auf eine 14-mann Bude vertrauen würde...

lasst uns das aber mal hoffen...

[Tristanus]

Was nützt einem Unternehmen das beste Produkt, was nützen einem Unternehmen diverse Aufträge, was nützen einem Unternehmen diverse Kooperationen, was nützen einem Unternehmen diverse Unterstützer usw., wenn niemand etwas davon erfährt.
Wir reden hier von einer Aktiengesellschaft, die daran interessiert sein sollte, für ihre Produkte und für ihre Aktien einen Abnehmer zu finden.
Und das geht nun mal nicht, indem man potentielle Abnehmer einfach im Dunkeln stehen lässt.

[binda]

Zitat von whoever77: naja, 14 mann ist auch für eine softwarebude klein, wenn sie in einer höheren Liga spielen wollen. und dazu kommt noch, dass VMED die eigentlich IT-Architektur (Platform) nicht selbst macht, sondern von Visual Healthcare (WKN A0DPPZ) bezieht.

ich bin nicht sicher, ob ich als Krankenhausleiter auf eine 14-mann Bude vertrauen würde...

lasst uns das aber mal hoffen...

Visualmed ist sozusagen der Frontsänger dieser Band.


Hier findet man so einige Infos, jedoch nichts Neues für die alten Hasen:
http://newsvisualhealthcare.wordpress.com/2012/08/24/visual-…


Verdammt viele VisualMeds, kann man leicht den Überblick verlieren

The Corporation began operating in 1996 as Cherry Tree Capital Corp., a Corporation active in Science and Technology investments. It was first registered in the State of Florida on October 4, 1996 and subsequently reincorporated in the state of Nevada on January 29th, 1999. The company entered into a medical business partnership agreement l May 9, 2000 with VisualMED Clinical Systems Inc., a private medical technology Canadian business with a focus to expand its activities in the US hospital market. Subsequent to this agreement, in a further step it was agreed that all of the shares of VisualMED Clinical Systems Inc would be acquired from the shareholders of that company. As a result, in order to benefit from the accumulated good will we changed our name to VisualMED Clinical Systems Corp. The product lines had first been created at McGill University Royal Victoria Hospital, in the department of medicine, now a campus of the McGill University Health Center, one of the largest university teaching hospital complex in the world. The product line was also expanded at the Montreal Heart Institute, a world leader in cardiac surgery, and it has consistently received positive evaluations from prominent American industry groups such as The Leapfrog Group and was selected to make a bid for Johns-Hopkins hospitals in 2001 as Looking to further extend our distribution and diversify our market presence, we entered into another major distribution agreement for the distribution rights to a suite of clinical software modules for non acute medical facilities with a focus on the private sector. This agreement was signed with VisualMED Clinical Solutions Corp, a Nevada corporation (VMCS) on October 13, 2004 and, in consideration for the software distribution rights and suites of medical applications, we received an amount of equity capital in that company representing an 80% ownership stake of the common stock of VMCS.

Consolidated financial statements of Visual Healthcare Corp. include the accounts of the Company and its wholly-owned Canadian subsidiary, VisualMED Clinical Systems Inc



At the close of this transition year, we look to 2013 with renewed optimism thanks to our new involvement in the U.S. National Security market. In the course of 2012 the Company has had a major market breakthrough for some of its cutting proprietary technology platforms. Our affiliate VisualMED Clinical Solutions Corp. has diversified into new areas of Public Health namely National Emergency First Response in the United States as well as other aspects of National Security. VisualMED has become part of a public/private partnership with the State of Maryland, Bowie State University, Verizon and Intelaform that is currently developing the first....


Und so stellt sich Visualmed Clinical Solutions Corp vor: http://www.visualmedsolutions.com/VisualMED Annual Disclosure Statement 2012

We were incorporated in the State of Nevada on September 7,
1999 under the name Ancona Mining Corp. (Ancona) as a mining and exploration
company. After initial disappointing results from our mining exploration, we did very little
business and showed very limited activity, with no profitability. On September 23, 2004,
after receiving advice that our mining properties were not deemed to be economically
attractive, we chose to enter the emerging field of clinical information systems and
entered into an agreement, in principle, to purchase the distribution rights to a suite of
clinical software modules, as well as some minor office equipment and all of the issued
and outstanding common shares of VisualMED Marketing Inc., an inactive company with no revenue, from Visual Healthcare Corp. (formerly known as VisualMED Clinical
Systems Corp.), a Nevada corporation (VHCC). We refer to this asset purchase
transaction as the Acquisition. We consummated the Acquisition on October 13, 2004
and, in consideration for the assets purchased, we issued what then amounted to 80%
of our common stock to VHCC. As a result of the Acquisition, we have the right to
exploit, commercialize, install, support and upgrade the clinical software modules
purchased. Our rights to exploit, commercialize, install, support and upgrade the
modules are worldwide, except for that part of the U.S. market, as well as the Chinese
and the Japanese language markets, into which VHCC has entered into similar
agreements with other non-related companies.


As of June 30 2012, Visual Healthcare Corp. owns approximately 15% of our issued and
outstanding common stock

We do not consolidate the results of Visual Healthcare Corp. in the financial statements


As of June 30, 2012, the only person that owns in excess of 5% of the common stock of the
company is Visual Healthcare Corp, which controls 77,465,259 shares of the company. No
Directors or Officers have any shares in the company. Michel Maksud has options as listed
above to purchase 310,000 shares of common stock




Blickt da noch jemand durch

Gute Nacht, binda

[Tristanus]

Antwort auf Beitrag Nr.: 44.056.410 von binda am 23.01.13 22:56:44

Bedauerlicherweise ist selbst für "neue Hasen" nichts Neues dabei.
Nichts für ungut, aber sämtliche Informationen findet man schließlich schon seit längerer Zeit im Netz.
VMCS sollte endlich mal anfangen, ihre (potentiellen) Abnehmer auf dem Laufenden zu halten.
Schließlich leben wir im Informationszeitalter und nicht in der Steinzeit

[whoever77]

genau! die wesentliche Frage ist eigentlich: Wer bzw wodurch wird das "Projekt VisualMed" eigentlich finanziert... und wenn selbst finanziert durch unsere Gelder... wie lange reicht das noch?

[Tristanus]

http://newsvisualmed.wordpress.com/2013/02/06/visualmed-quar…

[Kostobeeky]

Et tut sisch wat!

[whoever77]

Antwort auf Beitrag Nr.: 44.123.162 von Kostobeeky am 09.02.13 20:43:19

mmmmh - ja???? ik seh nix! ausser, dass die Umsätze in der ersten Februarwoche ziemlich hoch waren (sofern man das "hoch" nennen kann)


Datum Eröffnung Hoch Tief Schluss Umsatz
13.02.2013 0,015 0,015 0,015 0,015 50.000
12.02.2013 0,015 0,015 0,013 0,015 35.800
08.02.2013 0,0111 0,015 0,0111 0,015 152.379
07.02.2013 0,011 0,012 0,011 0,012 277.700
06.02.2013 0,01 0,012 0,01 0,012 218.250
05.02.2013 0,01 0,0125 0,01 0,01 265.549
04.02.2013 0,013 0,013 0,012 0,012 152.000
31.01.2013 0,013 0,013 0,013 0,013 1.000
30.01.2013 0,013 0,014 0,013 0,014 91.700
29.01.2013 0,013 0,014 0,013 0,014 112.357
28.01.2013 0,014 0,014 0,013 0,013 19.360
24.01.2013 0,012 0,014 0,012 0,014 3.750
23.01.2013 0,013 0,013 0,013 0,013 500
22.01.2013 0,011 0,012 0,01 0,012 86.150
18.01.2013 0,014 0,015 0,014 0,015 23.300
17.01.2013 0,015 0,015 0,015 0,015 14.000
15.01.2013 0,015 0,015 0,015 0,015 32.547

[Tristanus]

Zitat:

mmmmh - ja???? ik seh nix! ausser, dass die Umsätze in der ersten Februarwoche ziemlich hoch waren (sofern man das "hoch" nennen kann)


Was kann man auch schon erwarten, wenn man nichts Neues vom Unternehmen hört?!

[whoever77]

Antwort auf Beitrag Nr.: 44.144.303 von Tristanus am 15.02.13 10:10:29

einig! war ja auch nur meine Reaktion auf den vorherigen Post... "es tut sich wat"...

[Tristanus]

Es scheint so, als wolle das Unternehmen seine Internetpräsenz verändern:

http://www.visualmedsolutions.com

[binda]

Zitat von Tristanus: Es scheint so, als wolle das Unternehmen seine Internetpräsenz verändern:

http://www.visualmedsolutions.com

This Page Is Under Construction - Coming Soon!

[binda]

Zitat von Tristanus: Es scheint so, als wolle das Unternehmen seine Internetpräsenz verändern:

http://www.visualmedsolutions.com

Ist wieder erreichbar.

Sehe keine Veränderungen

[Tristanus]

Zitat:

Ist wieder erreichbar.

Sehe keine Veränderungen



Habe leider auch keine Veränderungen feststellen können.
Wurde wahrscheinlich nur zu Wartungszwecken vorläufig vom Netz genommen.

VisualMED Clinical Solutions Corp.(VMCS) braucht sich bei der miserablen Informationspolitik nicht zu wundern, wenn ihr demnächst sämtliche Anleger den Rücken kehren.
Sollte sich daran in der nächsten Zeit nichts ändern, wird das nämlich mit sehr großer Wahrscheinlichkeit passieren.

[whoever77]

Antwort auf Beitrag Nr.: 44.224.589 von Tristanus am 07.03.13 11:34:56

naja, ich sehe das leicht verschoben: die Frage ist, wie bekommt man neue Aktionäre? Sprich, wie erhöt man das Interesse? Alle derzeitigen Aktionäre (die Trader mal ausgenommen, sofern es hier überhaupt noch welche gibt), haben soviel gelitten, dass die paar Prozente bis zum Totalverlust auch nix mehr ausmachen... oder bin ich da der Einzige...;-)

[whoever77]

kaufe ein "h"

[Tristanus]

Mit "sämtliche Anleger" meinte ich natürlich nicht nur die alten, sondern auch die neuen Anleger.

Es ist unstreitig, dass VisualMED Clinical Solutions Corp.(VMCS) als Aktiengesellschaft dringend neue Aktionäre benötigt.

Dabei darf man aber nicht vergessen, dass die alten Aktionäre auch die Aktionäre von morgen sein können.

Zumal es nicht nur auf die Quantität der Aktionäre, sondern auch auf die Quantität der verkauften Aktien ankommt.

Unstreitig ist ebenfalls, dass es dazu unbedingt erforderlich íst, das Interesse an VMCS zu erhöhen.

Und das geht halt nur über eine vernünftige Informationspolitik.

Denn was nützt einen die beste Firma bzw. das beste Produkt, wenn niemand davon weiß bzw. er/sie nichts aktuelles darüber in Erfahrung bringen kann.

Wie heißt es doch so schön: Aus den Augen, aus dem Sinn!

[Goetterdaemmerungen]

Antwort auf Beitrag Nr.: 44.195.931 von Tristanus am 28.02.13 09:18:19

Hiermit möchte ich meiner Meinung kund tuen das der traid ziemlich an qualität verloren hat! Es ist sogar ziemlich nevend was manchmal geschrieben wird!! Meine Meinung ist das es eine gute Leistung von Visualmed ist in der Krise noch zu bestehen, mehr aber auch nicht!!

Lassen wir uns überaschen!! Schönen Gruß !!

[Tristanus]

Zitat:

Hiermit möchte ich meiner Meinung kund tuen das der traid ziemlich an qualität verloren hat! Es ist sogar ziemlich nevend was manchmal geschrieben wird!! Meine Meinung ist das es eine gute Leistung von Visualmed ist in der Krise noch zu bestehen, mehr aber auch nicht!!

Lassen wir uns überaschen!! Schönen Gruß !!



JA NE IS KLAR!

Es mag ja durchaus sein, dass es eine gute Leistung von VisualMed Clinical Solutions Corp. (VMCS) ist, in der Krise noch zu bestehen.
Aber reicht das auch den alten und neuen Aktionären?
Denn schließlich kommt es bei einer Aktiengesellschaft genau auf diese an. Im Bereich der Informationspolitik wage ich das stark zu bezweifeln.

[whoever77]

Daumen hoch für Tri...

[Kostobeeky]

Wenn die jetzt noch en paar 100 % machen, kann ich mir ne Currywurst mit Pommes dafür kaufen.

Mit Mayo versteht sich!!!

[Rattogo]

!

Dieser Beitrag wurde von CloudMOD moderiert. Grund: SPAM

[binda]

Tristanus
schrieb am 07.02.13 08:27:42
http://newsvisualmed.files.wordpress.com/2012/09/visualmed-q…

einige Ausschnitte:

Posted on February 6, 2013
Quarterly Disclosure Statement
For the fiscal quarter ended – September 30, 2012




(i) Period end date; September 30th, 2012
(ii) Number of shares authorized; 325,000,000 common and 25,000,000 preferred stock
(iii) Number of shares outstanding; 264,763,445 outstanding common shares
(iv) Freely tradable shares (public float); 81,009,751
(v) Total number of beneficial shareholders; one: Visual Healthcare Corporation
(vi) Total number of shareholders of record. 83 holders of record of our common stock, including the Deposit Trust Corporation


Net income (loss) for year 106,099 Vorjahr 90,902
Cash at End of Period 36,000 Vorjahr 21,697

At September 30, 2012 the Company had a working capital surplus of $480,713 and has incurred losses of $31,352,664 since inception. The Company has emerged from the development stage and is dependent upon the successful efforts of the commercial companies to which it has granted operational licenses. Although there is no guarantee that these companies will be able to successfully market our systems, there is nonetheless a reasonable expectation of revenues from their operations. It should be noted that the Company has completed its core development work, and has sufficiently reduced its operating expenses, and no longer relies on equity financing to continue its operations.


Overview
During Q1 the Company has moved definitively toward the aggressive development of mobile applications for our technologies; and has focused on initiatives in the Washington/Maryland capital region to develop Transitional Care solutions, and to work with our partners there to secure contracts for the national deployment of a national emergency response network database.


Bin mal gespannt, ob die noch was Zuwege bringen.

Gruß binda

[binda]

und nun der aktuelle 2Q-Bericht vom 31.März 2013:
For the fiscal quarter ended – December 31, 2012
http://www.visualmedsolutions.com/VisualMEDQ22013Final.pdf

(i) Period end date; December 31, 2012
(ii) Number of shares authorized; 325,000,000 common and 25,000,000 preferred stock
(iii) Number of shares outstanding; 264,763,445 outstanding common shares
(iv) Freely tradable shares (public float); 81,009,751
(v) Total number of beneficial shareholders; one: Visual Healthcare Corporation
(vi) Total number of shareholders of record. 83 holders of record of our common stock,
including the Deposit Trust Corporation.

At December 31, 2012, the Company had a working capital of $409,213 as compared to a
working capital of $376,468 for Q2 2012, and has incurred losses of $31,278,906 since
inception.
We had revenues of $475,000 for Q2 2013 as compared to $600,000 for Q2 2012 and with a
net income of $73,758 as compared to $207,521 in Q2 2012.
Operating expenses for Q2 2013 were $401,242, in part due to a major push to develop mobile
applications for our American partnerships

[Tristanus]

Zitat:

Bin mal gespannt, ob die noch was Zuwege bringen.

Gruß binda




Immerhin ist schon mal etwas Bewegung drin.

Die Reduzierung der Kosten für Umsatz, Vertrieb & Verwaltung sowie Andere, in Verbindung mit der Erhöhung der Kosten für Entwicklung & Forschung (nach eigenen Angaben hauptsächlich zur Entwicklung mobiler Anwendungen für die amerikanischen Partnerschaften), sind zumindest einmal ein guter Ansatz bzw. ein Schritt in die richtige Richtung.

Bleibt abzuwarten, wie sich bzw. was sich nun aus dieser Vorgehensweise entwickelt.

[binda]

In response to your questions I cannot comment on the information you quote but I will admit we are very advanced in our retail business. Unfortunately we will not provide details until our clients do so themselves.

They get to choose when to announce the product we sell them in terms of their own marketing priorities. They face tough competition and want to gain an edge in their own way.

Please note that in the past motivated investors have been able to determined some of our deals from simple internet research but it was not with our help so we did respect our confidentiality agreements.

What I can tell you is that two of our simpler mobile apps will be now distributed through a distribution company that serves more than 2000 drug stores across the US. These pharmacies reach some 20 million clients.

Our main app provides a secure access by mobile phone to the clients drug file at the pharmacy. It helps the client monitor his drugs, show them to other clinicians and help manage compliance. The other app provides a simple adequacy test on drugs verses diagnostics as a mean to provide clinical guidance for patients. Drug errors have emerged as a major cause of mortality and morbidity in America.

For the pharmacy this is part of a new wave of wellness product that should help cement the relationship with the client and build a sense of loyalty.
It is expected that these apps will have a particular appeal for mothers and the elderly.
VisualMED will collect 60 cent clear per prescription. The drug store is expected to charge $2.00 and pay $1.20 to the distribution company. The distributor estimates we will reach 10 million prescription by the end of year one.

It has taken us more than two years to find the right product and service that we can sell to drug stores. We are very encouraged by these developments.
I hope this answers your questions.
Thank you for your interest
Best Regards
Gerard Dab

http://investorshub.advfn.com/boards/read_msg.aspx?message_i…

[binda]

Dear Shareholders
My letter of earlier today about recent retail distribution of SafeDrug App and DrugAccess, two of our mobile medical applications, have brought us interesting mail including a heartfelt appreciation from the medical director of a 250 beds in patient unit, a world leader in patient safety:

....I imagine that your are now more focused on pharmacies.
I believe that the possibilities for useful tools in the field of E health are infinite"

Another interesting reaction comes from a physician involved in World health writing the following:

"...I would like to encourage you to look at new emerging economies where there is much demand for health services which are lagging behind. Pharmacies should be a great partner, they are run like a business.
Pharmacy driven applications like yours can have more of an impact on medical quality than government infrastructure which has failed to keep up with economic growth.

Thanks to all of them and all of you for your interest and support
Cheers

Gerard Dab

Gerard Dab
Chairman and CEO
VisualMED Clinical Solutions Corp

[Tristanus]

Na, das sind doch mal erfreuliche Nachrichten

Da scheint sich die Erhöhung der Kosten für Entwicklung & Forschung - hauptsächlich zur Entwicklung mobiler Anwendungen für die amerikanischen Partnerschaften - tatsächlich positiv auszuwirken.

[Tristanus]

Zitat:

In response to your questions I cannot comment on the information you quote but I will admit we are very advanced in our retail business. Unfortunately we will not provide details until our clients do so themselves.

They get to choose when to announce the product we sell them in terms of their own marketing priorities. They face tough competition and want to gain an edge in their own way.

Please note that in the past motivated investors have been able to determined some of our deals from simple internet research but it was not with our help so we did respect our confidentiality agreements.

What I can tell you is that two of our simpler mobile apps will be now distributed through a distribution company that serves more than 2000 drug stores across the US. These pharmacies reach some 20 million clients.

Our main app provides a secure access by mobile phone to the clients drug file at the pharmacy. It helps the client monitor his drugs, show them to other clinicians and help manage compliance. The other app provides a simple adequacy test on drugs verses diagnostics as a mean to provide clinical guidance for patients. Drug errors have emerged as a major cause of mortality and morbidity in America.

For the pharmacy this is part of a new wave of wellness product that should help cement the relationship with the client and build a sense of loyalty.
It is expected that these apps will have a particular appeal for mothers and the elderly.
VisualMED will collect 60 cent clear per prescription. The drug store is expected to charge $2.00 and pay $1.20 to the distribution company. The distributor estimates we will reach 10 million prescription by the end of year one.

It has taken us more than two years to find the right product and service that we can sell to drug stores. We are very encouraged by these developments.
I hope this answers your questions.
Thank you for your interest
Best Regards
Gerard Dab





Wie schon zuvor erwähnt:

Was nützten einem Unternehmen die besten Produkte, was nützen einem Unternehmen diverse Aufträge, was nützen einem Unternehmen diverse Kooperationen, was nützen einem Unternehmen diverse Unterstützer usw., wenn niemand etwas davon erfährt.

Solange keine offiziellen Informationen preisgegeben werden (können), wird sich daher an dem momentanen Zustand (durchaus geringe Kurssteigerungen, jedoch ohne viel Volumen) auch nicht großartig etwas ändern.

[Tristanus]

Absolut unbegreiflich diese Tatlosigkeit!

[Tristanus]

Nur weiter so mit der Tatlosigkeit, dann ist die Aktie bald gar nichts mehr wert.

[binda]

am 30.juni endet das geschäftsjahr.
bin gespannt, ob es "schon" zu umsatzsteigerung und gewinn kam.

denn: "VisualMED will collect 60 cent clear per prescription. The drug store is expected to charge $2.00 and pay $1.20 to the distribution company. The distributor estimates we will reach 10 million prescription by the end of year one.


REVENUE 2012 :1,446,000
2011 :1,543,510

netto income: 286,869
: 367,823

http://newsvisualmed.files.wordpress.com/2012/09/visualmed-c…

[Tristanus]

Antwort auf Beitrag Nr.: 44.821.535 von binda am 10.06.13 19:14:27

Bleibt abzuwarten!

In der Zwischenzeit sollte VisualMED Clinical Solutions Corp. (VMCS) endlich einmal ein paar offizielle Informationen preisgeben.

[Goetterdaemmerungen]

Gaaaaaaaaaaanz bestimmt!

[Tristanus]

Und noch immer hat VisualMED Clinical Solutions Corp. (VMCS) keine offiziellen Informationen bzw. Neuigkeiten preisgegeben.

Dürfte mit großer Wahrscheinlichkeit daran liegen, dass es wohl auch gar keinen aktuellen Anlass dafür gibt.
Wahrscheinlich wieder alles nur ...

'Eines merke dir mein Freund, will dir jemand was erzählen, so höre nicht auf sein Geschwätz, sondern sieh auf seine Taten'.

[Tristanus]

Immer nur weiter so VisualMed Clinical Solutions Corp. (VMCS), dann ist die Aktie bald völlig im Keller.

[chriwass]

Hallo Mitstreiter von Visualmed,

wer glaubt noch an eine Verbesserung der Lage von VisualMed??

Ich persönlich bin seit mehreren Jahren dabei, und glaube nur noch an ein trauriges Ende.
Wenn doch noch mal eine positive Meldung kommen würde, wäre ich schon sehr überrascht!!

Meine ganz persönliche Meinung.

[binda]

Ist diese Seite neu? Ich kannte sie noch nicht. Da gehts doch um " unsere " visualmed, oder?

http://www.visual-med.com/

[binda]

Antwort auf Beitrag Nr.: 44.893.723 von binda am 21.06.13 10:42:26

Da steht:

Visual MED software application development has always been focused on supporting the objectives of the end user in the healthcare industry. Our software is designed to help practices expand and enhance services, control costs, and protect revenue opportunities, with an intuitive interface that does not require the user to become a graphic artists or IT professional.

Jedoch eine ganz andere Adresse

Visual-MED
11110 Westlake Drive,
Charlotte NC, 28273

[Tristanus]

Spätestens anhand der nächsten Geschäftszahlen werden wir ja sehen, ob es nur ...... war, oder doch eine reelle positive Entwicklung.

Bis dahin bleibt es abzuwarten!

[Tristanus]

Die Homepage von VisualMed Inc. existiert schon seit längerer Zeit im Netz.
Kann sich durchaus um eine Tochterfirma von VisualMed Clinical Solutions (VMCS) oder VisualHealthcare (VSHC) handeln.
Das hilft der Aktie von VisualMed Clinical Solutions (VMCS) jedoch auch nicht weiter!

[Tristanus]

Und, wie sieht es aus mit den Quartalszahlen? Positive Entwicklung oder doch nur ?

[Tristanus]

Wo bleiben den nun die aktuellen Geschäftszahlen?

[Tristanus]

VisualMed Clinical Solution Corp. (VMCS) hat es scheinbar nicht so eilig mit der Veröffentlichung des aktuellen Quartalsbericht.

Ein Schelm, wer Böses dabei denkt?

[Tristanus]

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=90175398




War ja mittlerweile auch nicht anders zu erwarten...doch nur wieder .........

[binda]

"We have been unusually busy and while progress is slow in these uncertain times, we are moving forward at a steady pace."


Wir waren außerordentlich beschäftigt und obwohl der Fortschritt in diesen unsicheren Zeiten langsam ist, kommen wir in einem gleichmäßigen Tempo voran.

soso

[binda]

"This is a short note to announce that financial results will soon be posted and circulated before the end of July. Much of our longer than usual delay has resulted from a serious confidentiality undertaking on our part at the request of third parties."


Dies ist eine kurze Notiz, um zu verkünden, dass die finanziellen Ergebnisse in Kürze veröffentlicht und in Umlauf gebracht werden, bevor Ende Juli. Ein Großteil unserer mehr als üblichen Verzögerung beruht auf einer ernsten Verpflichtung zur Vertraulichkeit unsererseits auf Antrag Dritter .

Sehr spannend


üblichen Verzögerung Er gibt zu, dass das schon zur Gewohnheit geworden ist. Pünktlich waren die noch nie.

[binda]

before the end of July


mit heute noch 9 Tage. Den 31. zähle ich nicht mit da ja before gesagt wurde.

[Tristanus]

Meiner Ansicht nach nur wieder alles Blablabla bzw.

[binda]

Zitat von Tristanus: Meiner Ansicht nach nur wieder alles Blablabla bzw.

ich erwarte nichts.

[Tristanus]

Ich ab heute auch nicht mehr, da ich nämlich mittlerweile von VisualMed Clinical Solutions Corp. und Co. die Nase voll habe.

Melde mich daher ab!

[Tristanus]

Antwort auf Beitrag Nr.: 45.091.313 von binda am 22.07.13 15:55:27

Nicht nur unpünktlich, sondern scheinbar auch unzuverlässig.
Da wundert einen gar nichts mehr.

[Tristanus]

Antwort auf Beitrag Nr.: 45.158.827 von Tristanus am 01.08.13 10:08:26

Mit so einem permanenten Missmanagement kann man selbst das beste Produkt zugrunde richten.

[Tristanus]

Nerv...Nerv...Nerv...

Permanentes Missmanagement?

Das Management scheint wohl eher völlig überfordert und unfähig zu sein!

[ricky2009]

Item 4 Management’s discussion and analysis of financial condition and results of operation.

Overview
During Q2 the Company has continued its aggressive development of mobile applications for our technologies; and continues to focus on initiatives in the Washington/Maryland capital region to develop solutions that will reduce the impact of hospital readmissions, one of the major financial burdens on the healthcare system. Discussions for a deployment of transitional care technology in the Province of Quebec are under way, ideally to be deployed in synch with the American capital region. We continue to work with our partners to secure contracts for the national deployment of a national emergency response network database.

We refer to the three month period ended March 31 2013 as Q3 2013.

At December 31, 2012, the Company had a working capital of $361,026 as compared to a working capital of $409,213 for Q2 2013, and has incurred losses of $31,193,995 since inception.

We had revenues of $507,320 for Q3 2013 with a net income of $84,911.

[binda]

Quarterly Disclosure Statement
For the fiscal quarter ended – March 31, 2013

http://www.visualmedsolutions.com/VisualMED%20Q3%202013%20Fi…

[binda]

Dear Shareholders
Please find attached our latest disclosure statement which are late as we like many other companies are dealing with constant regulatory issues. The results show no surprise and are par for the course. We are experiencing delays in most of our business lines and are caught in the heated debates over healthcare issues and the push back against Obamacare. We have made most progress in first response preparedness and health surveillance with our intelaform partners in Maryland.
A first response intelligent alert system has been stood up and made operational at Johns-Hopkins campus in Baltimore finally opening the way for commercial sales to regular civil defense organizations and public health departments.
I regret that I was not able to maintain regular correspondence in the past few months, mainly due to personal family issues. I will resume answering emails as usual come September.
Best Regards



--
Gerard Dab
Chairman and CEO
VisualMED Clinical Solutions Corp
50 West Liberty Street, Suite 880
Reno, Nevada 89501
Tel. [phone]
[e-mail]

[Tristanus]

Leider wieder nur 'Aussichten' (Blablabla) und immer noch keine 'Resultate'!

Dementsprechend fallen daher natürlich auch wieder die aktuellen Geschäftszahlen aus!

[chriwass]

Ist es möglich, wenn B.Obama die Gesundheitsreform durchbekommt daß dann der
Kurs endlich mal anspringt?
Wäre doch mal möglich,was meint Ihr??

Gruß chriwass

[Tristanus]

Zitat von Tristanus: Die Umsetzung dauert halt ihre Zeit, auch wenn so manch einer schon ganz ungeduldig ist oder vieleicht sogar schon die Hoffnung verloren hat.
Man darf dabei nämlich nicht vergessen, dass der "Patient Protection and Affordable Care Act" (PPACA) erst im Jahr 2010 verabschiedet wurde und seitdem juristisch und politisch sehr umschritten war.

Der PPACA gilt als zentraler Bestandteil der Politik des wiedergewählten US-Präsidenten Barack Obama (daher auch OBAMACARE genannt).

Erst im Jahr 2012 wurde der PPACA vom Supreme Court of the United States nahezu vollständig bestätigt.

Hinzu kommt, dass zum PPACA unzählige Einzelregelungen gehören, welche über mehrere Jahre in Kraft treten, um ausreichend lange Übergangsfristen zu schaffen.

Damit dürfte deine Frage eigentlich beantwortet sein, oder?

[binda]

Wichtig wäre es, dass eine gesetzl. Krankenkasse gegründet wird. Bis jetzt gibt es nur private Versicherungen( die durch diese gut gemeinte " Zwangsversicherung" profitieren würden). Bei einer gesetzl. Krankenkasse denke ich, dass Visualmed davon profitieren könnte, wenn es sie bis dahin noch gibt.

Die Kernpunkte von Obamas Gesundheitsreform: http://www.rp-online.de/politik/ausland/die-kernpunkte-von-o…

10. Versicherungsmarkt:
Kleinunternehmen und Verbraucher sollen auf einen neuen Versicherungsmarkt ihre Versicherung auswählen können. Dort soll auch eine neue staatliche Krankenversicherung angeboten werden. Auch genossenschaftliche Krankenkassen sollen ihre Produkte dort verkaufen können.

Wie funktioniert Obamacare:
http://videos.arte.tv/de/videos/usa-wie-funktionniert-obamac…

[chriwass]

Ja danke für die Erklärung, sollte Visualmed davon profitieren ginge der Kurs mit hundertprozentiger Sicherheit ab wie Schmidts Katze.
Ich würde mir wünschen es käme öfters mal eine positive Nachricht, oder mal was verbindliches wie weit Sie mit den Aufträgen sind.


Die Hoffnung stirbt am Ende

Gruß chriwass

[Tristanus]

Zitat:

Es war ein langer Tag, doch es gab noch ein Happy End: Der Haushaltsstreit ist abgewendet. Noch in der Nacht zum Donnerstag Washingtoner Zeit hat US-Präsident Barack Obama den lange erwarteten Kompromiss zwischen Republikanern und Demokraten unterzeichnet…
...ihre wichtigste Forderung wurde erfüllt: Obamas Prestigeprojekt Gesundheitsreform bleibt bis auf wenige kleine Änderungen unangetastet…

Quelle: http://www.handelsblatt.com/politik/international/durchbruch…

[Tristanus]

Zitat Handelsblatt:

...

Die Seite Healthcare.gov, die am 1. Oktober an den Start ging, ist der zentrale Anlaufpunkt für die Bürger, die von der Reform profitieren wollen. Sie ist eine Art Marktplatz: Jeder, der nach dem neuen Gesetz eine Krankenversicherung abschließen will, kann sich zunächst dort anmelden und muss dann unzählige Daten über sich eintragen. Auf dieser Grundlage erscheinen dann maßgeschneiderte Angebote von Versicherungen, die der Kunde kaufen kann. Die Assekuranzen, das ist eine der entscheidenden Neuerungen, müssen alle Versicherten aufnehmen, auch mit Vorerkrankungen.

...



https://www.healthcare.gov/

[Tristanus]

http://www.handelsblatt.com/unternehmen/it-medien/technische…

[Goetterdaemmerungen]

Hallo ich wollte mich auch nochmal melden! Es ist natürlich eine riesen Ent-
täuschung was die Veranwortlichen von Visualmed Info- mässig rüber geben!

Aber das Umfeld gibt auch nichts her!!! Obamacare ja/nein keiner weiss wie es weiter geht! Wird doch bald alles gestoppt oder geht es endlich mit ausblick in eine Entwicklung mit zukunft weiter! ich habe daher ein wenig Verständniss! Aber auch nur eun wenig!!!!

[Tristanus]

Alles was Geld kostet dauert halt seine Zeit, auch im Gesundheitswesen.
Vor allem, wenn es das Geld von anderen ist.
Und genau hier könnte der Vorteil von VisualMed Clinical Solutions Corp. (VMCS) bzw. dessen Produkten sein.
Sie könnte(n) dabei helfen, eben genau dieses Geld zu sparen.

[chriwass]

Ich glaube hier tut sich nichts mehr in diesem Jahr, keine Info´s, keine guten oder schlechten Nachrichten, ab in den Müll mit dieser Aktie.
Oder weiss Irgendwer mehr???????

Ich wünsche der Gemeinde ein schönes Fest und einen guten Rutsch.

chriwass

[Tristanus]

So langsam kommt wieder Bewegung in die Geschichte:

http://www.tagesschau.de/inland/bahr-obamacare100.html

[chriwass]

Hallo Visualmed Gemeinde,
ob sich hier doch noch was tun könnte?
Oder ist das nur ein Strohfeuer Heute ma wieder mit 52%
Richtung Norden, und Morgen wieder 60% Richtung Süd. :O

[Tristanus]

Zur Zeit hat die USA andere Probleme als ihr nicht vorhandenes Geld in das Gesundheitswesen zu investieren.

Erst muss die USA zusehen, dass sie ihre Einnahmen erhöht wie z.B. durch ihre Expansionspläne im Bereich Öl und Gas.

Wie zuvor schon gesagt: Alles was Geld kostet dauert halt seine Zeit, auch im Gesundheitswesen - vor allem, wenn es das Geld anderer Leute ist.

Hauptsache ist, dass immer ein klein wenig Bewegung drin bleibt, denn Stillstand bedeutet Rückgang.

[binda]

Q2 Bericht

http://www.visualmedsolutions.com/VisualMED-Q2-2014.pdf

[Tristanus]

Nicht wirklich eine gute Nachricht.

Scheint wohl so, als würde es noch sehr lange dauern, bis das Unternehmen endlich positive Nachrichten vermelden kann - wenn es überhaupt noch dazu kommen wird.

War wohl doch ein Satz mit x bzw. das war wohl nix.

Aber vieleicht haben ja unsere Nachkommen noch etwas davon.
Vorausgesetzt natürlich, das Unternehmen gibt es bis dahin noch bzw. die Papiere sind bis dahin nicht schon vom Markt genommen worden.

[Tristanus]

VISUALMED CLINICAL SOLUTIONS


08.05.2014 - 15:34:36


+0,0052 $

+108,33 %


Volume: 20.000


Wie bitte, + 108,33 % mit nur einem Volumen von 20.000 Stück?


Sehr merkwürdig!

[Tristanus]

Da das Unternehmen VISUALMED CLINICAL SOLUTIONS in den USA scheinbar nicht genügend zahlungskräftige Abnehmer für seine Produkte hat, sollte das Unternehmen es mal in China versuchen.
Der Markt dafür wäre in Zukunft sicherlich gegeben und an finanziellen Mitteln scheint es in China offenbar auch nicht zu mangeln:

http://www.wiwo.de/politik/ausland/denkfabrik-china-muss-die…

[Tristanus]

http://www.handelsblatt.com/politik/international/sylvia-mat…


Als ehemalige Budgetchefin von Präsident Barack Obama im Weißen Haus dürfte sich die neue US-Gesundheitsministerin ja eigentlich mit Zahlen auskennen.

Vielleicht erkennt Sie ja das enorme Einsparpotential im Gesundheitswesen durch Firmen wie VisualMED Clinical Solution Corp. (VMCS) oder Visual Healthcare Corp. (VSHC).

[chriwass]

Antwort auf Beitrag Nr.: 47.113.718 von Tristanus am 06.06.14 07:56:07

Ja, dann hoffen wir mal dass sie Leben in die Bude bringen mag,

ich kannst schon bald nicht mehr glauben das wir hier noch mal über 0,01 US cent kommen.

[Tristanus]

Spätestens wenn das geplante Freihandelsabkommen TTIP verabschiedet worden ist - was nur eine Frage der Zeit sein dürfte - und damit in den USA die geplanten Millionen von neuen Arbeitsplätzen geschafft werden, kommen VisualMED Clinical Solutions (VMCS) und Visual Healthcare Corp. (VSHC) - aufgrund der mittlerweile eingeführten Krankenversicherungspflicht - endlich zum Zug.

[Tristanus]

Antwort auf Beitrag Nr.: 48.354.268 von Tristanus am 18.11.14 21:23:14

http://www.tagesschau.de/ausland/merkel-ttip-101.html

Sieht wohl so aus, als müssten wir uns noch eine ganze Weile gedulden.

[chriwass]

Upss wer hat den da in den USA wieder ein wenig eingekauft?
Es ist doch noch Leben in dieser Aktie!!!!!!!!????????